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ABSTRACT 
 
 The postprandial state is characterised by an increment in whole-body insulin 
sensitivity. This increased insulin-stimulated glucose disposal seen after a meal has been 
proposed to be regulated by a mechanism to which the integrity of the hepatic parasympathetic 
nerves (HPN) is crucial. The present thesis focus on the hypothesis that a dysfunction of the 
HPN-dependent component of insulin sensitivity is involved in the insulin resistance seen in 
various conditions related to the aetiology of type 2 diabetes. 
The physiological impacts of age and gender were here studied in Wistar rats. In males, 
age was correlated with a gradual decrease of total postprandial insulin sensitivity. However, 
while the HPN-independent component of insulin action decreased early, between 6 and 9 
weeks of age, and remained unchanged thereafter, the HPN-dependent component decreased 
from 9 weeks of age throughout ageing. Females showed similar developmental changes, 
although at different rates in some stages. 
The repercussion of lifestyle on postprandial insulin sensitivity was evaluated by 
providing Wistar and Sprague-Dawley rats with a high-sucrose supplement. The high-sucrose 
diet induced a decrease in insulin sensitivity by affecting solely the HPN-dependent component. 
Additionally, this development of postprandial insulin resistance was evident after only 2 weeks 
of diet manipulation; prior to inducing weight gain and hyperglycaemia. 
 Studies in healthy animals argued in favour of the integration of the HPN on the hepatic 
insulin sensitising substance (HISS) pathway. Blockade of the HPN through physical sectioning 
or pharmacological muscarinic antagonism, or inhibition of the synthesis of hepatic nitric oxide, 
another proposed step of the HISS pathway, were shown to similarly abrogate the postprandial 
increment of insulin sensitivity; while having no effect on fasting insulin sensitivity. 
 The analysis of a rat model of essential hypertension (SHR) has shown an impairment 
of the HISS-dependent component of insulin action, partially compensated by an increase of the 
HISS-independent component; in relation to normotensive Wistar rats. That another 
normotensive control strain for the SHR, the Wistar Kyoto, showed already a decreased in the 
HISS-dependent component hints to a possible genetic interference on the HISS pathway; 
particularly on parasympathetic function. Ageing studies further support these conclusions. 
 In summary, dysfunction of the HPN-determined branch of the HISS mechanism was 
shown here to be involved in the development of insulin resistance related with ageing, diet-
induced metabolic deregulation, and hypertension. This was also shown to predate other risk 
factors for the development of type 2 diabetes and related pathologies; and seems to constitute 
an attractive target for behavioural and pharmacological interventions, especially those able to 
ameliorate parasympathetic function. 
 xv 
RESUMO 
 
 O estado pós-prandial é caracterizado por um incremento da sensibilidade à insulina. 
Este aumento da captação celular da glucose por acção da insulina, observado após a ingestão 
de uma refeição, parece estar relacionado com um mecanismo dependente da integridade dos 
nervos parassimpáticos hepáticos (HPN). A presente dissertação teve como base a hipótese de 
que a disfunção desta componente dependente dos HPN está relacionada com a insulino-
resistência observada em várias condições envolvidas na etiologia da diabetes tipo 2. 
 O impacto da idade e do género foram aqui estudados em ratos Wistar. Em machos, 
observou-se que a idade está relacionada com um decréscimo gradual da sensibilidade total à 
insulina. No entanto, enquanto a componente independente dos HPN decresceu entre as 6 e 9 
semanas de idade, mantendo-se depois inalterada, a componente dependente dos HPN decresceu 
com o envelhecimento a partir das 9 semanas de idade. As fêmeas demonstraram alterações de 
desenvolvimento semelhantes aos machos, apesar de algumas diferenças na taxa de decréscimo. 
 A influência do estilo de vida sobre a sensibilidade pós-prandial à insulina foi avaliada 
fornecendo um suplemento de sacarose a ratos Wistar e Sprague-Dawley. A dieta rica em 
sacarose induziu um decréscimo na sensibilidade à insulina, afectando apenas a componente 
dependente dos HPN. Mais, o desenvolvimento de insulino-resistência pós-prandial foi obtido 
após 2 semanas de manipulação; antes do surgimento de obesidade e hiperglicémia. 
 Estudos em animais saudáveis apoiam a integração dos HPN na via da substância 
hepática sensibilizadora da insulina (HISS). O bloqueio dos HPN por intervenção cirúrgica ou 
antagonismo muscarínico químico, assim como a inibição da síntese de óxido nítrico hepático, 
outro passo proposto da via da HISS, provocaram a anulação total do incremento pós-prandial 
de sensibilidade à insulina; não tendo tido, no entanto, qualquer efeito no estado de jejum. 
 A análise de um modelo animal de hipertensão essencial (SHR) revelou um decréscimo 
da acção da insulina dependente da HISS, parcialmente compensada por um aumento da acção 
da insulina independente da HISS; em relação aos ratos normotensos Wistar. O facto de outro 
controlo normotenso dos SHR, o Wistar Kyoto, apresentar já uma diminuição da componente 
dependente da HISS sugere uma possível determinação genética da via da HISS, provavelmente 
actuando sobre a função parassimpática. Estudos com a idade fortalecem estas conclusões. 
 Em conclusão, a disfunção da componente dependente dos HPN na via da HISS foi aqui 
demonstrada estar envolvida no desenvolvimento da insulino-resistência relacionada com o 
envelhecimento, a desregulação induzida por factores nutricionais, e a hipertensão. Foi também 
observado que essa disfunção antecipa outros factores de risco para o desenvolvimento de 
diabetes tipo 2 e patologias relacionadas; o que parece constituir um alvo promissor para 
intervenções comportamentais e farmacológicas capazes de melhorar a função parassimpática. 
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1. INTRODUCTION 
 
1.1. Thesis rationale 
 
The basis of this doctoral thesis is related to the involvement of the hepatic 
parasympathetic nerves (HPN) on the augmented whole-body insulin sensitivity seen in 
the postprandial state; and the possible contribution of the disruption of HPN function to 
the genesis of insulin resistance and type 2 diabetes.  
Ingestion of a meal is the greatest challenge faced by glucose homeostasis. The 
surge of nutrients has to be disposed off quickly, as their high concentrations in the 
bloodstream may have pathophysiological effects; and properly, as misplaced reserves 
may induce problems on the affected tissues. Thus, loss of the ability to adequately 
dispose of ingested nutrients can be expected to lead to a deterioration of glucose 
metabolism control, and favour the development of the aforementioned pathologies.  
 
This dissertation regards studies designed to uncover the behaviour of metabolic 
pathways determined by HPN function status, both in physiology and pathophysiology. 
Likewise, the inquiry spread to address the impact of modern lifestyle, especially 
feeding habits, on the HPN control of glucose metabolism. This was done bearing in 
mind that the HPN may have a particular relevance during the postprandial state as a 
determinant in the action of a hormone, the hepatic insulin sensitising substance (HISS), 
which has been implicated in the peripheral allocation of the ingested glucose.   
The term “HISS” is not yet a scientific household name. With it, as befits the scope 
of a doctoral thesis, there are certainly many biological whys and hows to be addressed 
in this “fairy tale”, as Marie Curie would call it1. For that, a case will be presented based 
both on the performed experiments and on the evidence found in other works, as to the 
validity of this novel mechanism. Surely, when that is done, the scientific notions and 
data provided throughout this work will have earned due consideration. 
To begin with, the current dimension of diabetes will be alluded to, and the concepts 
of diabetes and prediabetes will be clarified. 
                                               
1
 “I am among those who think that science has great beauty. A scientist in his laboratory is not only a 
technician: he is also a child placed before natural phenomena which impress him like a fairy tale.” Marie 
Curie (1867-1934). 
1.Introduction 
 2 
 
1.2. Diabetes as a modern epidemic 
 
The Western World has seen in the last decades a sharp increase in the general 
incidence of diabetes mellitus (Zimmet et al., 2001). More, the Developing Countries 
have been witnessing ever more rapid rates of incidence and, similarly, an increasingly 
lower age of disease onset (Tong and Cockram, 2003). This has made diabetes into one 
of the most alarming worldwide health problems facing us presently, to the point of 
being recently recognised by the United Nations as a full epidemic (United Nations 
Resolution 61/225, 2007). 
As if this scenario was not bad enough, it is expected to deteriorate further in the 
near future. From the estimated 150 million people affected worldwide in 2000, the 
incidence of diabetes is foreseen to rise to a total of 366 million people by 2030 (King et 
al., 1998; Wild et al., 2004). Even worse if taken into account that these are 
conservative estimates (Wild et al., 2004); the higher incidence of obesity and diabetes 
in children, the rise in life expectancy enlarging the elderly strata of the population, 
compound sedentary and stressful lifestyles, and urbanisation of developing countries, 
can further exacerbate these extrapolations. 
 
Diabetes mellitus has a considerable premature morbidity and mortality, especially 
due to the accompanying panoply of complications and associated pathologies (Zimmet 
et al., 2001). It is now considered to be globally the fifth leading cause of death (Roglic 
et al., 2005). Additionally, it has a radical impact upon a growing portion of the world 
population, in terms of life quality, and to society in a whole, in terms of an increased 
expenditure of either private or public national systems of Health (Bruno et al., 2008; 
Dall et al., 2009).  
This is especially true for Portugal. With a number of documented cases of diabetes, 
between the ages of 20 and 80, reaching around 0.5 million in 2003, predictions were 
that the number of cases would rise by 2025 to 0.7 million (IDF, 2003; King et al., 
1998). Unfortunately, the recent disclosure of the preliminary report for the first 
Portuguese epidemiologic study solely dedicated to diabetes (PREVADIAB-2009) has 
surpassed the worst expectations (Pina e Brito, 2009). In it, it was found that more than 
10% of individuals between ages 20 and 80 are already diabetic, which represents an 
astounding 0.9 million people. To make matters worse, an additional 1.8 million 
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Portuguese (23%) were found to suffer from at least one kind of prediabetes2. 
Summarising, more than a third of the Portuguese population is either already diabetic, 
or possesses a significant impairment of glucose metabolism that increases the risk of 
developing diabetes in the near future. Considering that the rate of mortality from 
diabetes in Portugal was more than double the mean in the European Union, and was 
rising (WHO, 2003), this poses a dire prospect in terms of national Health. 
 
Beyond finding ways to treat this hailing and financially cumbersome disease, it 
becomes essential to understand the physiological mechanisms that are related to the 
development of insulin resistance, the step that seems to predate and link diabetes and 
its cluster of commonly associated pathologies (Gerich, 1999; Reaven, 1988).  
To act in an early phase of this process would consequently provide the best 
approach to a line of research capable of bearing answers into postponing the metabolic 
degradation that eventually leads to type 2 diabetes. To contribute to this approach was 
the main thought at the basis of this dissertation. 
 
 
1.3. Concept, classification and diagnosis of diabetes and prediabetes 
 
One of the oldest surviving accounts of the existence of diabetes is a basic 
description recorded by Aretaus of Cappadocia in the 2nd century AD. Aretaus used the 
Greek word for ‘siphon’ to first coin the term ‘diabetes’, ‘because the fluid does not 
remain in the body, but uses the man’s body as a channel whereby to leave it’ 
(Tattersall, 2003)3. 
Diabetes mellitus is in our days more than simply a disease; it is now consensually 
described as ‘a group of metabolic diseases characterised by hyperglycaemia resulting 
from defects in insulin secretion, insulin action, or both. The chronic hyperglycaemia of 
diabetes is associated with long-term damage, dysfunction, and failure of various 
organs, especially the eyes, kidneys, nerves, heart, and blood vessels.’ (ADA, 1997). 
 
                                               
2
 The definition and characteristics of the prediabetes stage(s) will be further discussed in the next item. 
3
 This description is a clear allusion to the state of polyuria that sets later in the condition, often the tell-
tale sign that alerts people to the onset of the disease; ultimately leading to death, if untreated. The term 
‘mellitus’ was coined well after that, in the 19th century, based on the Greek and Latin word for ‘honey’. 
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In our times, classification criteria aim mainly to reflect the aetiology and 
pathogenesis of diabetes (ADA, 1997; Genuth et al., 2003). There are two main forms 
of diabetes. Type 1 diabetes involves the autoimmune-mediated failure or destruction of 
pancreatic β–cell islets, eventually leading to absolute insulin deficiency (Dotta and 
Eisenbarth, 1989; Muir et al., 1992). These patients, generally young people and 
children (Taplin and Barker, 2008), rely on exogenous insulin for survival, and are 
prone to ketoacidosis, coma and death. Type 2 diabetes is by far the most prevalent 
form, representing 90% of diabetes cases. It is an heterogeneous and multifactorial 
condition, probably determined by the crosstalk of several pathophysiological 
mechanisms. Of both genetic and environmental origin (Beck-Nielsen and Groop, 
1994), type 2 diabetes is characterized by defects in insulin action (insulin resistance) 
and/or in insulin secretion (β-cell dysfunction) (Kashyap and Defronzo, 2007), either of 
which may predominate (Gerich, 1999). Other forms of diabetes include gestational 
diabetes mellitus, which is defined as any degree of inability to deal with a glucose load 
(i.e. glucose intolerance) during pregnancy (independently of the onset of diabetes being 
during or prior to that state), and several rarer forms induced by endocrinological, drug 
or chemical, infectious, autoimmune, or genetic factors (ADA, 1997). 
The epidemic of diabetes is thus more correctly referred to as an epidemic of type 2 
diabetes. Indeed, even among young adults and children, where type 1 diabetes was the 
most common chronic disease (Rosenbloom et al., 1999), the rising incidence of 
physical inactivity, bad food habits, and obesity, is allowing a higher prevalence of type 
2 diabetes (Cali and Caprio, 2008; Ten and Maclaren, 2004). 
 
Diabetes is diagnosed when exaggerated blood glucose levels and/or abnormal 
handling of a glucose load are detected (ADA, 2009). This diagnosis is based on 
glycaemia magnitude in relation to established reference, or “cut-off”, values (Figure 1). 
Hyperglycaemia is an important risk factor (Stratton et al., 2000); and the cut-off values 
are chosen taking into account the prevalence thresholds for several diabetic 
complications, especially retinopathy. From this stems that diagnosis can be made 
already with or without the presence of known symptoms of diabetes4. With new 
developments in the clinical and research fields, the cut-off values have been 
                                               
4
 Common symptoms of already established diabetes include polyuria (excessive excretion of urine), 
polydipsia (excessive or abnormal thirst), ketonuria (presence of excessive ketone bodies in the urine) and 
rapid weight loss. 
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progressively adapted following current knowledge. It is presently considered that 
diabetes is established if blood glucose level after an overnight fast is equal or over 126 
mg/dl, and/or the blood glucose level obtained two-hours after an oral glucose tolerance 
test (OGTT)5 is equal or over 200 mg/dl. Although the debate raged from early on about 
the best method for evaluating diabetes, fasting or 2h post-challenge plasma glucose, 
mainly an effort was made to try to find cut-off points that represent similar biological 
risk factors in the two approaches. 
 
 
2h-post challenge blood glucose level (mg/dl)  
< 140 140-199 ≥ 200 
< 100 Normal IGT 
 
100-125 
 
IFG 
 
IFG/IGT 
Diabetes 
(isolated post-
challenge 
hyperglycaemia) 
 
 
Fasting 
glucose level 
(mg/dl) ≥ 126 Diabetes (isolated fasting 
hyperglycaemia) 
 
Diabetes 
 
Figure 1- Current criteria to diagnose diabetes and prediabetes. Glycaemic control evolves from 
normal homeostasis to diabetes, with visible degradation either in the fasted state or in response to a 
glucose challenge, or both. Impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) 
represent stages of prediabetes (adapted from (Tong and Cockram, 2003)). 
 
 
A further distinction has been created, to describe an intermediate stage between 
normal glucose homeostasis and diabetes; which has become known as ‘prediabetes’. 
This stage can be characterized either by impaired fasting glucose (IFG) or impaired 
glucose tolerance (IGT) (Figure 1). IFG is considered when the fasting glucose level is 
higher than 100 mg/dl but lower than 126 mg/dl, and IGT is considered when blood 
glucose assessed 2h after an OGTT is higher than 140 mg/dl but lower than 200 mg/dl 
(Ryden et al., 2007). Less commonly, patients show both IFG and IGT. This last 
condition presents a more extreme stage of prediabetes, sometimes able to develop 
independently (Perreault et al., 2008), which usually progresses more rapidly towards 
type 2 diabetes (de Vegt et al., 2001; Meigs et al., 2003; O'Rahilly et al., 1994). 
                                               
5
 Usually by ingestion of a glucose load containing 75g anhydrous glucose in water after an overnight 
fast. 
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Prediabetes is estimated to affect presently almost 350 million people worldwide 
(Garber et al., 2008). Its importance is highlighted by the increased medical costs 
associated (Zhang et al., 2009), since a considerable proportion of prediabetics already 
present microvascular and cardiovascular complications (Garber et al., 2008). 
 
Some authors argue that, more than a risk factor for diabetes, prediabetes is in itself 
a disease state that must be clinically addressed (Eldin et al., 2008). Others see the 
constant lowering of cut-off points, especially those related to IFG, as a risk of losing 
biological relevance and a danger of generalising treatments with possible side-effects 
over groups that would never evolve type 2 diabetes or suffer from cardiovascular 
complications (Rosenstock, 2007). 
Anyway, IFG and IGT seem to be both related to the development of type 2 diabetes 
through the presence of insulin resistance; even if possibly under slightly different 
pathophysiological mechanisms (Meyer et al., 2006; Nathan et al., 2007; Perreault et al., 
2008; Weyer et al., 1999). IFG seems to be connected mainly to early defects in the 
pancreas and liver; a loss of the first-phase of insulin secretion and a decreased capacity 
of insulin to inhibit hepatic glucose output. Paradoxically, this seems to be accompanied 
by normal skeletal muscle insulin sensitivity (Nathan et al., 2007). On the contrary, IGT 
seems to only present hepatic insulin resistance at a later stage, or not at all, but 
develops extensive peripheral insulin resistance by lack of ability to sensitise the 
skeletal muscle6 (Crandall et al., 2008; Garber et al., 2008; Guerrero-Romero and 
Rodriguez-Moran, 2006; Stancakova et al., 2009). Eventually IGT may also show 
alterations in both early- and late-stage insulin secretion (O'Rahilly et al., 1994). 
Nonetheless, notwithstanding dynamic changes in insulin secretion, hyperinsulinemia is 
usually a sustained feature in prediabetes (Weyer et al., 1999)7. 
 
In real life these expressions of prediabetes show a considerable heterogeneity, 
especially in individuals with isolated IFG (Kim and Reaven, 2008). This is not 
surprising in terms of a natural history of development of type 2 diabetes. Traditionally, 
                                               
6
 Peripheral insulin resistance that leads to IGT development has been retraced even to the stage where 
individuals are still within normal 2h-post challenge blood glucose levels (Stancakova et al, 2009). 
7
 The eventual failure of the ability of β-cells to compensate for the rise on blood glycaemia by producing 
more insulin may well be the hallmark of the final progression of prediabetes to type 2 diabetes 
(Guerrero-Romero and Rodriguez-Moran, 2006; Crandall et al, 2008). Strategies to spare and maintain β-
cell function as long as possible are nowadays one of the main clinical targets (Crandall et al, 2008; 
Garber et al, 2008). 
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type 2 diabetes has been seen as arising from early defects in peripheral insulin 
sensitivity. The pancreas counterbalances the growing loss of tissue sensitivity by 
secreting more insulin, leading to a maintained state of hyperinsulinemia. This process 
continuously degrades, with both glycaemia and insulinemia rising, until β-cell islets 
reach a critical point and begin to fail. Other sites, as the liver and adipose tissue, begin 
to also be affected. By then, usually diabetes sets with both full-blown hyperglycaemia 
and possibly a decrease in insulinemia due to β-cell exhaustion. Intuitive as this order of 
events may seem, in reality these processes are so interrelated that evolution to type 2 
diabetes may begin in any of those steps. 
As in other biological processes, nature seldom finds only one way of doing and 
undoing things, unlike what humans so often find comfortable to conceptualise. 
However, it is true that some mechanisms may be more relevant than others. And in 
pathophysiological issues this relevance may lie in those physiological pathways more 
prone to be disrupted by environmental factors, since those are the ones that will 
aggravate what can be the unavoidable disadvantages of the genetic background (Buren 
and Eriksson, 2005). The natural history of progression from normal glucose 
metabolism to type 2 diabetes, and logically the possibility of successful intervention to 
delay it, may thus depend heavily on the correct identification of the aetiological defect. 
It should also be critical to detect it at an early stage of the prediabetic range. 
This rationale seems to be supported by epidemiological follow-up studies. In those 
studies, people diagnosed with IFG and/or IGT are revaluated after several years of the 
first diagnosis. Even taking into account all the circumstances that may induce 
variability on the quantification given by the OGTT, which may (Ko et al., 1998; 
Yudkin et al., 1990) or may not (de Vegt et al., 2001; Ko et al., 1998) make the OGTT a 
lesser reproducible method than the measurements done on the fasting state (Balion et 
al., 2007), reversion from IGT to normalcy seems to be more common than from IFG 
(Lu et al., 2008). Considering that a first diagnosis of IGT or IFG is followed by an 
increased awareness of each afflicted individual to the potential outcome of a 
prediabetic condition, and that this may lead to immediate changes in lifestyle, this data 
may hint to a higher sensitivity of IGT to environmental factors. 
 
As mentioned before, IFG is diagnosed simply by assessing the blood glucose level 
in the fasted state; and IGT is diagnosed through an OGTT. During an OGTT, after the 
ingestion of a known solution of glucose, the changes of blood glycaemia, and 
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insulinaemia, are followed at regular intervals to assess the ability of the organism to 
deal with the glucose challenge. Additional analytical quantifications and mathematical 
models are able to provide more information on the dynamics of glucose 
appearance/disappearance in the blood and the response of the pancreas in secreting 
insulin and of the liver in insulin removal (Abdul-Ghani et al., 2007; Cobelli et al., 
2007).  
The OGTT is usually reported as assessing glucose metabolism response in a 
postprandial state, in opposition to the fasting state evaluation. However, this method 
may not be the most suited for this purpose (Lefebvre and Luyckx, 1976). Indeed, the 
comparison of the OGTT with a meal tolerance test (MTT)8 shows that a challenge of 
only glucose leads to a higher level of blood glycaemia and triggers insulin secretion in 
a different dynamic curve than a challenge posed by a mixed meal (Berthiaume and 
Zinker, 2002; Meier et al., 2008; Rijkelijkhuizen et al., 2009). This is explained by the 
fact that glucose appearance in the blood is quicker when it comes from a diluted 
solution than when the same quantity of glucose is part of a mixed meal, and by the 
additive secretory response of the pancreas to nutrients other than carbohydrates (Bock 
et al., 2007b), namely protein (Bock et al., 2007b; Krezowski et al., 1986). Additionally, 
the arrival of solely glucose to the intestine was shown not to be enough to produce 
some of the feeding signals involved in postprandial glucose homeostasis (Sadri et al., 
2006). 
It becomes evident that a mixed meal challenge will constitute a more appropriate 
test to fully assess the postprandial state. It would also be more accurate to evaluate 
changes in real-life postprandial glucose metabolism, as has been already proposed 
(Meier et al., 2008). Further, the previous considerations indicate that both clinically 
advised measurements for evaluating diabetes and prediabetes, fasting and 2h post-
OGTT plasma glucose levels (ADA, 2009), may be unable to adequately detect the 
impairment of real-life glucose metabolism responses in the postprandial state.  
 
Now the question remains if those potential real-life alterations in postprandial 
nutrient handling are relevant to the natural history of the development of type 2 
diabetes; and if the additional effort in detecting them has any real clinical applicability 
                                               
8
 The MTT is initiated by the ingestion of a standardised mixed meal, but is in all the rest similar to the 
OGTT; potentially sharing the same methodological approaches to assess both insulin secretion and 
insulin sensitivity parameters. 
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(specifically, if they are able to predict development to type 2 diabetes; if they are 
sensitive to strategies aimed at averting or postponing that development; and, in later 
stages, if there is a potential for therapeutic pharmacological intervention). 
However, before focusing on those points, the relevance of setting the cornerstone 
of the present doctoral thesis on the study of alterations of insulin sensitivity can only be 
ascertained after dealing with one other subject, envisioned today as one of the most 
heated debates in the international field of diabetes clinical research: currently called 
‘the metabolic syndrome’. 
 
 
1.4.Clinical relevance of the metabolic syndrome, type 2 diabetes, and insulin 
resistance  
 
Type 2 diabetes is related to a multitude of complications, especially cardiovascular, 
undoubtedly due to concomitant dysfunctions throughout several pathways involved in 
energy management, as for example carbohydrate and lipid metabolism. Even 
prediabetes can likewise be involved, since the risk of complications can already be 
evident at this stage9 (Goldberg et al., 2009; Haffner et al., 1990). For this, prediabetes 
and type 2 diabetes can also be regarded as part of a broader picture.  
In 1988, Gerald Reaven proposed (Reaven, 1988) that insulin resistance and 
hyperinsulinemia are the main factors involved in the aetiology of conditions like type 2 
diabetes, hypertension and coronary artery disease. This was termed “Syndrome X”. In 
its initial proposition, Syndrome X was an informal cluster of risk factors that included 
decreased sensitivity in insulin-stimulated glucose uptake, glucose intolerance, 
hyperinsulinemia, dyslipidemia (increased very-low-density lipoprotein triglycerides 
and decreased high-density lipoprotein cholesterol), and hypertension. Although it was 
named “syndrome”, this was more a recognition of a set of whole-body metabolic and 
hemodynamic alterations induced by the sustained hyperinsulinemia that compensated 
for insulin resistance and glucose intolerance than a suggestion for a real new disease 
(Kim and Reaven, 2004). In a later paper, the same author expanded the number of 
cardiovascular conditions possibly related to the Syndrome X (Reaven, 1993). 
                                               
9
 In the same way, the reversion from prediabetes, specifically IGT, to normal glucose tolerance, achieved 
through intensive alterations in lifestyle (food habits, exercise, etc.), leads to an improvement in risk 
factors related to cardiovascular diseases (Goldberg et al, 2009).  
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 Soon after, the initial proposal was taken by others; not always with the same focus. 
From 1988 to 1991, the Syndrome X was given a multitude of other incarnations 
(‘deadly quartet’, ‘insulin resistance syndrome’, ‘visceral fat syndrome’, ‘atherogenic 
metabolic triad’, among others) (Oda, 2008). While some preserved insulin resistance 
and hyperinsulinemia at the core of this cluster (Balkau and Charles, 1999; DeFronzo 
and Ferrannini, 1991; Ferrannini, 2006; Ferrannini and Balkau, 2002), others argued 
that the central aetiological role should be given to obesity (Oda, 2008; Samaras et al., 
2006; Yudkin, 2007). From 1991 onwards, several organisations established clinical 
guidelines for this supposed entity, by then mostly named “metabolic syndrome” 
(Grundy, 2006a). These guidelines also reflected the variability of aetiological points 
and diseases considered by previous descriptions of the syndrome (Kim and Reaven, 
2004; Oda, 2008); with some of them even excluding insulin resistance as a parameter 
worth evaluating, either due to technical or conceptual issues (Alberti et al., 2006; Kim 
and Reaven, 2004)10. Not surprisingly, a comparison between the applicability of 
several of the most used definitions for the metabolic syndrome wielded the result of 
less than 30% of people surveyed being eligible for treatment simultaneously by all 
three of them (Day, 2007). 
Not surprisingly with a high prevalence worldwide (Grundy, 2008), by now the 
proper clinical relevance, and even desirability, of the existence of the “metabolic 
syndrome” category has been put in question (Alberti and Zimmet, 2008; Gale, 2008; 
Kahn et al., 2005). While supporters of the metabolic syndrome argue that it is not an 
attempt to label a new disease, but to identify a risk state, like prediabetes (Alberti and 
Zimmet, 2008; Grundy, 2006b), detractors highlight the confusion arising from 
considering the same conditions as both risk factors and outcomes, and the redundancy 
of the diagnosis of the metabolic syndrome in comparison to the diagnosis and 
treatment of each of its components (Gale, 2008; Kim and Reaven, 2008; Sundstrom et 
al., 2006). 
It has been shown that the prevalence of the individual components of the metabolic 
syndrome increases with decreasing insulin sensitivity (Lee et al., 2007). However, that 
a common aetiological feature has yet to be established, even among well known 
                                               
10
 It is also relevant to point out that even those criteria guidelines that took into account measurements of 
insulin resistance were generally inconsistent in regards to the use and significance given to IFG and IGT 
(Kim and Reaven, 2004). 
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associations of included pathologies, further complicates the analysis of these matters 
(Gale, 2008). 
Besides those objections, the simultaneous occurrence of obesity may be more a 
complication than an aetiological factor for this cluster. There is no doubt that obesity is 
related to insulin resistance. Indeed, obesity may aggravate insulin resistance and other 
features of the metabolic profile by fat mass deposition (Alberti et al., 2006) and an 
higher release of free fatty acids (Opie, 2007), or/and a rise in secretion of inflammatory 
cytokines from the adipose tissue (Oda, 2008; Yudkin, 2007). However, the other 
features of the metabolic syndrome seem to develop independently of these obesity-
induced factors (Petersen et al., 2007; Reaven, 1993), when already in the presence of 
peripheral insulin resistance (Petersen et al., 2007). 
To highlight this fact, it has been observed that a minority of primarily obese people 
develop diabetes (Perreault et al., 2008); while lean prediabetics generally progress to 
diabetes and obesity (Perreault et al., 2008). Consistent with this, obesity has been 
described has presenting, in the absence of the other defects, a minor risk factor 
(Kaplan, 1998). Thus, obesity may be related to the metabolic syndrome not by a direct 
effect but by increasing the chance of an individual to become less sensitive to insulin-
stimulated glucose uptake (Matthews, 1999; Reaven, 2006) and/or by accelerating the 
metabolic degradation that follows insulin resistance. 
Elevated blood pressure is another common feature of the metabolic syndrome with 
ties with insulin resistance, obesity, and cardiovascular complications (Antic et al., 
2003; Reaven, 2006). And although only half of patients with essential hypertension 
show insulin resistance and hyperinsulinemia (Reaven et al., 1996; Zavaroni et al., 
1992), those are precisely the ones that develop the other features of the metabolic 
syndrome (Reaven, 2006; Zavaroni et al., 1999). 
In healthy individuals, insulin has a net vasodilator effect (Anderson et al., 1991); 
which reflects the balance between the vasoconstrictor and vasodilator effects of insulin. 
These effects are originated both through the central nervous system and directly at the 
peripheral vasculature (Cabou et al., 2007; Sartori et al., 2005); and are integrated in the 
overall control of blood pressure. Several mechanisms have been proposed to contribute 
to the link between insulin resistance and essential hypertension (Antic et al., 2003; 
Ginsberg, 2000): a defect in the pathway by which insulin stimulates the release of 
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nitric oxide, a potent vasodilator11, from endothelial cells (Claxton and Brands, 2003; 
Cook et al., 2003; Macedo and Lautt, 1996; Mather et al., 2001; Montagnani et al., 
2002; Sartori et al., 2005; Steinberg et al., 1994; Turini et al., 2007), the increased 
reabsorption of sodium and water due to hyperinsulinemia (DeFronzo et al., 1975), 
and/or an exaggerated overactivity of the sympathetic nervous system in response to 
insulin (Kopp, 2005; Lembo et al., 1992). Again, insulin resistance seems to lie at the 
genesis of a pathology included in the metabolic syndrome. 
Ageing has also been related with features of the metabolic syndrome; such as 
obesity, hypertension, and diabetes (Denys et al., 2009). The normal process of ageing 
is known to gradually present insulin resistance (Scheen, 2005), which has been 
proposed as a possible common origin to this cluster (Muller et al., 1996). The 
development of these other would also determine the acceleration of the age-determined 
defects (Morley, 2008).  
If the criteria for metabolic syndrome diagnosis was created to find individuals who 
have an increased risk of developing diabetes and cardiovascular disease (Oda, 2008), 
then it seems more profitable to centre this question in insulin resistance instead; as was 
initially proposed (Reaven, 1988). Furthermore, excessive dependence upon the 
diagnosis of the metabolic syndrome may provide a sense of false security for those 
with abnormalities not yet serious enough to be classified as suffering from the 
metabolic syndrome (Kim and Reaven, 2004); which falls paradoxically short from the 
declared objective of creating a social weapon for public awareness about the epidemic 
of type 2 diabetes and associated pathologies, like obesity and hypertension. 
 
Even considering the aforementioned relevance, insulin resistance estimates are 
badly regarded in the clinical field; either when derived from fasting or post-challenge 
insulin blood level measurements (Chevenne et al., 1999; Kahn et al., 2005; Samaras et 
al., 2006). Also, prediabetes, with no organ damage per se yet established, is regarded 
solely as an indicator of potential future complications (Genuth et al., 2003). In spite of 
this, the alternative (Samaras et al., 2006), nearly comes up to waiting for the ‘metabolic 
                                               
11
 This dysfunction can be due either to an inability of insulin action or to a defect on nitric oxide 
synthesis/bioavailability (Sartori et al, 2005). Furthermore, the vasodilator effect of nitric oxide is felt 
peripherally, by relaxation of the vascular smooth muscle (Steinberg et al, 1994; Mather et al, 2001), and 
centrally, by suppressing the sympathetic outflow (Turini et al, 2007) that locally induces peripheral 
vasoconstriction (Macedo and Lautt, 1996; Claxton and Brands, 2003). This has prompted that defective 
nitric oxide availability was proposed as a common point to the development of several abnormalities 
included in the metabolic syndrome (Cook et al, 2003).  
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syndrome’ to become visible. This may sum to an aggravation of metabolic and 
hemodynamic complications, leading, in the near future, to a harder-to-maintain quality 
of life. 
On the other hand, the cautions of clinical intervention seem well founded. Mainly, 
it is ruled by finding the best way to foresee and prevent life-threatening conditions or 
those that lead to gross deterioration of general health; making a diagnosis through the 
most practical and cost-effective method of analysis. This implies a difficult balance 
between the ability of a risk factor to predict a real future progression of a disease and 
the possible negative side-effects that a pharmacological intervention may carry. 
 
The present situation seems to hinge in a dispute between the relevance of insulin 
resistance to the aetiology and early prediction of future metabolic degradation and the 
necessity of recognising an immediate negative impact upon a patient to make a medical 
intervention worthwhile in terms of cost effectiveness and patient safety. Browsing 
through the literature, one could become convinced that a stalemate about this question 
has been reached. If so, perhaps exploring the possibly distinct defects inherent to each 
type of prediabetes (i.e., determined either in fasting or post-ingestion) may shed more 
light into the relevance of the loss of insulin sensitivity to the development of 
prediabetes and diabetes; and to the features associated with the metabolic syndrome. 
 
 
1.5.Tracking the influence of the prandial state to prediabetes and diabetes 
 
Circulating glucose is able to glycosylate valine residues of erythrocyte 
haemoglobin, in a process that evolves linearly with blood glucose concentration (Little 
and Sacks, 2009). Due to the long half-life of erythrocytes, glycosylated haemoglobin 
(HbA1c) is used to estimate the degree of glycemic control in the last 2 to 3 months. A 
higher HbA1c is indicative of exposure to longer or more extreme hyperglycaemia12 
(ADA, 2010; Fonseca et al., 2009; Genuth et al., 2003; Kilpatrick et al., 2009; TIEC, 
                                               
12
 Glycosylated haemoglobin (HbA1c) has been pondered as a potential tool in the diagnosis of diabetes. 
Its use in that capacity was considered up until now premature (Genuth et al, 2003); while still 
maintaining its role as an evaluator of glycemic control effectiveness. Indeed, a recent report (TIEC, 
2009) spurred the adoption of HbA1c ≥6.5% as criteria for the diagnosis of diabetes by the American 
Diabetes Association (ADA, 2010). However, this is still under considerable dispute (Fonseca et al, 2009; 
Kilpatrick et al, 2009). 
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2009). The current recommendation is that HbA1c should be lower than 6.5%, to reduce 
the risk of microvascular complications (ADA, 2010; Ceriello and Colagiuri, 2008). 
Prospective studies have shown clearly that intensive glycemic control can lead to a 
lowering of HbA1c, and a decrease of the risk of microvascular complications with type 
2 diabetes (Matthews, 1999). This was achieved solely by intervening on fasting 
glucose levels; which correlate well with HbA1c (Wettre et al., 1993), but produced a 
much smaller impact on cardiovascular disease risk reduction than expected and, on 
follow-up studies, soon shown an inability to staunch the progression of glycemic 
deregulation (Del Prato, 2002). Indeed, the relative importance of either augmented 
fasting glucose levels or postprandial glucose excursions to the formation of HbA1c has 
been subject to debate (Avignon et al., 1997; Bonora et al., 2001). Nonetheless, it now 
seems that, in individuals with declared diabetes, postprandial hyperglycaemia is the 
primer determinant factor in subjects with moderate glycemic control (ie, with moderate 
values of HbA1c) (Monnier et al., 2003), while fasting hyperglycaemia is more 
determinant in stages of higher values of HbA1c (Bonora et al., 2001; Monnier et al., 
2003). This raises the hypothesis that reaching fasting hyperglycaemia may represent a 
state of worsened metabolic profile; and that at this stage the importance of fasting 
hyperglycaemia masks the greater relevance of postprandial glucose excursions to 
HbA1c on earlier glucose metabolism deregulation (Monnier et al., 2003). The rise of 
HbA1c with worsening diabetes would thus indicate a transition between an earlier 
phase of metabolic compromise dictated by postprandial hyperglycaemia and a later 
phase of diabetes deterioration determined by the deleterious effect of fasting 
hyperglycaemia (Monnier et al., 2003). This has been shown in type 2 diabetics, where 
the primary loss was of postprandial glycemic control, mainly at breakfast, followed by 
deterioration of the pre-meal periods, and only after that was possible to observe a 
maintained hyperglycaemia during the night period where fasting is more pronounced 
(Monnier et al., 2007). 
The above argument also hints to the hypothesis that the distinct prediabetic states 
mentioned earlier, IFG and IGT, influence differently the formation of HbA1c, the 
development towards diabetes, and cardiovascular complications. 
IGT and IFG are both predictors for type 2 diabetes, showing a higher risk than 
normal subjects in prospective or retrospective studies; but IGT seems to provide a 
more wide recognition of individuals that progress to this disease (DECODE, 1999; 
Ferrannini et al., 2009; Qiao et al., 2003b). Likewise, IGT is a better predictor than IFG 
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of future cardiovascular complications, morbidity and mortality (Heine et al., 2004); 
independently of further development of diabetes (Qiao et al., 2003a). Several studies 
showed that the risk of cardiovascular disease and mortality of people with IGT was 
almost as high as on subjects already diabetic, and that IFG showed a similarly lower 
risk as individuals with normal fasting glycaemia (DECODE, 2001; IDF, 2003; Qiao et 
al., 2002; Tominaga et al., 1999). Furthermore, most individuals with HbA1c between 
6.0 and 7.0% have normal fasting glucose but already abnormal 2h post-OGTT glucose 
levels (Woerle et al., 2004). 
This makes the isolated IGT prediabetics the most promising group for intervention 
to prevent the development of type 2 diabetes and metabolic complications (DECODE, 
1999). Interestingly, controlling postprandial glycaemia in patients that have already 
IFG was shown not to prevent the development of type 2 diabetes, probably because by 
then they had developed β-cell dysfunction (Kirkman et al., 2006). Furthermore, HbA1c 
may not reflect all the relevant influence of hyperglycaemia. Indeed, the same HbA1c 
level may be related to different glycemic control profiles, depending on glucose level 
fluctuations (Del Prato, 2002). Since fluctuations are expected to be of a higher 
magnitude precisely during postprandial excursions, this provides an additional 
contribution of postprandial glucose levels to the development of type 2 diabetes and 
other complications, even if these hyperglycaemias are sporadic and otherwise glycemic 
control is still maintained (Bonora, 2002; Wettre et al., 1993). 
The prior mentioned results where obtained by using the OGTT, but the same is 
expected to happen in response to a meal (Del Prato, 2002). Certainly, glucose 
excursions measured by the OGTT are more pronounced than when the MTT is used 
(Berthiaume and Zinker, 2002; Meier et al., 2008); and individuals characterised as IGT 
by an OGTT can show a normal glucose level in response to a MTT, due to an adequate 
hyperinsulinemia brought by the sum of glucidic and non-glucidic driven insulin 
secretion (Bock et al., 2006), and to other factors that influence insulin sensitivity and 
are only present in response to a mixed meal (Sadri et al., 2006). But this does not 
necessarily indicate that the MTT is a less adequate test in detecting defects in glucose 
metabolism. Indeed, the MTT is a more physiological test, as people usually consume 
mixed meals and not pure glucose loads. Furthermore, after the MTT, the rise in other 
nutrients, as lipids and aminoacids13, may independently uncover further risks for 
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 These non-glucidic nutrients can influence glucose metabolism through indirect metabolic pathways. 
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complications (Del Prato, 2002; Heine et al., 2004; Henkel et al., 2002; Kim et al., 
2000; Rebolledo and Actis Dato, 2005)14. 
 
Since subjects with postprandial glucose intolerance have been described to present 
similar endogenous glucose production after feeding as normal individuals, the site of 
defect of postprandial glucose disposal in IGT must lie at the peripheral tissues (Weyer 
et al., 1999). This stage corresponds to an hypersecretion of insulin; which may partially 
offset peripheral insulin resistance, but is not enough to avoid higher-than-normal 
postprandial glycemia. Later, with β-cell exhaustion, IGT is expected to finally evolve 
to type 2 diabetes. 
Interestingly, a lower insulin-stimulated glucose uptake at the peripheral tissues may 
also be happening in the early stages of IFG. In the fasted state, these individuals 
present an higher hepatic glucose output, and lower skeletal muscle glucose disposal, 
than normal subjects; leading to fasting hyperglycemia. On the other hand, in the 
postprandial state, the rise in circulating insulin is able to induce an adequate shutdown 
of the hepatic glucose output. However, not even this insulin level seems able to 
compensate for the skeletal muscle insulin resistance (Bock et al., 2007a); albeit this 
defect is not yet severe enough to provoke postprandial hyperglycemia. 
 
Skeletal muscle, the major peripheral insulin-sensitive tissue, seems to be affected 
by insulin resistance before the liver or the adipose tissue (Petersen et al., 2007). As 
reported, peripheral insulin resistance is the underlying defect for IGT subjects, and may 
be even present in early IFG ones. In fact, it may even be acquired as a hereditary trait, 
since normoglycemic first-degree relatives of type 2 diabetic patients can already show 
similar skeletal muscle insulin resistance to IGT subjects (Abdul-Ghani et al., 2006). 
Furthermore, the mentioned studies support the notion that these defects are expressed 
earlier, and in a more insidious way, in the postprandial state. This, taken together with 
the fact that microvascular and macrovascular complications begin several years before 
overt diabetes, provides the clinical relevance desired to warrant a closer look into the 
contribution of postprandial insulin resistance in the development of type 2 diabetes and 
other related pathologies. 
                                               
14
 However, it must be referred that glucose intolerance was shown to predate lipid intolerance (Henkel et 
al, 2002; Heine et al, 2004), which may show at a later stage, specifically when the excess of nutrients 
unable to be stored in skeletal muscle overburdens the adipose tissue or when glucose metabolism at the 
liver is already compromised (Kim et al, 2000). 
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The next sections will provide an overview into the mechanistic physiology of 
whole-body glucose metabolism and insulin action, giving a particular attention to the 
prandial status. After that, a novel mechanism will be presented that seems to contribute 
specifically to postprandial insulin-stimulated glucose uptake at certain peripheral 
tissues, as skeletal muscle. In that respect, the importance of the autonomic nervous 
system to postprandial glucose metabolism will also be highlighted; and the liver will 
rise as more than a target for insulin action, but also as a promoter of insulin sensitivity 
in the extrahepatic tissues. 
 
 
1.6.The need for glucose homeostasis 
 
The energy required for both resting and active functions of the body is obtained by 
the oxidation of ingested nutrients. Thus, each gram of carbohydrates provides 4 kcal, 
of fat 9 kcal, and of proteins 4 kcal. A monosaccharide (glucose) and lipids (fatty acids 
and ketone bodies) are the major oxidative fuels; and, in line with a rationale of energy 
management, glucose and fatty acids are physiological competitors (Frayn, 2003). 
 
The challenges posed presently by nutrition are quite different from those that 
shaped our inherited ability to deal with nutrient disposal. This impacts our metabolism 
in two major ways: frequency and composition. 
Nowadays, we are exposed to an almost ubiquitous access to food, at least in 
considerable parts of the globe, which is much unlike what happened during our 
evolutionary early times. As hunter-gatherers, human beings would best prosper if able 
to store enough energy during the feast periods to maintain activity during the famine 
periods (Neel, 1962). This ability ultimately determined the capacity of procuring for 
the next period of nourishment. Since then, this “thrifty genotype”15 has seemed to lose 
its evolutionary advantage and became a ground for possible metabolic deregulation of 
                                               
15
 Regarded as “thrifty genotype” or “thrifty phenotype”, depending on the relevance given to the actual 
influence of type 2 diabetes on the pre- and post-reproductive periods (Ozanne and Hales, 1998). The 
latter would make evolution “blind” to the detrimental effect of diabetes through reproduction. However, 
it must not be forgotten that metabolic deregulation related to the eventual development of diabetes may 
predate the onset of disease by several decades. Nonetheless, the influence of the phenotype seems 
beyond debate, independently of the real relevance of the genotype. 
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energy fluxes, with ramifications into general physiological control (Ozanne and Hales, 
1998). 
 The economy of energy is self-evident in terms of evolutionary value; 
independently of the evolutionary advantage being determined either by a sharp action 
of insulin in inducing nutrient storage during feasting times (Neel, 1962), or by the 
imposement of insulin resistance in peripheral tissues during famine periods (Reaven, 
1998). The former would prevent wasting nutrients that later could be much needed, 
while the latter guarantied the unfaltering provision of glucose to the central nervous 
system while still preventing the necessity to degrade muscle protein (Wang and 
Mariman, 2008). 
More importantly, diet composition has changed dramatically (Eaton, 2006; Mann, 
2000); as well as the balance between energy intake and energy expenditure16. This can 
lead to early detrimental effects on insulin sensitivity, either by exposure to a high 
nutrient uterine environment (Mingrone et al., 2008; Shankar et al., 2008), or to a 
mismatch between the prenatal and postnatal energy balance (Hanson and Gluckman, 
2008; Thompson et al., 2007).  
 
The new challenge presented by overnutrition, changes in food composition, and 
lowered physical activity, likely involves the subversion of both mechanisms related to 
insulin sensitivity mentioned above; leading simultaneously to maintained 
hyperinsulinemia and insulin resistance (Wang and Mariman, 2008). Not only meals are 
supersized, but foodstuff has become calorie dense, low on fibres, and of a high-
glycemic index; at the same time, less physical work is required of us17 (Lieberman, 
2003).  
 
Furthermore, the pathways related to the metabolism of carbohydrates, lipids and 
proteins are interconnected at several steps; which enables the organism to shift energy 
production and storage depending on the prandial state, and on energy requirements and 
availability. If there is a problem of inadequate energy fluxes within normal 
                                               
16
 Perhaps against popular belief, ancestral humans seem to have had an even higher energy intake than in 
present times; which was, of course, met by also a much higher energy expenditure than ours (Eaton, 
2006).  
17
 And even the mental state of the modern way of life may be of relevance: traditional physiological 
stress responses that mobilise glucose to the bloodstream, like adrenalin secretion, are no longer met with 
an increase in physical activity as in the primordial fight-or-flee dilemma; originating a link between the 
so-called “stress diseases” and type 2 diabetes (Neel, 1962). 
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metabolism, it might lead to the development of insulin resistance and type 2 diabetes. 
A closer look (Figure 2) shows that the key molecules that mark the critical points 
between these pathways are glucose-6-phosphate, pyruvic acid, and acetyl coenzyme A. 
 
 
 
 
Figure 2 - Pathways of nutrient metabolism crosstalk. Key molecules and pathways linking 
carbohydrate, lipid, and protein metabolism (Adapted from (Tortora and Grabowski, 1996)). 
 
 
As mentioned above, glucose and fatty acids are the main oxidative fuels. This fact 
is not without control, and the interdependent relation between glucose and fatty acids 
seems to lead to the preferential usage of glucose, when available, sparing fat depots as 
reservoirs to be tapped during long-term fasting or exercise periods. This highlighted 
importance of glucose is also seen as to its consumption as fuel for the central nervous 
system. 
During fasting, the brain is responsible for almost 60% of whole-body glucose 
uptake from blood circulation; being it almost all spent in oxidative metabolism (Amiel, 
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1995). The rate limiting step in this process is glucose transport. Indeed, unlike other 
tissues, brain glucose uptake is not dependent on insulin or blood flow but only 
determined by the gradient difference through the blood-brain barrier (Dienel and Hertz, 
2001), mediated by glucose facilitative transporters. For this, glucose is the main 
substrate in the blood that is able to supply the energy demands of the brain (Dienel and 
Hertz, 2001). After a meal, the brain is responsible for disposing of ~20% of the 
ingested glucose (Kelley et al., 1988; Meyer et al., 2002). This new–arrived glucose is 
oxidised in place of blood glucose originated by the breakdown of reserves stored in 
other organs, which is the way the level of blood glucose is maintained during a short-
term fasting. 
Additionally, under conditions of glucose shortage, the brain is able to consume 
other substrates. With increased time of fasting, or during exercise, it becomes capable 
of uptaking lactate with adequate effectiveness (Dienel and Hertz, 2001). Lactate also 
seems to be shuttled between different neural cells, to provide for local increases in 
energetic necessities (Pellerin, 2008)18, or to be eliminated to the bloodstream, as a 
result of the excess of glucose taken by the brain (Dienel and Hertz, 2001). If fasting is 
prolonged into starvation, the brain may start to consume ketone bodies, β-
hydroxybutyrate and acetoacetate (Amiel, 1995). By this time, the other body tissues are 
consuming mainly fatty acids and ketone bodies. 
In times of nutrient shortage, the other body tissues are coerced to give priority to 
the brain (Peters et al., 2004). The first physiological response is the secretion of 
adrenaline and an activation of the hypothalamic-pituitary-adrenal axis and the 
sympathetic nervous system (Amiel, 1995; Wang and Mariman, 2008). Then, glucose 
output is promoted from reserves at the liver, and in less magnitude in the kidneys, 
while glucose uptake is inhibited in skeletal muscle and adipose tissue. Similarly, fatty 
acids are launched into the blood, by increased lipolysis in adipose tissue. This helps the 
peripheral tissues to change from glucose to fatty acid oxidation as an energy source 
(Frayn, 2003), leaving more glucose available for brain uptake. The brain also acts to 
promote food intake, by stimulating feeding behaviour through neuroendocrine factors 
(Burcelin, 2005). 
                                               
18
 This is related to the increased neural activity in selective parts of the brain, due to the quick summon 
of cognitive functions, and the necessity to promptly allocate energy to those specific points (Pellerin, 
2008). 
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If even this is not enough to prevent hypoglycaemia, body proteins, especially from 
the skeletal muscle, may be degraded to provide fuel for de novo glucose synthesis in 
the liver. Eventually, this necessity to compensate for hypoglycaemia can lead to tissue 
wasting, coma and eventually death. Likewise, an excess of glucose availability in the 
blood can be harmful to tissues throughout the whole body. Circulating hyperglycaemia 
can become toxic, mainly leading to damage by oxidation and free radical formation 
(Brownlee, 2001), and even inflammatory reactions (Ceriello, 2005; Evans et al., 2002).  
Due to the risks derived from these two situations – hypoglycaemia and 
hyperglycaemia - the level of glucose in the blood has to be actively clamped by the 
organism within a tight range (in humans, roughly around 90 mg/dl). For this, energy 
must be adequately stored and utilised. 
 
Although three forms of carbohydrates are absorbed into the blood, fructose and 
galactose are quickly converted to glucose in the liver. Since glucose is a preferential 
source of energy, its fate is mainly ATP production (glycolisis) or storage as either 
glycogen (glycogenesis) or eventually triglycerides (lipogenesis). Glycogen can later be 
converted back to glucose (glycogenolysis) in several tissues, although only the liver 
and the kidneys have the ability to release it as glucose back into the blood circulation; 
thus providing glucose for other tissues. To complement this, the liver is also able to 
uptake certain intermediaries of lipid and protein metabolisms, and produce new 
glucose (gluconeogenesis). Glucose can likewise be used to provide the backbone for 
amino acid synthesis, later incorporated into new proteins. If glucose is excreted in the 
urine, it marks one of the main symptoms that diabetes is already established. 
Lipids are also oxidised to provide energy; it should not be forgotten that one lipid 
molecule yields more than twice the energy of a glucose molecule. If in excess, lipids 
are stored as triglycerides in adipose tissue; making in fact the largest reserve of energy 
in the organism. However, triglycerides are continuously degraded and resynthesised; 
which means that they are turned over between the blood and adipose tissue. This 
favours the availability of lipids to be included in the formation of several substances 
needed for structural and regulatory functions. 
In contrast, digested proteins and amino acids are not stored. But they are likewise 
turned over. Body protein is constantly degraded, and the resulting amino acids are used 
either in new protein synthesis or oxidised for very specific functions. If amino acids are 
in excess, they are not excreted but rather are converted into glucose or triglycerides. 
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If glucose homeostasis is thus affected by the metabolism of non-carbohydrate 
nutrients, then a proper control to maintain it requires the interrelation of the whole 
organism. A tight account must be kept to optimise glucose availability, but likewise to 
prevent the adverse effects of too much circulatory glucose. The correct relation to lipid 
and protein metabolism has also to be maintained, as gluconeogenesis may provide an 
unwelcome increase in circulating glucose. Several pathways of information and 
intervention, both neural and humoral routes of signalling, have to be simultaneously 
managed to provide an optimal level of control (Wasserman, 2009). And to be able to 
withstand all the energy requirements during the periods of wanting, the first critical 
constraint of the organism is to be capable of properly storing energy when nutrients are 
available. 
 
 
1.7.Hormonal and nervous control in the fed/fasting/fed transitions  
 
Digested carbohydrates and lipids, if not directly oxidised to provide energy in the 
form of ATP, are dispatched to storage. Carbohydrates are stored as glycogen, and 
lipids are stored in fat as triglycerides. Amino acids are integrated in the whole-body 
course of protein turnover. Within a few hours, body reserves are summoned to help 
maintain glucose homeostasis. But reserves are not indefinite, and eventually food 
ingestion is again wanted.  
 
Metabolic reactions in the immediate postprandial state are under strong hormonal 
regulation, with insulin as the major coordinator of several processes. 
Insulin secretion in response to feeding happens in three distinct phases. Upon 
feeding or even by the presentation of a meal, which can be referred broadly to as a 
preabsorptive phase19, the parasympathetic autonomic nervous system mediates the 
secretion of a first peak of insulin from the pancreas, called the cephalic phase (Ahren 
and Holst, 2001). This first burst of insulin20 is thought to be important in the measure 
                                               
19
 This phase is restricted to the first 10-15 min after meal ingestion. It can be referred to as preabsorptive, 
since plasma glycemia only starts to rise from 15 min after meal ingestion onwards (Ahren and Holst, 
2001).  
20
 Since insulin is secreted continuously in a pulsatile manner (Porksen et al, 2002), the term “burst” is 
used here to express the increase in mean insulin secretion. Postprandial changes in insulin secretion seem 
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that it may prepare the liver for the impending influx of nutrients, shifting it from 
glucose output to uptake; and is dependent on insulin already synthesised and stored in 
vesicles docked to the plasma membrane in pancreatic β-cells21 (Bratanova-Tochkova et 
al., 2002). Lack of this response influences negatively the glucose disposal through the 
entire postabsorptive period (Ahren, 2000). This is followed by an early and later phases 
in insulin secretion, dependent on subsequent insulin synthesis, transport, vesicle 
docking and exocytosis (Duckworth et al., 1998), which vary in kinetics dependent 
upon the type of meal stimulus provided22 (Caumo and Luzi, 2004). 
 
The initial cephalic phase is complemented by responses induced by the arrival of 
nutrients to the stomach, their absorption in the intestine and delivery to the blood 
circulation, and subsequently to the local effects of nutrients at the pancreas. Hence, 
gastrointestinal peptides (specifically, GLP-1 and GIP; also known as incretins) are 
released from the stomach upon food arrival. This, plus the rise in blood glucose 
concentration in the hepatoportal circulation (phase 2 of insulin secretion) and 
eventually in the pancreatic circulation (phase 3 of insulin secretion), further stimulates 
insulin release from pancreatic β-cells.  
The effect of glucose-sensing at the hepatic portal circulation on pancreatic insulin 
secretion (phase 2) is mediated by the parasympathetic nervous system; first by an 
afferent, from liver to brain, and then by an efferent pathway, from brain to pancreas 
(Lee and Miller, 1985).  
In relation to the direct pancreatic effect of glucose on insulin release (phase 3), the 
contribution of glucokinase must be pointed out. This enzyme functions, in the 
pancreas, as a glucose sensor (Matschinsky et al., 1998). Additionally, other nutrients 
besides glucose, mainly amino acids, also have a direct effect on modulating pancreatic 
insulin secretion (Bock et al., 2007b). 
 
Glucokinase is the enzyme responsible for the intracellular phosphorilation of 
glucose into glucose-6-phosphate; the first step to several metabolic pathways, as seen 
                                                                                                                                          
to be translated in higher insulin burst mass magnitude, rather than in changes of burst frequency. Also, 
this pulsatile behaviour is shown even after hepatic insulin extraction (Porksen et al, 2002b).  
21
 The state of maturation of the insulin granules seems to configure at least three pools: a reserve pool, a 
physically docked pool, and a readily releasable pool (Bratanova-Tochkova et al, 2002). 
22
 Glucose ingestion produces a well-defined early peak of insulin, followed by a steep descent and 
eventually a more delayed rise. In a mixed-meal ingestion, this is substituted by an early fast-rising 
insulin secretion and a later maintenance of the level achieved (Caumo and Luzi, 2004). 
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before. It plays a vital role in glucose homeostasis; with different, although 
complementary, roles in the pancreas and liver23 (Al-Hasani et al., 2003; Levin et al., 
2004; Matschinsky et al., 1998). Due to the equilibrium in glucose concentration 
between the blood and both hepatocytes and pancreatic β-cells, achieved through 
facilitative transport provided by glucose transporter 2 (GLUT2), the glucose sensor 
needed by these cells is able to rest intracellularly, rather than on the surface of cell 
membranes. This, together with a cooperative relation between glucose and glucokinase 
(Iynedjian, 2009), contributes to the close maintenance of a glucose set point. Any 
deviation from this set point, either positive or negative, makes the body respond in a 
coordinated effort to maintain euglycemia (Zelent et al., 2005). 
Glucokinase expression and activity is highly tissue-specific and dependent on 
prandial status. In hepatocytes, during fasting, glucokinase is inactivated by binding to 
the glucokinase regulatory protein (GKRP). This complex is stored in the hepatocyte 
nuclei. After a meal containing carbohydrates, blood glucose rises, as well as liver 
fructose-1-phosphate24. Entering through nuclear pores, fructose-1-phosphate breaks the 
sequestered glucokinase-GKRP complex, and allows glucose to bind to glucokinase. 
The new complex is shuttled to the hepatocyte cytoplasm, where it catalyses glucose-6-
phosphate generation. Fructose-6-phosphate, which is in equilibrium with the 
concentration of glucose-6-phosphate by isomerisation, provides a negative feedback to 
control glucokinase activity; by competing with glucose and inactivating the enzyme 
when able to bind to it (Iynedjian, 2009). Further, while hepatic glucokinase mRNA is 
almost absent during fasting and rises sharply with feeding, pancreatic glucokinase 
mRNA and protein levels are constitutive, independently of prandial status (Iynedjian et 
al., 1989).  
However, the later is still activated by feeding, but by increased catalytic activity 
(Iynedjian et al., 1989). Feeding also potentiates this mechanism through the vagus 
nerve and incretins, bypassing glucokinase. Acetylcholine released by increased activity 
of the pancreatic parasympathetic vagus innervation, and incretins, bind to receptors in 
the β-cell membrane, and promote insulin exocytosis by enhancing the effect of 
intracellular calcium (Matschinsky et al., 1998) in specific pools of insulin-containing 
granules (Bratanova-Tochkova et al., 2002). In relation to acetylcholine, this action has 
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 Glucokinase also has a role as the main brain glucose sensor (Levin et al, 2004). 
24
 Fructose-1-phosphate is generated by phosphorilation of ingested fructose. It is further metabolised into 
glyceraldehyde-3-phosphate and dihydroxyacetone, which then enter glycolysis. 
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been shown to be mediated by muscarinic M3 receptors, in the pre-meal and 
postprandial stages (Gautam et al., 2007; Gilon and Henquin, 2001). 
In β-cells, GKRP is essentially absent (Iynedjian, 2009). This makes pancreatic 
glucokinase activity more strictly dependable on glucose concentration. Thus, it 
facilitates the coupling of glucose metabolism, signalled by the metabolic products 
arising from the pathways to which glucose-6-phosphate is the precursor, to other 
pancreatic functions essential for whole-body glucose homeostasis, as insulin secretion 
(Matschinsky et al., 1998). The increased rate of glycolysis and oxidative metabolism, 
induced by a rise of available β-cell pooled glucose-6-phosphate, leads to the production 
of ATP. The rise in intracellular ATP/ADP ratio causes the inactivation of ATP-
sensitive Kir6.2 potassium channels, inducing depolarization of the cell membrane 
(Miki et al., 1998). This leads to the activation of voltage-sensitive calcium channels, 
with the subsequent influx of calcium to the cytoplasm (Ashcroft and Gribble, 1999). 
Cell membrane depolarization and calcium influx seem to be related to the inducement 
of exocytosis of different pools of insulin granules (Bratanova-Tochkova et al., 2002; 
Straub and Sharp, 2002); hence the ability of the pancreas to coordinate various phases 
of insulin secretion25 (Straub and Sharp, 2002; Zawalich et al., 1989). 
 
Insulin is a major effector in the anabolic metabolism that prevails in the immediate 
postprandial state. It facilitates tissue uptake of glucose and enhances active uptake of 
amino acids. It also stimulates phosphorylation of glucose and conversion to glycogen 
in hepatocytes and skeletal muscle (Al-Hasani et al., 2003). Further, in hepatocytes and 
adipocytes, insulin enhances triglyceride synthesis. Protein synthesis is likewise 
stimulated by insulin. 
All these actions fit together, whole-body wise, as for the direct and indirect insulin 
action on the control of hepatic glucose metabolism. Insulin acts directly on the liver to 
enhance glucose uptake and glycogen formation, and indirectly by favouring the release 
of gluconeogenic substrates from the periphery to the liver (Edgerton et al., 2006). 
Further, insulin has a role in the “turn off” of responses that are related to the fasting 
state. In fact, the relation in concentrations of insulin and glucagon, released 
respectively by β- and α-cells of the pancreas, is highly dependent, and at the same time 
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 This is further modulated by cephalic and incretin factors (Zawalich et al, 1989). These signals promote 
the readiness of releasability of the insulin granules already docked to the plasma membrane (Straub and 
Sharp, 2002). 
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influential, on the prandial status. Thus, postprandial increased insulin release blocks 
the output of glucose from the liver; since at this stage the available ingested glucose 
can be used to fuel the tissues that, during fasting, where dependent upon hepatic-
generated glucose. 
 
The regulation of the aforementioned processes in the fasted and fed states is further 
conditioned by a more wide control of food intake and disposal. This mechanism has 
both short and long-term control loops. The first, as seen before, answers rapidly to 
dietary challenges and is involved in meal initiation and termination. This short-term 
response depends on blood concentrations of nutrients and metabolites, and on signals 
from the gastrointestinal tract (Havel, 2001). The second is responsible for alterations in 
feeding patterns, and is modulated by the status of the stocks of energy. This long-term 
control is mainly influenced by signals that are proportional to body adipose tissue, as 
insulin and leptin (Havel, 2001). 
 
Consistent with this, acute hepatic denervation does not alter feeding patterns 
(Martin et al., 1990). Thus, although the central nervous system is able to manage 
alterations of hepatic glucose metabolism during fast/fed/fast transitions through the 
hepatic autonomic nervous system (Edgerton et al., 2006), it seems that the long-term 
control of energy balance and feeding behaviour is able to function properly in the 
absence of this signal. Hepatic parasympathetic afferents seem however to be related to 
fat intake (Warne et al., 2007), and to the regulation of plasma metabolite levels 
dependent on the insulin/corticosterone balance (Cailotto et al., 2005). This hints to a 
different regulation of the mechanism of choice of caloric source, modulated by insulin 
action. 
 
Body energy balance is monitored mainly by brain centres located in the 
hypothalamus. While the feeding centre in the lateral hypothalamus is related to the 
necessity of food ingestion, the satiety centre in the ventromedial nuclei of the 
hypothalamus is responsible for inducing the sense of fullness. Apparently, the instinct 
to eat is always present, which makes the feeding centre always active, and it is the 
satiety centre that modulates it. The hypothalamus integrates information from all over 
the body, either through nervous or hormonal pathways. Changes in neuron activity 
within each centre leads to changes in feeding behaviour. 
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Hypothalamic control of feeding behaviour can be perceived as a response either to 
a positive or negative energy balance. A decrease of blood glucose concentration may 
signal the depletion of energy reserves. This leads to a decrease in the firing frequency 
of neurons in the satiety centre, with a subsequent decrease in the inhibition maintained 
upon the feeding centre, and resulting stimulation of food intake. On the other hand, an 
increase in the amount of adipose tissue and circulating lipids leads to the activation of 
neurons in the satiety centre, thus increasing inhibition on the feeding centre and 
decreasing food intake. 
 
The central nervous system is also responsible for a circadian rhythmic control in 
the daily variation of glucose metabolism (Cailotto et al., 2005; Kalsbeek et al., 2004). 
This mechanism allows, even prior to food ingestion, blood glycemia to rise at dawn, in 
anticipation of the beginning of higher body activity. It also influences blood glycemia 
in the remaining parts of day.  
This circadian signal seems to be mostly modulated by the sympathetic connection 
between brain and liver (Cailotto et al., 2005). Since the hepatic parasympathetic nerves 
are related to the afferent and efferent central responses necessary to regulate the 
disposal of a meal, this hints to a possible critical role of the autonomic sympathovagal 
balance in the global regulation of glucose metabolism. 
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Figure 3 - Autonomic nervous control of glucose homeostasis through central integration (Adapted 
from Niijima, 1989). This is a general representation of parasympathetic (blue) and sympathetic (red) 
autonomic nervous signals that influence glucose homeostasis management. Afferent (continuous lines) 
parasympathetic innervation provides the brain with data from nutrient mechanical and chemo sensors. 
This is integrated, mainly in the hypothalamus, with information from nutrient sensors within the brain. 
Parasympathetic and sympathetic efferent signals (dotted lines) participate in the regulation ascertained 
by the brain on several organs. 
 
 
Brain inputs are provided by humoral factors and neural pathways (mainly from gut, 
adipose tissue, and liver) (Yamada and Katagiri, 2007).  
Signals received by the hypothalamus are several, as well as the organs they control 
(Figure 3); allowing the hypothalamus to function as the brain main integrator and 
effector in terms of energy homeostasis (Yamada and Katagiri, 2007). After receiving 
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information both from local sensors and from afferent nerves, the hypothalamus exerts 
control over several organs either by stimulating efferent nerves or by hormones 
secreted from the pituitary gland. 
 
The liver is chief among the organs in which the hypothalamus interferes on 
metabolic homeostasis (Kiba, 2002; Uyama et al., 2004). Afferent signals from the 
hepatic region26 are believed to be related to cytokines and nutrient metabolites sensors 
(Berthoud, 2004; Berthoud, 2008; Uyama et al., 2004). Additionally, intrinsic hepatic 
nerves may also have sensory functions27 (Forssmann and Ito, 1977). The hypothalamus 
has direct efferent innervation to the liver, but also influences it by stimulating three 
endocrine axis; modulating actively the pancreas, adrenal glands, and the pituitary 
gland. 
As mentioned, the pancreas secretes both insulin and glucagon, which have 
antagonic effects upon glycogenesis, glycogenolysis, and gluconeogenesis. Insulin 
favours anabolic processes, while glucagon favours catabolic reactions. Catecholamines 
are released from the adrenal glands, and mainly facilitate glycogen degradation and 
gluconeogenesis. The hypothalamus also regulates adrenal glands indirectly, by leading 
to adrenocorticotropic hormone (ACTH) release from the pituitary gland, which 
stimulates the production of cortisol and corticosterone from the adrenal glands. These 
act on peripheral tissues to facilitate gluconeogenesis at the liver. Likewise, growth 
hormone, released from the pituitary gland, increases hepatic glucose production 
indirectly, by stimulating lipolysis in adipose tissue. Thyroid hormones have a direct 
effect on the liver promoting gluconeogenesis, besides enhancing the action of 
catecholamines and glucagon (Uyama et al., 2004). 
In this intraorgan communication, the liver may also be able to influence β–cell 
mass through the existing neural relay mediated by the central nervous system. This 
mechanism is stimulated by hepatic extracellular signal-regulated kinase (ERK) 
signalling, through the parasympathetic nervous system (Imai et al., 2008; Uno et al., 
                                               
26
 These nerves are originated at the hepatoportal region and not from the liver proper (Berthoud, 2004; 
Uyama et al, 2004). 
27
 The distribution of these intrahepatic nerves is highly species-dependant; and may be inversely related 
to the degree of direct parasympathetic innervation of hepatic lobules (Forssmann and Ito, 1977). 
Alternatively, hepatic parasympathetic innervation feeds into the hepatocyte triads. 
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2006); and may be involved in the adaptative behaviour to an increase in fat 
accumulation within the liver28 (Eaton et al., 2009), the so-called “fatty liver”. 
Adipose tissue has direct parasympathetic innervation (Kreier et al., 2006). It also 
has sympathetic innervation, which acts by inducing lipolysis (Bartness and Song, 
2007). Again, energy-related information derived from the liver can influence the 
adipose tissue, through a neuronal pathway (Uno et al., 2006). Additionally, the adipose 
tissue releases several adipokines able to interfere on skeletal muscle glucose uptake 
(Sell et al., 2006b). This relation between adipose tissue and skeletal muscle is at the 
basis of the detrimental effects of inflammation on whole-body glucose uptake.  
This is even more relevant as an impairment of parasympathetic function has been 
related to an overexpression of the inflammation response (Czura and Tracey, 2005; 
Sloan et al., 2007). Indeed, the parasympathetic autonomic nervous system seems to be 
involved in the regulation of cytokines release (Sloan et al., 2007). Thus, a decrease in 
parasympathetic function would, besides from determining possible alterations in 
glucose metabolism by interfering in glucose absorption and insulin secretion, further 
hinders insulin-stimulated glucose uptake by inducing the interference of major 
pathways of inflammation, cellular stress, and mitogenesis (Sell et al., 2006a). 
 
To conclude, changes in the ability of any tissue to adapt to the transition between 
the fasting and fed states, may hamper the regulation of glucose fluxes body-wise; by 
disrupting the aforementioned hormonal and nervous crosstalk systems (Ukropec et al., 
2008). 
 
 
1.8.Glucose transport and intracellular signalling 
 
Glucose entry on cells is generally achieved by facilitated diffusion29 (Wood and 
Trayhurn, 2003). Circulating glucose attaches to the extracellular face of a carrier 
protein that spans the entire plasma membrane. These glucose transporters (GLUT) 
                                               
28
 It has been proposed that those intrahepatic fat deposits are a critical determinant of metabolic 
deregulation, rather than visceral or subcutaneous body fat deposition (Eaton et al, 2009). 
29
 Apart from the facilitative transporters, the GLUT family, glucose can also be transported by another 
class, the sodium-dependent glucose co-transporters (SGLT). These are present mainly in cells lining the 
intestinal lumen and the proximal tubules of the kidneys, to ferry glucose against the concentration 
gradient. This transport is powered by a sodium gradient provided by the sodium-potassium ATPase 
pump (Wood and Trayhurn, 2003). 
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undergo conformational changes, ferrying the glucose molecules to (and, in some cases, 
from) the cell cytosol; this depending upon the existence of a concentration difference 
between the two media. As already mentioned, this allows glucose to keep moving into 
cells to produce energy or be stored, and out to provide energy for other tissues. 
There are more than a dozen isoforms of the GLUT family; slightly different in 
tissue distribution, specificity and affinity for sugars, and in additional stimuli able to 
change these characteristics (Mueckler, 1994; Wood and Trayhurn, 2003). 
The GLUT1 is present in all tissues, being related to basal glucose uptake. Albeit its 
ubiquitous function, it is especially critical in providing glucose to the brain, through the 
blood-brain barrier (Leybaert, 2005). GLUT2 is expressed mainly in pancreatic β-cells, 
hepatocytes, enterocytes, and renal tubules. It is responsible for the ability of β-cells to 
act as glucose sensors for insulin secretion, and of hepatocytes to shift between output 
and uptake of glucose. Likewise, it is involved in the intestinal absorption and renal 
reabsorption of glucose (Wood and Trayhurn, 2003). The GLUT3 has the highest 
affinity to glucose. For this, it is expressed in situations of high demand of this fuel, as 
during fetal development and in the brain (Simpson et al., 2008). In some types of 
glucose transporters, especially GLUT4, which can be found mainly in skeletal muscle 
and adipose tissue, the rate of facilitated diffusion is able to be accelerated by insulin 
and other stimuli (Huang and Czech, 2007; Khan and Pessin, 2002). These mechanism 
arise from the necessity of either quickly disposing of glucose from the blood, as in 
immediately after a meal, or providing glucose for energy production, as in exercise, 
cold exposure, or hypoxia (Dohm, 2002; Huang and Czech, 2007). Some transporters 
ferry other hexoses than glucose; like fructose, in the case of GLUT5 (Douard and 
Ferraris, 2008). 
The characteristics of these and other facilitative hexose transporters can be found in 
Table 1. 
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Table I - Tissue distribution and function of facilitative glucose transporters. Adapted from (Doblado 
and Moley, 2009; Mueckler, 1994; Rogers et al., 2002; Stuart et al., 2009; Wood and Trayhurn, 2003). 
 
Name Tissue expression Proposed function 
GLUT1 Ubiquitous; adipose, muscle, liver, 
especially brain and erythrocytes 
Basal glucose metabolism; transport across 
blood-brain barrier 
GLUT 2 Hepatocytes, pancreatic β-cells, intestine, 
kidneys 
Glucose sensing; high-capacity low-
affinity transport; transepithelial transport  
GLUT 3 Especially important in brain High affinity for glucose; basal transport; 
uptake from cerebral fluid into brain 
parenchimal cells 
GLUT 4 Skeletal muscle, heart, adipocytes Insulin-stimulated glucose uptake; 
especially important in the postprandial 
state 
GLUT 5 Small intestine, testes, adipose, muscle, 
brain, and renal tissues 
Intestinal absorption of fructose 
GLUT 6 Brain, spleen, leucocytes Glucose transport 
GLUT 7  Hepatocytes and gluconeogenic tissues Mediates flux across endoplasmic 
reticulum membrane 
GLUT 8 Testes, brain, and other tissues Glucose transport 
GLUT 9 Liver, kidneys Hexose and uric acid transporter 
GLUT 10 Liver, pancreas n.d. 
GLUT 11 Heart, skeletal muscle, liver, lung Fructose and glucose transport 
GLUT 12 Heart, prostate, muscle, small intestine, 
adipose tissue 
Provides redundancy for the insulin-
stimulated GLUT4 
 
 
As stated before, GLUT4 is especially relevant for insulin-stimulated glucose 
uptake. In the basal state, GLUT4 cycles slowly between being inserted at the plasma 
membrane and being stored at intracellular sites. These sites, where GLUT4 molecules 
are sequestered within vesicles, include the trans-Golgi network, recycling endossomes, 
and diverse tubulo-vesicular bodies (Ishiki and Klip, 2005). At this stage, only a small 
fraction of GLUT4 is integrated in the cell membrane at a given time (Kanzaki, 2006). 
The 90% that are sequestered may be so in two “pools”, corresponding to different 
intracellular structures (Ishiki and Klip, 2005; Thong et al., 2005). 
Insulin action triggers a series of signalling pathways that change the traffic of the 
GLUT4-containing vesicles among diverse intracellular depots, accelerates their 
translocation to the plasma membrane, as well as sometimes decreases GLUT4 
endocytosis from the membrane back into vesicles (Ishiki and Klip, 2005). The 
activation provided by insulin may also lead to differences in the GLUT4-containing 
vesicles that are translocated to the cell membrane; specifically, in the content of 
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proteins involved in vesicular docking/fusion to the plasma membrane30 (Pessin et al., 
1999; Thong et al., 2005). Furthermore, the action of insulin on GLUT4 trafficking is 
likely due to changes in actin and microtubule cytoskeleton (Chang et al., 2004; He et 
al., 2007). 
GLUT4 endocytosis is a subject less well known than exocytosis. However, the 
effect of insulin on reducing the rate of internalisation of GLUT4 seems to be relevant 
in adipocytes but not in myocytes (Antonescu et al., 2009). In adipocytes, insulin seems 
to prevent the endocytosis of GLUT4 in caveolae31 (Khan and Pessin, 2002), rather 
redirecting them to be internalised through slower clathrin-coated vesicles. In skeletal 
muscle cells, insulin seems to have no effect on endocytosis rate, in opposition to its 
drastic increase in GLUT4 exocytosis. Nonetheless, the same decrease in endocytosis 
seen in adipocytes can be elicited in myocytes, but rather by influence of factors related 
to muscle contraction (Wijesekara et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               
30
 This is related mainly to the vesicular content of SNARE protein VAMP2, which interacts with its 
SNARE protein counterpart on the plasma membrane to induce docking and fusion of the GLUT4-
containing vesicle (Pessin et al, 1999). 
31
 Caveolae are small (50-80 nm) invaginations in the lipid rafts of plasma membrane, maintained by the 
protein caveolin (Kahn and Pessin, 2002). 
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Figure 4 - Induction of GLUT4 translocation. Representation of stimuli and intracellular pathways that 
lead to GLUT4 translocation and activation (adapted from (Higaki et al., 2001; Jessen and Goodyear, 
2005; Long and Zierath, 2005; Rockl et al., 2008; Thong et al., 2005)). Insulin is represented by red 
triangles and glucose is represented by blue circles. A160: Akt substrate of 160 kDa, Akt: protein kinase 
B, AMP: adenosine monophosphate, AMPK: 5’adenosine monophosphate-activated protein kinase, 
aPKC: atypical protein kinase C, ATP: adenosine triphosphate, CAMK: Ca2+/calmodulin protein kinase, 
Cbl: Casitas b-lineage lymphoma protooncogene, IRS: insulin receptor substrate, MAPK: mitogen-
activated protein kinase, NO: nitric oxide, P: phosphate group, PDK: 3-phosphoinositide-dependent 
kinase, PI3K: phosphoinositide-3-kinase, PI(3,4,5)P3: phosphatidylinositol-3,4,5-triphosphate, TC10: 
GTPase protein, VAMP2: vesicle-associated membrane protein. 
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The transmembrane insulin receptor has two α extracellular subunits, where insulin 
binding occurs, and two β intracellular subunits, with various sites32 of 
autophosphorylation with tyrosine kinase activity (Chang et al., 2004). After insulin 
binding is effective, the activated receptor induces the phosphorylation of tyrosine 
residues on intracellular substrate proteins.  
The intracellular substrate proteins bind to the activated insulin receptor and are 
responsible for signal transmission to the diverse metabolic, mitogenic, and anti-apoptic 
signalling pathways that are modulated by insulin33. These proteins are named insulin 
receptor substrates (IRS) and possess several isoforms, with tissue-specific functions 
(Thirone et al., 2006). Among them, IRS1 and IRS2 seem to play the most important 
part in glucose homeostasis (Fritsche et al., 2008; Thirone et al., 2006); with 
complementary actions among them34 (Chang et al., 2004). The phosphotyrosine 
residues in these IRS provide docking sites for other proteins, belonging to different 
signalling pathways (Khan and Pessin, 2002). 
 
Although insulin actions, relayed by activated IRS proteins, are widely diverse, its 
effect on GLUT4 translocation is mainly achieved through the phosphatidylinositol-3-
kinase (PI3K) pathway (Khan and Pessin, 2002). Additionally, apparently on adipose 
tissue but not on skeletal muscle (JeBailey et al., 2004), that signal has to be 
complemented with the contribution of a second signalling pathway, the Cbl-TC10, to 
allow for correct GLUT4 translocation and induction of glucose uptake (Khan and 
Pessin, 2002). Both pathways will be briefly described below. 
 
PI3K is essential to the metabolic and mitogenic actions of both insulin and insulin-
like growth factor 1 (IGF1) (Saltiel and Kahn, 2001). In the case of insulin action on 
glucose metabolism, the activated IRS interacts with the p85 regulatory subunit of 
                                               
32
 The intracellular portion of the insulin receptor has sites for phosphorylation at juxtamembrane, kinase, 
and C-tail regions (Chang et al, 2004). 
33
 The insulin receptor substrates (IRS) are also responsible for relaying the signal from insulin-like 
growth factor I (IGF1) binding. IGF1 can bind either to specific receptors, or hybrid receptors that bind 
both IGF1 and insulin. This versatility explains how the same signal can be diverted into different 
pathways. 
34
 This has been observed in studies regarding specific IRS knock-out (KO) mices. IRS1KO are growth 
retarded, have peripheral insulin resistance, and show glucose intolerance, albeit not becoming diabetics. 
IRS2KO present both peripheral and liver insulin resistance, and develop type 2 diabetes (Chang et al, 
2004). 
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PI3K. This activates the other half of the PI3K dimmer, the p110 catalytic subunit. The 
enzyme then catalyses the phosphorilation of the lipid substrate phosphatidylinositol-
4,5-biphosphate (PI(4,5)P2). The resultant phosphatidylinositol-4,5-triphosphate 
(PI(3,4,5)P3) migrates but remains bound to the plasma membrane, from where it 
regulates the activity of several effector proteins in the insulin signalling pathways 
(Thong et al., 2005). PI(3,4,5)P3 recruits these effectors to the plasma membrane and 
activates them. These include PDK1, which then phosphorilates other downstream 
effectors, as protein kinase B (known as Akt or PKB) and atypical protein kinase C 
(PKC ζ/λ) (Khan and Pessin, 2002). Akt further acts on the substrate AS160, 
inactivating its GTPase-activating domain by phosphorylation, and removing the block 
that AS160 imposes on GLUT4 translocation when able to interact with Rab proteins 
pertaining to GLUT4-containing vesicles. In turn, PKC ζ/λ may induce actin 
remodelling essential for GLUT4 translocation. These effectors seem to produce a 
general signal for the trafficking of GLUT4-containing vesicles among intracellular 
pools, and translocation to the cell surface. 
As mentioned, this general signal may not be enough to promote glucose transport 
into the cell; even when it leads to GLUT4 translocation to the plasma membrane 
(Sweeney et al., 2004). A second signal has been identified as being generated from 
lipid raft microdomains (Chang et al., 2004). These plasma membrane regions are 
highly enriched in cholesterol, sphingolipids, and assorted anchored proteins. Likewise, 
insulin receptors reside in these lipid rafts, by interaction with the protein caveolin 
(Kanzaki, 2006). The activation of insulin receptors in these caveolae leads to the 
tyrosine phosphorylation of proto-oncogenes Cbl (Kanzaki, 2006; Thong et al., 2005), 
by formation of a complex with the associated protein substrate, APS. Further, the Cbl-
associated protein, CAP, is also recruited to the complex. Upon phosphorylation, Cbl 
interacts with the protein CrkII, which is constitutively associated with the nucleotide 
exchange factor C3G. The C3G stimulates the activation of a small G-protein, TC10, by 
substituting GDP with GTP. The activated TC10 is a potent regulator of actin 
remodelling (Kanzaki, 2006), through pathways that likely intersect the PI3K pathway 
by also recruiting PKC ζ/λ (Chang et al., 2004). The crosstalk between these two 
pathways seems thus to govern the translocation, tethering and fusion of GLUT4-
containing vesicles, and the activation of glucose transport proper.  
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Although the previous mechanism for GLUT4 activation seem to be present in 
adipocytes but absent in skeletal muscle cells (JeBailey et al., 2004), several studies  
have raised the hypothesis that nonetheless the myocytes present a similar signalling 
differentiation between translocation and activation (Michelle Furtado et al., 2003; 
Somwar et al., 2001). According to this, insulin also activates the p38 mitogen-activated 
protein kinase (MAPK). Interestingly, p38 MAPK is recruited to the plasma membrane, 
where it may be involved in activating the GLUT4, either by promoting their 
dephosphorylation35 or by removal of another inhibitory protein (Michelle Furtado et 
al., 2003). This is consistent with the specificity of insulin action; although the PI3K 
pathway is activated by other hormones and growth factors, only insulin induces this 
effect on GLUT4 translocation and activation (Isakoff et al., 1995).  
 
Besides the previously mentioned sites for tyrosine phosphorylation on the insulin 
receptor and on the IRS, that induce an increase in insulin-stimulated glucose uptake, 
additional sites of phosphorylation, but with serine kinase activity, are further involved 
in the regulation of the insulin receptor activation (Saltiel and Kahn, 2001); but 
providing a negative feedback for insulin signalling. Thus, several protein 
serine/threonine phosphatases have regulatory functions of insulin signalling, either 
with stimulatory or inhibitory effects (He et al., 2007). Likewise, nitric oxide is reported 
to potentiate insulin signalling at low doses, but to attenuate that signal when in high 
doses, by S-nitrosation of the insulin receptor, IRS1, and Akt36 (Badal et al., 2006; 
Carvalho-Filho et al., 2005; Fritsche et al., 2008; Wu, 2009; Wu et al., 2009). 
Pathophysiologically, a wide range of factors (hyperglycemia and hyperinsulinemia, 
fatty acids, cytokines, glycated proteins, and others) have the ability of interfering with 
at least one of the multiple steps of insulin signalling (Pirola et al., 2004; Yu et al., 
2002). 
 
Beyond the action of insulin in stimulating glucose removal from the blood to the 
cell, thus crucially helping to manage postprandial blood glucose levels, intracellular 
                                               
35
 GLUT4 are more phosphorylated when fused to the myocyte plasma membrane than when sequestered 
on intracellular compartments. However, paradoxically, surface GLUT4 loose more than half their 
phosphorylation when insulin is present, while intracellular GLUT4 phosphorylation is unaffected by 
insulin administration (Michelle Furtado et al, 2003).  
36
 This may be specifically related to the expression of the inducible nitric oxide synthase (iNOS), and 
hence with inflammatory stimuli that induce insulin resistance at the skeletal muscle (Carvalho-Filho et 
al, 2005; Badal et al, 2006). The amount of nitric oxide production originated by iNOS when activated far 
surpasses that of the constitutive isoforms. 
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insulin signalling is responsible for its role in regulating overall glucose and lipid 
metabolism, and in blocking catabolic reactions.  
Especially in the liver, increased insulin signalling and glucose concentration induce 
the transcription of glycolytic and fatty-acid synthetic genes in the nucleus and the 
activation of cytosol enzymes (Saltiel and Kahn, 2001). Similarly, genes related to 
gluconeogenesis and lipolysis are down-regulated; by Akt/PKB or atypical PKC 
phosphorylation of several transcription factors, as, for example, fork-head box proteins 
(Fox0). Since this insulin action does not affect gluconeogenic enzymes already present 
in the cytosol, this is not a rapid inhibition (Fritsche et al., 2008). Insulin signalling has 
also a role in protein metabolism, increasing synthesis and blocking degradation of 
proteins through activation of the mTOR pathway (Saltiel and Kahn, 2001), which is 
also related to the mitogenic and growth effects of insulin. 
 
It remains to be referred the question of insulin signalling initiation/termination. It 
seems consensual that insulin stimulation of glucose uptake is initiated when insulin 
binds to its receptor on the cell surface. However, from then on, insulin has several 
possible fates, which surely impinge on signal termination. 
The insulin bound to the receptor may be released or be caught by internalisation; 
considering that, even when it is released without internalisation, it may have been 
partially degraded by enzymes present in the cell surface (Duckworth et al., 1998). The 
clearance of insulin from the blood happens primarily in the liver and kidneys, and in a 
lesser degree in the skeletal muscle and other insulin sensitive tissues. When the 
complex insulin/insulin receptor is internalised into endosomes, insulin may suffer 
differential degrees of degradation, mainly induced by the insulin degrading enzyme 
(IDE)37 (Camberos et al., 2001; Hersh, 2006; Valera Mora et al., 2003). These 
sequential steps induce first cleavages of the insulin B-chain at several points, and only 
then the cleavage of disulfide bonds, by the protein disulfide isomerase (PDI). The 
results are multiple; mainly yielding intact A-chains and several B-chain fragments. By 
this time, the fragments may be further degraded inside the endosomes, freely or still 
bound to the receptor. Potentially at any of these steps, intact or fragment insulin may 
                                               
37
 Insulin degrading enzyme (IDE) activity is inhibited by ATP (Camberos et al, 2001). This may allow 
the regulation of insulin degradation by the current cell energy status; linking the need/surplus of energy 
signalled by the availability of ATP to the processing of insulin, both by regulating the extracellular 
concentration of insulin by modifying the rate of insulin clearance and/or modulating the intracellular 
signalling by insulin and its degradation products.  
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be able to stimulate or inhibit intracellular processes; expectedly those related to lipid or 
protein metabolism, cell growth or mitogenesis (Duckworth et al., 1998). 
If intended for disposal, insulin or its fragments are delivered to lysosomes. The 
endosomes can eventually fuse again with the plasma membrane, releasing to the 
exterior the intact insulin or its fragments. The insulin receptor is reinstated to its 
transmembrane position (Duckworth et al., 1998; Zhang and Radziuk, 2001).  
 
Insulin was thus shown to be the main coordinator of the metabolic responses after a 
meal, in tissues as liver and skeletal muscle. On the other hand, during fasting, when 
circulating insulin levels decrease, this predominant role is taken by other hormones, as 
glucagon, catecholamines, and glucocorticoids. 
Glucagon binds to its respective plasma membrane receptor, inducing the activation 
of adenylate cyclase, which catalyses the formation of cyclic adenosine monophosphate 
(cAMP). The increased cAMP binds to protein kinase A (PKA), resulting in the 
blockade of glycogen synthesis and glycolysis, and the activation of glycogenolysis 
(Jiang et al., 2001). Catecholamines act through α-adrenergic receptors in a cAMP-
independent manner, but with the same results of increased glycogenolysis and 
gluconeogenesis (Clark et al., 1983). Glucocorticoids have to reach the nucleus to bind 
to their receptor, where they increase the transcription of genes related to 
gluconeogenesis, lipid β-oxidation, and ketogenesis (Fritsche et al., 2008). This favours 
the release of glucose from the liver during short-term fasting or exercise38 (Farghali et 
al., 2008), as well as the production of gluconeogenic substrates and ketone bodies for 
longer fasting periods. As expected, the hormones involved here act at quite the same 
points as insulin does, but in an inverse manner. 
 
Still, other stimuli are able to lead to cell glucose uptake, independently from 
insulin. 
With exercise, contraction increases glucose uptake by skeletal muscle cells, but in 
an insulin-independent manner (Wasserman, 2009). This pathway is not yet well 
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 The same mechanism seems to be triggered in response to inflammation (Farghali et al, 2008).  This 
opens the hypothesis of a dose-dependent mediation of glycogenolysis by hepatic nitric oxide; where high 
concentrations of nitric oxide, achieved through activation of inducible nitric oxide synthase, would 
favour hepatic glycogen degradation.  
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established39 (Clark et al., 1983), but AMPK, calcium, and nitric oxide seem to play an 
important role on the signalling that leads to contraction-induced glucose uptake 
(Dohm, 2002; Jessen and Goodyear, 2005; McConell and Wadley, 2008; Zierath, 2002). 
AMPK is a metabolic sensor, activated when the cell is deficient of energy; this feature 
may enable it to fine tune the crosstalk between the contraction- and insulin-stimulated 
pathways of glucose uptake (Long and Zierath, 2005). 
Hypoxia seems to constitute the stimulus for a third pathway that is able to stimulate 
skeletal muscle glucose uptake, which may or may not overlap certain steps of the 
previous two pathways (Brahimi-Horn et al., 2007; Mu et al., 2001). It has been recently 
proposed that all these pathways converge on a single nexus within the skeletal muscle, 
by activating the AS160 (Kramer et al., 2006) through phosphorylation of the TBC1D1 
protein (Taylor et al., 2008). 
Other peptides, derived from the biosynthesis of insulin, as connecting peptide (C-
peptide)40, may also have an effect on glucose uptake (Forst and Wahren, 2008). C-
peptide binds to the plasma membrane through a G-protein coupled receptor, and 
increases glucose uptake at the skeletal muscle by activation of MAPK and endothelial 
nitric oxide synthase (Hills and Brunskill, 2008; Li et al., 1999). This effect of C-
peptide on glucose utilisation seems to overlap insulin intracellular signalling, although 
bypassing the insulin receptor and early stages of insulin signalling (Wilhelm et al., 
2008). Additionally, considering the unknown areas regarding the hepatic endossomal 
metabolism of the insulin/insulin-receptor complex, products of the 
degradation/alteration of the insulin molecule proper may yet likewise come to be found 
to have a biological action on glucose metabolism. 
 
This interplay of intracellular processes provides a combined metabolic regulation 
of the alternation between fasting and fed periods; explaining how the phenomena 
described on topic 1.7 are induced. As described, almost each step in these processes is 
subjected to diverse activating and inhibitory influences; with the main objective of 
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 Contraction-stimulated glucose uptake seems to be modulated by the effect of an adrenergic balance. 
The α- and β-receptors mediate responses on liver, pancreas, heart, and skeletal muscle, which lead to 
lower insulin release, tissue glycolysis, glycogenolysis, and gluconeogenesis (Clark et al, 1983). This 
explains how, outside exercise, catecholamines induce insulin resistance; by decreasing pancreatic insulin 
release, and increasing the pool of available intracellular glucose-6-phosphate.  
40
 The connecting peptide (C-peptide) favours the structural assembly of the A- and B-chains of insulin 
(forming proinsulin). The cleavage of C-peptide happens within β-cell granules, prior to exocytosis. Until 
recently, C-peptide was thought to have no biological effect once released concomitantly with insulin into 
the bloodstream (Forst and Wahren, 2008).  
                                                                                                                      1.Introduction 
 41 
integrating information from parallel pathways. This is yet a burgeoning field of study, 
with novel mechanisms being investigated; as is the case of the suggested prandial-
dependent modulation of peripheral insulin sensitivity by an hepatic signal that is 
presented below. 
 
 
1.9.Hepatic modulation of postprandial peripheral insulin sensitivity 
 
It is well known that insulin-stimulated whole-body glucose uptake assessed after a 
meal doubles that observed in the fasted state. This has been mainly attributed to the 
increase in insulin secretion in response to a meal, with a subsequent rise in circulating 
insulin bathing the peripheral tissues. The greater insulin availability would explain the 
increase in insulin-stimulated glucose uptake. Thus, the classic role of the liver in 
influencing peripheral insulin action would be derived from how hepatic insulin 
extraction modulates the concentration reaching the peripheral tissues (Balks and 
Jungermann, 1984; Jaspan and Polonsky, 1982)41. 
However, it was observed that this postprandial increase in insulin sensitivity can be 
blocked without changing postprandial peripheral insulin levels (Lautt, 1999). This has 
led to the proposition of a new hypothesis, one that involves the liver as a key effector 
in the modulation of peripheral tissue insulin sensitivity. This hypothesis relates the 
hepatic parasympathetic nerve tonus to the insulin sensitivity at the skeletal muscle 
through the action of a hormone tentatively called “HISS”, which stands for hepatic 
insulin sensitising substance (Figure 5). 
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 Hepatic insulin extraction has been shown to also reflect insulin action at the liver. After a meal, when 
insulin secretion is augmented, insulin extraction is both fractionally and quantitatively larger. This has 
been related to the action of insulin in suppressing glucose output and promoting glucose uptake in the 
liver (Jaspan and Polonsky, 1982), but can be expected to favour also other pathways associated with 
insulin-processing in the liver. 
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Figure 5 - Proposed hypothesis for the postprandial regulation of peripheral glucose uptake. Several 
feeding signals trigger the release of the Hepatic Insulin Sensitising Substance (HISS) from the liver. This 
will act at the skeletal muscle, either through a direct interaction with the insulin receptor or through a 
direct action on other component of the plasma membrane, to potentiate intracellular insulin signalling. 
The effect will be an increase in GLUT4-mediated glucose uptake. Ach: acetylcholine, GSH: reduced 
glutathione, HISS: hepatic insulin sensitising substance, IR: insulin receptor, NO: nitric oxide. 
 
 
In the 1980s, the observation that the vagal parasympathetic innervation to the liver 
was essential to allow for the increase in insulin-stimulated glucose uptake seen after 
oral ingestion of a glucose load led to the hypothesis that hepatic autonomic dysfunction 
could lead to a decrease in hepatic glucose uptake and glycogen synthesis. This was 
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thus posited as a link between liver disease and type 2 diabetes; with autonomic 
neuropathy being proposed as an aetiological factor to diabetes development (Lautt, 
1980). Later studies were to dispel the former assumption, although still preserving the 
notion of liver-related dysfunctions as determinants of glucose metabolism 
deregulation, and diabetes.  
More than ten years passed until the study of this pathway could be properly 
addressed. First, it was shown that indeed it was the parasympathetic hepatic 
innervation that, if ablated, led to a decrease in the hypoglycaemic effect of insulin (Xie 
et al., 1993). The neutralisation of the hepatic sympathetic innervation had no additional 
detrimental effect (Xie et al., 1993). Then, it was shown that the administration of a 
cholinergic muscarinic antagonist, atropine, was able to produce the same degree of 
impairment of the hypoglycaemic action of insulin as the hepatic parasympathetic 
denervation (Xie and Lautt, 1994). Subsequently, more detailed studies identified the 
hepatic muscarinic M1 receptor as the one mediating this parasympathetic modulation 
of insulin action (Xie and Lautt, 1995b). Again, even considering that pharmacological 
parasympathetic blockade could influence other sites, atropine was shown not to have 
any additional detrimental effect over insulin-stimulated glucose uptake in relation to 
hepatic denervation (Xie and Lautt, 1995a). 
The influence of hepatic parasympathetic innervation was definitely established by 
showing that acetylcholine administered directly in the liver by the portal vein was able 
to regenerate the insulin-stimulated glucose uptake abolished after denervation (Xie and 
Lautt, 1996a). As expected, peripherally administered acetylcholine was unable to 
restore insulin-stimulated glucose uptake after denervation. Similarly, atropine was 
shown to induce the same degree of insulin resistance as hepatic denervation at a lower 
dose when given intraportally than intravenously (Takayama et al., 2000). 
Until this time, the studies performed analysed whole-body measures of insulin 
sensitivity. When arteriovenous glucose gradients were measured, surgical hepatic 
denervation was shown not to impair insulin-stimulated glucose uptake in the liver. 
Surprisingly, it was the skeletal muscle that revealed an impaired in insulin-stimulated 
glucose uptake after either hepatic denervation or atropine administration (Xie and 
Lautt, 1996b). This observation disproved the original hypothesis that hepatic 
parasympathetic dysfunction produced an impairment in liver glucose uptake, but, on 
the other hand, showed how those autonomic dysfunctions could be related to whole-
body insulin resistance, through decrease of skeletal muscle glucose uptake. This led to 
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the hypothesis that the liver, after stimulation by insulin and acetylcholine, secretes an 
hormone, tentatively called hepatic insulin sensitising substance, or HISS, which travels 
through the bloodstream to act selectively at the skeletal muscle (Lautt, 1999). 
 
Since many physiological actions of acetylcholine are mediated by nitric oxide, it 
was studied as a possible next step in the intrahepatic metabolic pathway that leads to 
HISS secretion. Indeed, the administration of a nitric oxide synthase inhibitor was 
shown to produce insulin resistance similar to atropine administration or hepatic 
denervation (Sadri and Lautt, 1999). Again, an intraportally dose capable of producing 
this magnitude of insulin resistance was not able to produce it when given 
intravenously. Also, the administration of a nitric oxide donor was able to reinstate 
normal insulin sensitivity after hepatic denervation or nitric oxide synthase inhibition 
when given intraportally, but not intravenously (Sadri and Lautt, 1999). 
By this time, the hypothesis was raised that some high variability seen in previous 
studies could be related to the lack of knowledge regarding the prandial status of the 
animal experiment subjects at the time of analysis. This prompted the study of the 
relative importance of the HISS pathway on fasted and fed insulin sensitivity. This 
showed clearly that insulin sensitivity was higher immediately after feeding, and 
decreased gradually with time of fasting. Furthermore, it was shown that the component 
of insulin sensitivity preserved after atropine administration did not change, in rats, 
from the fed to, at least, the 24h-fasted state (Lautt et al., 2001). So, the HISS pathway 
was uncovered as being the responsible for the incremental insulin sensitivity seen after 
feeding.  
 
Since insulin sensitivity assessed in the fasted state or in the fed state after atropine 
were similar (Latour and Lautt, 2002b; Lautt et al., 2001), the HISS pathway is not only 
the responsible for the postprandial increment, but is also only activated after the 
ingestion of a meal. It decreases gradually with fasting duration (Latour and Lautt, 
2002b) and, given enough time, becomes in practicality non-existent. Similarly, hepatic 
parasympathetic denervation, atropine, or nitric oxide synthase inhibition, abolished 
entirely the effect of food to increase peripheral insulin sensitivity. 
 
 The dependence of the activation of the HISS pathway on the postprandial state 
raised the concept that a “feeding” signal would also be mandatory for this mechanism 
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to be properly expressed. Among the compounds that show an increase in their hepatic 
concentration after a meal ingestion, glutathione was uncovered to be of particular 
relevance to the postprandial increase in glucose tolerance. 
Reduced glutathione (GSH) was a prime candidate since it rises to unparalleled high 
hepatic concentrations in relation to all other coenzymes after a meal (Tateishi et al., 
1977). Furthermore, GSH impairment had been already linked to the development of 
glucose intolerance. Decreased levels of GSH were described to be present in diabetic 
patients, which was interpreted as either a consequence or a contributor to increased 
oxidative stress and subsequent defects on insulin secretion or action. However, 
surprisingly, GSH cellular depletion by synthesis inhibition was shown to be able to 
directly impair insulin action, without inducing changes in oxidative stress or insulin 
secretion (Khamaisi et al., 2000). 
This led to studies that showed that hepatic GSH was likewise essential for the 
optimal function of the HISS pathway (Guarino et al., 2003). The postprandial whole-
body insulin sensitivity was lower in rats subjected to chronic GSH depletion than in 
control animals. Furthermore, while in control animals the decrease in insulin sensitivity 
seen after inhibition of hepatic nitric oxide synthase was fully reinstated by the portal 
administration of the nitric oxide donor 3-morpholinosydnonimine hydrochloride (SIN-
1), in GSH-depleted animals SIN-1 had no effect on the observed insulin resistance 
(Guarino et al., 2003). This seemed to indicate that, although equally essential, GSH 
acted on the HISS pathway in a parallel stage to nitric oxide. 
Another piece of the puzzle was further glimpsed in the previous study (Guarino et 
al., 2003). Besides the positive results obtained with SIN-1, another nitric oxide donor, 
sodium nitroprusside (SNP), was used. However, SNP was not capable, under the same 
conditions, to restore the postprandial insulin sensitivity. Thus, the insulin resistance 
obtained after hepatic nitric oxide synthase inhibition remained unchanged with SNP. 
The main difference between these two nitric oxide donors is that SIN-1 acts similarly 
to the physiological effect of the enzyme nitric oxide synthase, by leading to the release 
of both nitric oxide and superoxide (O2-), while SNP releases solely nitric oxide. Since 
nitric oxide and superoxide can react rapidly with GSH, to form biologically active 
intermediates, S-nitrosothiols (Schrammel et al., 1998), this was proposed to be the 
common point in the parallel signalling pathways provided by nitric oxide and GSH. 
To ascertain the relevant pathways, the order of the factors had first to be checked; 
mainly to determine the relation between acetylcholine and nitric oxide. Intraportal 
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acetylcholine administration was unable to revert insulin resistance induced by hepatic 
nitric oxide synthase inhibition. On the other hand, the intraportal administration of the 
nitric oxide donor SIN-1 was able to ameliorate insulin sensitivity after parasympathetic 
blockade by atropine (Guarino et al., 2004). In conclusion, it is indeed the release of 
acetylcholine by the hepatic parasympathetic nerves that leads to the formation of nitric 
oxide, and the subsequent activation of HISS action. It was also postulated that the 
effect of hepatic nitric oxide on whole-body insulin sensitivity is further regulated by 
guanilate cyclase (Guarino et al., 2004). 
The necessity of the presence of the two signals was elegantly shown in fasted 
animals, where HISS is not present. Here, 24h-fasted rats were able to show normal 
postprandial insulin sensitivity only when both GSH and nitric oxide were administered 
to the liver (Guarino and Macedo, 2006). The prior administration of any one of them 
produced no effect on insulin sensitivity; the combined hepatic administration was 
indispensable to mimic normal postprandial HISS action (Guarino and Macedo, 2006). 
Again, the HISS mechanism was ascertained as the signalling pathway responsible for 
the increment in insulin sensitivity seen in the postprandial state. 
 
More recently, the identification of the trigger that induces this feeding response has 
been pursued. Intragastric administration of nutrients on fasted animals was used to 
assess the nature of the feeding signal that leads to HISS action. Administration of a 
liquid mixed meal in this way was able to produce normal postprandial insulin 
sensitivity (Sadri et al., 2006). It was concluded that it must have a chemical nature, 
rather than a physical one, since the administration of the same volume of water was 
unable to instigate any rise in insulin sensitivity. Likewise, the administration of a 
solution of glucose or sucrose was unable to properly generate the feeding signal that 
leads to insulin sensitivity potentiation. Hepatic denervation prior to the intragastric 
administration of the mixed meal prevented in absolute the triggering of the mechanism 
(Sadri et al., 2006). Again, the relevance of the hepatic parasympathetic nerves to this 
reflex was shown.  
The exact nutrient or combination of nutrients that induce this increased 
postprandial response in the skeletal muscle are not yet know; but is expectable that it 
might include proteins, since the consumption of a lipid enriched diet was shown to 
quickly induce the abrogation of HISS action (Afonso et al., 2007a). 
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Although the genesis of the autonomic nervous system feeding signal is still poorly 
understood, recent studies have uncovered that it is dependable of nutrient arrival at the 
intestine. Indeed, if the intragastrically administered mixed meal is prevented from 
progressing to the intestine, by a rubber band located at the pylorum, the postprandial 
response is blunted. On the other hand, if, also with the applied band, the mixed meal is 
given directly on the intestine, the increment in insulin sensitivity is optimal (Afonso 
and Macedo, unpublished results). 
 
Other recent advancements have reaffirmed that this increment in whole-body 
insulin-stimulated glucose uptake seen after feeding a mixed meal happens mainly at the 
skeletal muscle. In fed animals, hepatic parasympathetic nerve ablation has been shown 
to induce insulin resistance at soleus and extensor digitorum longus (EDL) skeletal 
muscles; and not at liver or adipose tissue (Fernandes and Macedo, unpublished results). 
The simultaneous dependence upon hepatic GSH and nitric oxide raised the 
hypothesis that they could be directly involved in the synthesis of HISS (Guarino et al., 
2003). Indeed, GSH and nitric oxide/superoxide react together to form S-nitrosothiols 
(RSNO). This has been since corroborated by the observation that intravenous S-
nitrosoglutathione (GSNO) administration is able to mimic postprandial insulin 
sensitivity in fasted animals (Fernandes and Macedo, unpublished results). Interestingly, 
if GSNO is perfused directly in the portal vein, it induces insulin resistance rather than 
augmenting insulin sensitivity. This suggests that RSNO may be related to the HISS 
concept, having a role in promoting peripheral insulin-stimulated glucose uptake; and 
that a negative feedback may be present if the RSNO concentration reaching the portal 
vein is too high. If the elusive HISS factor is indeed a RSNO, or another nitrosylated 
molecule for that matter42, remains to be shown (Ramachandran et al., 2001; Santos et 
al., 2006). However, the fact that a surgical or pharmacological intervention on fed 
animals is able to quickly abrogate the postprandial increment in insulin sensitivity 
argues for a short half-life of the HISS factor in circulation; which is consistent with 
these compounds. Furthermore, similar mechanisms involving 
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 Both the A and B chain of insulin have been shown in vitro to be able to bind one nitric oxide molecule 
(Santos et al, 2006). This raises the hypothesis that, in hepatocytes, insulin may be degraded and form 
adducts of each chain with nitric oxide. These would be able to be transported through the bloodstream 
and reach the skeletal muscle, where the cell surface-bound enzyme PDI seems to be able to promote 
intracellular s-nitrosilation by NO transfer from extracellular s-nitrosothiols (Ramachandran et al, 2001). 
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nitrosylation/denitrosylation have been proposed as simple, but highly selective, forms 
of nitric oxide-dependent physiological signalling (Tannenbaum and White, 2006). 
 
In summary, the HISS pathway seems to provide a way to optimise the removal of 
circulatory glucose to the skeletal muscle after the ingestion of a meal. This postulates a 
potentiating effect of HISS on insulin-stimulated glucose uptake, either directly at the 
insulin receptor or by synergistically activating the intracellular pathways that lead to 
GLUT4-mediated glucose uptake. This HISS mechanism is triggered by two feeding 
signals reaching the liver: GSH and the parasympathetic tonus, besides the presence of 
insulin. This provides a facilitator signal that, upon the increase in insulin concentration, 
potentiates insulin-stimulated glucose uptake. Absence of HISS is expected to favour 
that glucose remain more time in circulation, and eventually end up by being stored as 
fat. 
 
After the review of the basics of glucose metabolism, it remains to be addressed 
exactly what is the fate of the glucose ingested during a meal. 
 
 
1.10. Disposition of a meal and glucose metabolism 
 
Of the glucose ingested during a meal, the greater percentage is taken up by the liver 
and the skeletal muscle. Besides the 20% already mentioned that are taken up by the 
brain, around 30% is taken up by the splanchnic tissues, mainly the liver, and almost 
another 30-40%43 goes into the skeletal muscle (Foss, 1994; Holtz et al., 2008; Kelley et 
al., 1988; Meyer et al., 2002). The remaining 20% is taken by the kidneys (10%), heart 
(4%), fat (3%), and other tissues (Kelley et al., 1988; Meyer et al., 2002). 
 
The liver, for its anatomical location (receiving blood from the portal vein, directly 
from the gut outgoing circulation; which means that it is the most nutrient rich right 
after a meal), is in a prime position to act as a buffer for blood glucose. Indeed, one 
third of the hepatic glucose disposal of a meal is done on the first passage (Selz et al., 
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 Since skeletal muscle glycogen is spared when at rest, the ingested glucose directed to this tissue will 
depend upon physical activity intensity and glycogenolysis in the period between meals (Holtz et al, 
2008).  
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2003); this lowers the magnitude of the glucose excursion, thus greatly diminishing the 
degree of postprandial hyperglycemia that peripheral tissues are exposed to. Also, being 
the liver the main organ responsible for the maintenance of glucose homeostasis during 
fasting, and, together with the kidneys, unique on the capacity to both uptake and output 
substantial amounts of glucose (Moore et al., 2003), the repletion of hepatic glycogen 
reserves is a priority upon feeding44 (Capaldo et al., 1999; Greenberg et al., 2006).  
On the other hand, the skeletal muscle, although representing the greatest depot of 
glycogen, is unable to release it into the bloodstream as glucose. Furthermore, muscle 
glycogen is spared during fasting, since it must be instead available to be spent during 
physical exercise (Wasserman, 2009); so, the need to replenish it with ingested glucose 
is lower than that of the liver.  
The liver is also located immediately following the pancreas in terms of circulation, 
which is pertinent here mainly for the secretion of insulin45 (Bollyky and Greenbaum, 
2007). This allows the liver to modulate of the quantity of insulin being distributed 
systemically (Jaspan and Polonsky, 1982; Rabinowitz and Liljenquist, 1978); likewise 
contributing to delay peripheral glucose uptake and allow hepatic reserves to be firstly 
replenished46 (Bjorntorp and Sjostrom, 1978).  
Delay in insulin secretion produces changes in both carbohydrate and lipid 
metabolisms. The loss or delay of early insulin secretion allows higher postprandial 
glucose excursions to occur, and lowers inhibition of lipolysis. This is evident in type 2 
diabetics (Dimitriadis et al., 2004), and has been reversed by the pharmacological 
mimetisation of the normal insulin profile47. However, as stated before, defects in 
insulin secretion appear more generally at later stages of glucose intolerance (Saad et 
al., 2005), by effect of glucotoxicity. 
More, the hepatoportal region is rich in glucose sensors. This produces the so-called 
“portal signal” (Gardemann et al., 1986; Moore et al., 2003), which represents the 
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 Surprisingly, feeding also increases hepatic glucose cycling, with simultaneous degradation and 
synthesis (Capaldo et al, 1999; Greenberg et al, 2006). 
45
 The pancreatic secretion of glucagon may also be relevant, but its exact action in the metabolic balance 
needs yet to be clarified (Bollyky and Greenbaum, 2007). 
46
 Differences in glucose uptake determined by other routes of delivery further show the importance of 
the liver. Indeed, if glucose is administered intravenously, it leads to lower insulin secretion and 
consequently higher systemic hyperglycaemia, and a greater disposal of glucose into adipose tissue 
(Bjorntorp and Sjostrom, 1978). The response to an intravenous glucose load lacks the effect of several 
physiological triggers; as, for example, the cephalic phase of insulin secretion, the afferent neural 
signalling derived from the hepatoportal glucose sensors, or the presence of other nutrients besides 
glucose, like amino acids and fat. 
47
 This is much better achieved with an insulin secretagogue than by administration of exogenous insulin 
prior to a meal (Dimitriadis et al, 2004). This has also an ameliorating long-term effect on HbA1c.  
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glucose gradient between the arterial and portal circulations. Instead of depending solely 
on absolute glycaemia, this gradient permits to quickly stimulate hepatic glucose uptake 
even with a modest rise in blood glucose and insulin (Capaldo et al., 1999); thus also 
enhancing hepatic glycogen synthesis (Bollen et al., 1998). 
The liver as a buffer for energy storage is even more relevant when there is the need 
to handle greater glucose loads. In cases of the disposal of meals with complex 
carbohydrates, for example starch, which delay gastric emptying and thus prolong 
glucose absorption, hepatic glucose disposal may even reach 40% of the ingested 
glucose (Capaldo et al., 1999). As before, here the correspondent glucose disposal by 
skeletal muscle is estimated to be still around 30% (Capaldo et al., 1999). 
Nonetheless, in cases of exacerbated positive energy balance between intake and 
consumption, even the capacity of the liver to accommodate energy reserves may be 
overwhelmed. In this scenario, adipose tissue becomes the final destination for 
excessive carbohydrates (Bjorntorp and Sjostrom, 1978)48. This may lead to increased 
triglyceride accumulation in fat pads, liver, and, eventually, even in skeletal muscle. 
 
As stated before, insulin dominates the postprandial state as the main controller for 
glucose disposal fate; both by inhibiting endogenous glucose production, and free fatty 
acids release, and by promoting glucose disposal into tissues.  
Immediately after a meal, circulating insulinaemia is increased even more than what 
is accounted by the increase in pancreatic insulin secretion (Gibby and Hales, 1983). 
This is achieved first by a decrease in hepatic and skeletal muscle insulin fractional 
extraction (0-15 min from meal ingestion) and only after by an increase in pancreatic 
insulin secretion (from 10 min after meal ingestion onwards) (Brundin, 1999). This 
timing discrepancy may hint to a temporal uncoupling of the hepatic and extrahepatic 
effects of insulin. First by an action on the liver to inhibit endogenous glucose release 
and maximise glucose uptake (Brundin, 1999), then by sensitising peripheral tissues to 
glucose uptake49 (Gibby and Hales, 1983; Samnegard and Brundin, 2001). A small 
increment of circulating insulin suppresses hepatic glucose output and inhibits free fatty 
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 This ability of fat tissue to hold the excessive carbohydrate seems more efficient in other species, like 
rat, than in man (Bjorntorp and Sjostrom, 1978). This hints to an even lower tolerance of humans to 
overnutrition, leading to a more rapid and maintained circulating hyperglycaemia; even if thermogenesis 
is increased to compensate for the overwhelming energy intake. 
49
 On the other hand, the kidney seems to have a role in attenuating the postprandial accumulation of 
insulin in the systemic circulation (Samnegard and Brundin, 2001), by doubling renal insulin fractional 
extraction after a meal. Paradoxically, the renal fractional extraction of C-peptide (which is mainly 
cleared here, and not in the liver as insulin), is not altered by meal ingestion. 
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acids oxidation at the skeletal muscle (Groop et al., 1989). The latter helps peripheral 
tissues to switch from fat to carbohydrate consumption, an hallmark of the transition 
from the fasted to the fed state. Insulin has also effects on adipose tissue, suppressing 
lipolysis and free fatty acids release. The insulin-stimulated glucose uptake at the 
peripheral tissues, mainly the skeletal muscle, happens only at higher insulin 
concentrations. 
 
Besides the amount of glucose disposed of into each tissue, the metabolic fate of 
that glucose is also relevant. 
Almost 40% of the absorbed glucose is immediately oxidised (Fery et al., 1998). 
More than half of this is oxidised in the brain; corresponding to almost all the uptake of 
ingested glucose by this organ. Another 35% is oxidised in skeletal muscle. The heart 
(2%)50 and other tissues are responsible for the rest (Berger et al., 1976; Kelley et al., 
1988). 
Of the remaining 60% of ingested glucose, disposed by non-oxidative means (Fery 
et al., 1998), more than half is disposed of at the splanchnic tissues, mainly the liver 
(Kelley et al., 1988). This accounts for both glucose stored as glycogen by the direct 
pathway or indirectly by hepatic uptake of gluconeogenic substrates (Edgerton et al., 
2006), which have been proposed to contribute equally to postprandial hepatic glycogen 
formation (Huang and Veech, 1988; Kurland and Pilkis, 1989; Lefebvre and Scheen, 
1999)51. Only 15% of stored glucose was placed on skeletal muscle, and the kidneys 
stored 11% (Kelley et al., 1988); which is not surprising, since skeletal muscle is spared 
unless physical activity is required during fasting (Wasserman, 2009), and renal 
glycogen is turned over in response to a meal ingestion (Meyer et al., 2002). 
Indeed, to further facilitate glucose uptake by the liver, the hepatic endogenous 
release of glucose to the bloodstream, essential to maintain glucose homeostasis during 
fasting, is quickly inhibited after a meal (Moore et al., 2003). On the other hand, while 
hepatic glucose release is almost entirely suppressed by feeding, postprandial renal 
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 The myocardium has been described as resembling the contracting skeletal muscle in many ways 
(Berger et al, 1975). However, in terms of energetic fuel, it shows a more marked, and maintained, 
preference for fatty acids oxidation than the skeletal muscle.  
51
 The postprandial synthesis of hepatic glycogen is variably attributed to these two pathways; ranging 
from predominance of one, another, or an equal importance of both (Huang and Veech, 1988; Kurland 
and Pilkis, 1989; Lefebvre and Scheen, 1999).  
1.Introduction 
 52 
glucose release increases twofold52 (Meyer et al., 2002). This transient postprandial 
renal mechanism is believed to augment the efficiency of hepatic glycogen repletion. 
 
The fact that hepatic glycogen synthesis is not exclusively derived directly from 
ingested glucose should be underlined. After an overnight fast, around half of the 
remaining hepatic glycogen has been synthesised from glucose that was first converted 
to lactate and other gluconeogenic intermediaries (Bollen et al., 1998). This may seem a 
futile cycle; but may rather be an hepatic mechanism to prevent excess glycogen stores, 
and to provide a combined control over glycogenolysis and gluconeogenesis (Greenberg 
et al., 2006; Wise et al., 1997)53.    
 
Maintenance of glucose homeostasis in the postprandial state is dependent upon the 
suppression of glucose hepatic output, a shift from fat to glucose oxidation, and storage 
of glucose as glycogen at the liver and the skeletal muscle (Firth et al., 1986; Groop et 
al., 1989). So, in terms of postprandial usage of glucose in the skeletal muscle, much 
depends upon the metabolic flexibility of alternating between glucose and fatty acid 
catabolism (Corpeleijn et al., 2009; Storlien et al., 2004). However, since glucose 
oxidation in skeletal muscle is more rapidly saturated than nonoxidative metabolism 
(Foss et al., 1992), it can reveal to provide no great alternative if glycogen synthesis 
becomes impaired. 
It has been shown that glucose transport is the rate limiting step affected by the 
glucose metabolism deregulation involved in the progression to diabetes (Cline et al., 
1999). Indeed, the aetiology of the problems with postprandial handling seems generally 
to be restricted to glucose uptake. Impaired insulin-stimulated uptake is apparently 
already present when there is still a normal suppression of hepatic glucose output 
(Lefebvre and Scheen, 1999; Nielsen et al., 2005). Likewise, glucose intestinal 
absorption seems to remain normal, even with diabetes (Basu et al., 2001). 
The inability to properly dispose of ingested glucose at the skeletal muscle, a 
considerable portion of the total, even more if taken into account the glucose shuffled 
indirectly to the liver through the peripheral tissues, must lead to metabolic changes. 
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 The underestimation or disregard of renal changes may explain why the postprandial suppression of 
hepatic endogenous glucose production varies greatly among studies, between around 40 and 85% 
inhibition. 
53
 This feedback mechanism is further hinted by the influence of hepatic glycogen concentration on the 
balance between glycogenolysis and gluconeogenesis contribution to hepatic glucose endogenous 
production (Wise et al, 1997).  
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Among them is the increased postprandial accumulation of triglycerides in skeletal 
muscle and liver (Ravikumar et al., 2005). 
 
In this introduction, the hypothesis has been raised that the liver is able to influence 
extrahepatic glucose uptake during the postprandial state both by modulating insulin 
delivery to the peripheral tissues and producing an hormonal signal that potentiates 
insulin action at the skeletal muscle. This turns the spotlight into those pathologies that 
affect the health condition of the liver or the integrity of parasympathetic autonomic 
nervous system function, two essential points in the proposed mechanism. Not 
surprisingly, both conditions are known to present commonly glucose intolerance and a 
greater prevalence of diabetes.  
 
Patients with chronic liver disease present frequently disturbances of glucose 
homeostasis. However, they do not present insulin resistance at the liver, but do so at 
the skeletal muscle (Kruszynska et al., 1993; Selberg et al., 1993). Cirrhotic patients 
also present hyperinsulinemia in fasting and after oral glucose (Kruszynska et al., 1993; 
Letiexhe et al., 1993), due to increased insulin secretion and lower hepatic insulin 
extraction (Letiexhe et al., 1993). Even so, as in IGT and diabetics (Thorburn et al., 
1991), cirrhotic patients seem to hinge glucose intolerance upon the ability of 
hyperinsulinemia to compensate for the lower insulin action (Nielsen et al., 2005), the 
excess insulin levels are not always able to achieve that. 
Cirrhotic individuals present normal postprandial glucose oxidation, but lower 
nonoxidative glucose disposal, which accounts for the decreased glucose uptake (Riggio 
et al., 1992; Selberg et al., 1993). Thus, paradoxically to the affected organ, liver 
disease patients show decreased glycogen deposition at the skeletal muscle. 
This should not be derived from a defect in the molecular machinery needed for 
postprandial insulin-stimulated glucose uptake, since GLUT4 protein content and 
activity  (Holland-Fischer et al., 2007; Jessen et al., 2006) and the initial steps of 
intracellular insulin signalling (Jessen et al., 2006) seem to be similar to normal 
subjects54. Again, it argues for the impairment of a factor that potentiates insulin-
stimulated glucose uptake in the postprandial state. 
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 Even though these patients seem to loose the redundancy in GLUT4 expression, indicated by a decrease 
in GLUT4 mRNA (Holland-Fischer et al, 2007), the ability of the cell to function at an optimal level of 
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Also pathologies related to an impairment in parasympathetic nerve function, or an 
increase in sympathovagal balance, have been related to glucose intolerance and the 
development of diabetes. Not just neuropathies, but even more subtle conditions as 
depression (Das, 2007). 
 
Paradoxically, isolated skeletal muscle shows no difference in insulin-stimulated 
glucose uptake coming from short-term fasted or refed states (Berger et al., 1976). This 
discrepancy with the higher muscle insulin-stimulated glucose uptake and glycogen 
deposition seen in the postprandial state is explained by the presence of a circulating 
factor in response to a meal ingestion that potentiates insulin action; which is consistent 
with the presented HISS hypothesis.  
 
Animal models have been used widely to study insulin resistance, the development 
to type 2 diabetes, and the metabolic syndrome (Oron-Herman et al., 2008). On this 
basis, the present research was directed into what are considered to be the risk groups 
according to studies based on the OGTT analysis: history of diabetes, age, hypertension, 
and obesity (IDF, 2003). The uncovering of problems in glucose uptake related to the 
HISS mechanism would provide further avenues for prevention and treatment of 
glucose intolerance and type 2 diabetes, since glucose transport is seen as the more 
effective step in which agents will be able to improve insulin sensitivity (Shulman, 
2000). 
 
 
 
 
 
                                                                                                                                          
glucose uptake with a radical loss of this redundancy at either the insulin receptor or glucose transporter  
argues against a limitation in glucose uptake by this observation. 
                                                                                                                         2.Objectives 
 55 
 
2. OBJECTIVES 
 
The present work is based on the hypothesis that postprandial whole-body 
insulin sensitivity is regulated by a mechanism to which the integrity of the hepatic 
parasympathetic nerves (HPN) is crucial. In accordance with this, the overall objective 
of this doctoral thesis was to determine if a dysfunction of the HPN-dependent 
component of insulin sensitivity is involved in the insulin resistance seen in several 
situations related to the aetiology of type 2 diabetes. 
 
It is known that with age animals commonly become glucose intolerant and that 
the prevalence of type 2 diabetes is higher in old individuals. The first objective of this 
thesis was to assess what happens to the HPN-dependent component of insulin 
sensitivity in otherwise healthy male and female animals during those developmental 
changes. 
This thesis second objective was to evaluate the impact of environmental 
factors, such as diet manipulation, on postprandial insulin sensitivity. To this end, it was 
studied the exposure to several ways to administer a diet with a high content of the 
disaccharide sucrose, drawing a parallel to the increased diet ingestion of refined sugars 
seen today all over the world, and that undoubtedly contributes to the rising of type 2 
diabetes seen among children. 
Being type 2 diabetes a complex, multifactorial disease, the third objective was 
to study the postprandial increment of insulin sensitivity, and its possible dysfunction, 
in the presence of hypertension – a pathology usually related to insulin resistance and 
type 2 diabetes. The impact of the sustained presence of hypertension was also assessed. 
The fourth objective was related to the hepatic insulin sensitising substance (HISS) 
hypothesis, a proposed pathway that influences glucose uptake and to which the HPN 
seems to pertain. The status of other steps of the HISS pathway besides the hepatic 
parasympathetic nerves, specifically hepatic nitric oxide and hepatic glutathione, was 
also studied in the presence of hypertension. 
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3. MATERIAL AND METHODS 
 
3.1. Animals 
 
Several strains of rats were used in our studies, specifically Wistar, Sprague 
Dawley (SD), Wistar Kyoto (WKY) and Spontaneously Hypertensive Rats (SHR). The 
animals were obtained from Charles River Laboratories (Spain) and from the Animal 
House at the Faculty of Medical Sciences (FCM) of the New University of Lisbon 
(Portugal). When coming from Spain, animals were kept, after arriving at FCM, on a 
quarantine period of at least one week. 
The animals were housed in cages at the FCM Animal House, following the 
suggestions of the manufacturer for number of individuals per cage. This also depended 
at each time on the age of the animals. As an exception, the animal groups used for a 
special diet protocol were housed one per cage during the time of diet manipulation, to 
allow for the monitoring of food consumption. 
Conditions of controlled temperature and humidity were maintained (21.0 ± 5.0º 
C and 55.0 ± 5.0 %), as well as a 12h light-dark cycle (lights on from 8:00 to 20:00). 
Until the chosen age of study, more precisely until the day before the evaluation of 
insulin sensitivity, all animals had ad libitum access to water and solid pellets of 
standard chow (Panlab A04, Charles River) - composition: 15.5% protein, 58.5% 
carbohydrates and 2.7% fat - , with the exception of the groups of animals pertaining to 
the series of studies regarding the high-sucrose diet (detailed on item 3.1.2.3). 
Animals were cared for according to the current European and Portuguese 
legislation related to the protection and welfare of vertebrates used to experimental 
ends, namely the Directive 86/609/CEE of the European Council (24 of November, 
1986), and the National Decree 129/92 (6 of July, 1992).  
In these sets of experiments, all animals were maintained under anaesthesia from 
the time of preparation for the surgical protocol until the end of the experimental 
protocol. After, they were euthanized with a lethal dose of sodium pentobarbital. 
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3.2. Experimental design 
 
3.2.1. Studies related to aging  
 
To study the evolution of insulin sensitivity with age we used male Wistar rats. 
The animals were analysed, on the immediate postprandial state, at 6, 9, 16 and 52 
weeks, which translates, in human terms, to two phases of maturation (6 and 9 weeks of 
age), the end of puberty (16 weeks of age) and middle-age (52 weeks of age). The 
Wistar rat strain has a mean life expectancy of two years, and we have not recorded any 
spontaneous mortality in any of the age groups that we maintained at the Animal House. 
Additionally, we analysed male Wistar rats on the fasted state, at 9 and 52 weeks 
of age, to provide us with a comparing template to study the influence of age on the 
increment of insulin sensitivity observed after meal ingestion. 
 
3.2.2. Studies related to gender 
 
To clarify the possibility of differences in insulin sensitivity with age between 
genders, we used male and female Wistar rats, analysed in the postprandial state at 9 
and 52 weeks of age. After the first experiments, Wistar rats of both genders were also 
analysed in the postprandial state at old-age (78 weeks of age). 
 
3.2.3. Studies related to high-sugar content diets 
 
Wistar and SD rats were randomly divided into several groups and were given 
free access to water and standard solid food pellets (Panlab A04; Charles River) or to a 
liquid or solid supplement of sucrose on their diet, as detailed below per feeding 
protocol.  
The liquid diet was obtained by mixing sucrose in tap water in a 35% solution 
(w/v). Each bottle was filled with 200 ml of solution, changed each two days. 
Alternatively, the high-sucrose solid diet D11725 and corresponding control diet 
D11724 were used, both from Research Diets. These solid diets were formulated to 
differ only in the source of carbohydrates, that being sucrose in the first diet and corn 
starch in the control diet. Both have 20.0% protein, 66.0% carbohydrates and 5.0% fat. 
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The sucrose diet was coloured red and the control diet was coloured blue to avoid mix 
up when refilling the pellets partition in each cage. 
 
3.2.3.1. Effect of a liquid high-sucrose diet in Wistar rats  
 
Wistar rats were randomly divided into two groups. Both standard-fed and 
sucrose-fed groups had free access, for 6 weeks, to a standard solid diet (Panlab A04; 
Charles River) and water, but while the standard-fed group had only a bottle of drinking 
water, the sucrose-fed group had an additional bottle of a 35% sucrose solution. 
 
3.2.3.2. Effect of the duration of exposure to a liquid high-sucrose diet in SD rats 
 
SD rats were randomly divided into four groups. Each sucrose-fed group was 
given a standard solid diet (D11725, Research Diets) and a 35% sucrose solution for the 
last 2, 6 or 9 weeks. The standard-fed group was given the standard solid diet (D11724, 
Research Diets) and drinking water for the entire time period of the experiment. Thus, 
all animals were analysed with 12 weeks of age. 
 
3.2.3.3. Effect of a liquid vs solid high-sucrose diet in SD rats 
 
SD rats were randomly divided into three groups. The standard-fed group was 
given a standard solid diet (D11724, Research Diets) and drinking water for 9 weeks. 
Sucrose-fed groups were given either a 35% sucrose solid diet (D11725, Research 
Diets) and drinking water or a standard solid diet (D11724, Research Diets) and a 35% 
sucrose solution for the same period. Thus, all animals were analysed with 12 weeks of 
age. 
 
3.2.4. Studies related to hypertension 
 
For this we used the strain of Spontaneously Hypertensive Rats (SHR), as well 
as their normotensive control strains Wistar and Wistar Kyoto, analysed in the 
postprandial state at 9 weeks of age. To further evaluate the impact on the metabolic 
profile produced by the sustained high arterial pressure, these strains were also analysed 
at 16 weeks of age. 
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We also determined insulin sensitivity in the fasted state at 9 weeks of age in a 
group of SHR animals, using a group of 9 weeks old fasted Wistar rats as their 
normotensive control.  
 
3.3. Pre-surgical protocol 
 
All animals were fasted overnight for 16 hours (from 16:00 of the day prior to 
experiment to 8:00 of the day of experiment), but with free access to a bottle of drinking 
water. Animals to undergo insulin sensitivity testing in the fasted state were maintained 
fasting for an additional hour. Animals to undergo insulin sensitivity testing in the 
postprandial state were given access to a standard solid meal for an hour (from 8:00 to 
9:00). 
After fasting or after we assured that the animals had indeed eaten, and were in 
the immediate postprandial state, all animals were anesthetised with a solution of 
sodium pentobarbital (65 mg/kg bw) (Eutasil, Sanofi). This procedure was done with 
the help of a plexiglass restriction cage. The anaesthesia syringe was introduced 2 cm 
above the sexual organ, at the midline of the abdomen. 
The animal was left unmolested until fully anesthetised, which was checked by 
the pain reflex on the tip of the tail or the eye reflex. The animal was then removed from 
the cage and placed on a surgical table, over a heating pad (Homeothermic Blanket 
Control Unit 50-706, Harvard Apparatus) to maintain body temperature at 37.0 ± 0.5ºC, 
monitored with a rectal probe thermometer. 
   
3.4. Surgical protocol 
 
A small incision was made centrally from under the chin to the base of the neck 
of the animal. A tracheotomy was performed and a polyethylene tube (PE 240, Becton 
Dickinson) was inserted and secured to allow for spontaneous respiration. The left 
internal jugular vein was isolated from conjunctive tissue. Another small incision was 
made in the depression at the base of the left leg. The femoral artery was also isolated. 
Previously, an external arterial-venous shunt had been made with silicone and plastic 
connections (Figure 6). Three pieces of silicone tube (Silicone tubing L/S 14, 
Masterflex) were attached to a plastic T-junction. The end arm of the junction was 
closed with a three-way plastic valve.  To the other arms were connected two long 
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pieces of polyethylene tubing (PE 50, Becton Dickinson), with a wedge-cut tip. The 
shunt was primed with a saline-heparin solution (200 U/ml). 
 
 
 
 
Figure 6 - Extracorporal arterial-venous circuit. Inserted to permit external blood circulation from the 
femoral artery to the internal jugular vein. The arterial branch is used to collect blood samples. The 
venous branch is used to perfuse solutions through infusion lines. A third branch can be used to assess 
blood pressure, or to flush any blood clot that may be formed during experiment. (Adapted from (Lautt, 
1999)). 
 
 
 Each end of the arterial-venous shunt was used to catheterise one blood vessel, 
the internal jugular vein and the femoral artery, with the assistance of a magnifying lens 
apparatus (SMZ-2B, Nikon). After the loop was secured, and blood was flowing 
through by difference in pressure between the two ends, the remaining arm was used for 
periodic measurements of the arterial and venous pressures (Powerlab 8/s, 
ADInstruments; recorded, through a pressure transducer, by MacLab software); which 
was done by briefly clamping the opposite end with a surgical clamp. This setup also 
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enabled the quick detection and removal of any blood clot formed inside the system 
during the course of the experiment. 
 
For the experiments requiring surgical ablation of the hepatic parasympathetic 
nerves, a laparotomy was performed prior to the placing of the external shunt. Briefly, a 
large incision was made vertically on the abdomen, from 1 cm above the genitalia to the 
xiphoid cartilage. The viscera were gently moved upward (to the right side of the 
abdomen), taken especial care for the integrity of the pancreas which is diffuse in the 
rat, and the stomach was exposed. A metal manipulator was inserted above the stomach, 
pulling down and out the oesophagus, and the liver was carefully pushed. Running 
parallel to the esophagus, we identified the vagal nerve and, branching from it to the 
liver, running parallel to the hepatic common artery, we identified the hepatic branch, 
which possesses the majority of efferent hepatic parasympathetic nerves. The bundle of 
nerves was isolated and a thread passed behind it. All organs were repositioned in their 
anatomical place, and the thread extremities were externalised. To perform the selective 
hepatic vagotomy, the thread was pulled and the bundle of fibres was burned through 
with a cauteriser (High Temperature Cautery with 500394 tip, World Precision 
Instruments). 
  
For the experiments requiring the direct delivery of drugs to the liver, a 
laparotomy was likewise performed. This time, viscera were carefully put aside with the 
help of moist cotton swabs and covered with moist gauze. After, a catheter was inserted 
on the portal vein (Abbocath 24G Optiva IV 19 mm, Johnson & Johnson), connected to 
a syringe by PE50 tubing. The portal vein was punctured 2 cm upstream from the liver 
and the tip of the catheter was located 1 cm inward. The apparatus was stabilised by 
points of biological glue (Histoacryl, BBraun) carefully placed on the catheter and line. 
The laparotomy was finally covered with moist gaze and parafilm.  
 
In all protocols, anaesthesia was maintained throughout the experiments by 
continuous infusion of a sodium pentobarbital solution (1.0 mg/ml saline given at 1.0 
ml/100 g bw) through a cannula (infusion line PE 50 with a cut 23-g needle at the 
delivery end) inserted into the venous side of the shunt. All drugs and saline solutions 
were administered intravenously (i.v.) through this shunt or intraportaly (i.p.) through 
the portal vein catheter. 
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Operated animals were allowed to stabilise after surgery for at least 30 min 
before any tests were carried out. 
 
3.5. Insulin sensitivity evaluation 
 
To determine whole body insulin sensitivity, either on the fasted or postprandial 
state, we used the Rapid Insulin Sensitivity Test (RIST), a modified hyperinsulinemic 
euglycaemic clamp, as previously described in 1999 by Prof. Wayne Lautt (Lautt, 
1999). This test relies in an equipment, the glucose analyser, able to do separate 
measurements of blood glucose content in less than 2 min.  
 
3.1.5.1. Glucose Analyser 
 
 The YSI 1500 Sidekick (Yellow Springs Instruments) is able to determine the 
glucose content in a relatively small blood sample. The sample is collected directly by 
puncturing the silicone arterial branch of the external shunt with a microsyringe 
calibrated for 25 µl. The sample is then injected in the reaction chamber of the analyser.  
 A magnetic stirrer mixes the blood sample with the analyser buffer (YSI 2357 
Buffer, Yellow Springs Instruments). This chamber opens to a biological probe that is 
covered by a three-layer membrane. Here, a membrane impregnated with immobilised 
glucose oxidase is separated from the probe by a cellulose acetate membrane and from 
the sample by a polycarbonate membrane. When some of the substrate diffuses through 
the membrane, comes into contact with the oxidase and is promptly oxidised, producing 
hydrogen peroxide (H2O2). The H2O2 diffuses to the probe and is then oxidised by the 
platinum anode, producing electrons. When the rate of H2O2 production and the rate of 
diffusion become constant, a dynamic equilibrium is achieved. That steady state means 
that the electron flow is then linearly proportional to the steady state H2O2 concentration 
and, thus, to the concentration of blood glucose.  
 Prior to the experiment, the glucose analyser is calibrated with a 180 mg/dl 
glucose reference solution. This reference solution is also used during experiments to 
verify the analyser calibration. Sporadically, we also used a 50 mg/dl concentration 
solution to verify the linearity of the machine.  
 
 
3. Material and Methods 
 64 
 
3.5.2. Determining a baseline glycaemia 
 
 As the RIST is a euglycaemic clamp, it can only be performed when blood 
glucose level is stable. For this, blood samples are measured each 5 min, until three 
consecutive stable readings are obtained. The mean of those values is referred to as the 
basal glucose level, and is used as the reference value for the carrying out of the RIST.  
 
3.5.3. Rapid Insulin Sensitivity Test (RIST) 
 
 Minute 0 was set at the start of a 5 min i.v. insulin bolus (50 mU/kg bw) given 
using a perfusion pump (Perfusor fm, BBraun Medical). At minute 1, the arterial blood 
glucose concentration was measured and a glucose infusion (D-glucose/saline, 100 
mg/ml, i.v.) was started at a rate of 5 mg/kg/min to avoid hypoglicaemia. Arterial blood 
glucose concentration was measured at 2 min intervals and the rate of the glucose 
infusion was adjusted whenever necessary to maintain the glycaemia as near as possible 
to the basal glucose level. The RIST was concluded when no further glucose infusion 
was required to maintain euglycaemia (Figure 7).  
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Figure 7 - Example of Rapid Insulin Sensitivity Test (RIST). After the basal glucose level is 
ascertained, a bolus of insulin is infused. To prevent hypoglycaemia, a perfusion of glucose is started one 
minute after the beginning of insulin. Glucose perfusion rate is changed in response to changes in 
glycaemia, so that euglycaemia is maintained throughout the test. The test is completed when no more 
glucose is needed. The area under the curve is used to quantify the test, and is referred to as the RIST 
index (Adapted from (Lautt, 1999)). 
 
 
 When the protocol included a following RIST after surgical or pharmacological 
manipulation, glucose levels were allowed to stabilise for at least 30 min after the end 
of intervention, after which a new basal glucose level was determined and another RIST 
performed. 
 
3.5.4. Quantification and graphical representation of the RIST 
 
 The total amount of glucose infused quantifies whole-body insulin sensitivity 
and is referred to as the RIST index (mg glucose/kg bw). The RIST can be performed 
either in the fasted or postprandial state, providing the control fasted or control fed 
RIST indexes.  
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 By performing a RIST after surgical ablation of the common hepatic vagal 
branch, we obtain the HPN-independent component of insulin action. By subtracting the 
post-denervation RIST from the control fed RIST, we obtain the HPN-dependent 
component of insulin action, ie, the postprandial increment of insulin sensitivity. 
 Since the HPN seem to be one of the constituents of the overall HISS pathway, 
postprandial insulin action reflects the sum of the HISS-dependent and –independent 
components of insulin action. Thus, pharmacological blockade of the HPN or other step 
of the HISS pathway allows us to determine the HISS-dependent and –independent 
components. The RIST index obtained after muscarinic receptor antagonism with 
atropine (Giachetti et al., 1986) or hepatic nitric oxide inhibition with Ng-methyl-
arginine (L-NMMA) (Bryk and Wolff, 1999; Moore and Handy, 1997)55, represents the 
HISS-independent component of insulin sensitivity, which, subtracted from the control 
fed RIST index, wields the quantification of the HISS-dependent component of insulin 
action.  
 These components can be plotted individually in column bar graphs, or in 
matched pairs in stacked bars graphs with the HPN-independent component under the 
HPN-dependent component, thus giving a simultaneous representation of each of the 
components and of the postprandial control insulin sensitivity. 
 To obtain the curves representing the time-course of each RIST we plotted the 
mean values of glucose infusion rate, represented at 0.1 min intervals. The HPN-
dependent component action curve was obtained by subtracting the curve values 
obtained after pharmacological intervention from the corresponding control curve 
values. 
 
3.6. Glutathione analysis by High-Pressure Liquid Chromatography (HPLC) 
 
 The HPLC technique was implemented in collaboration with Prof Jorge Caldeira 
and Prof Celina Santos, from the Department of Chemistry, Faculty of Sciences and 
Technology, New University of Lisbon. This technique allows, with great precision, the 
quantification of glutathione in both the reduced (GSH) and oxidised form (GSSG). 
This method was adapted from a previously described one (Asensi et al., 1994; 
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 These drugs were used in concentration shown to produce full blockade of the HISS-dependent 
component of postprandial insulin action (Xie et al, 1995; Sadri et al, 1999). Atropine was given at 3 
mg/kg bw and L-NMMA was given at 0.73 mg/kg. 
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Giustarini et al., 2003); which was developed to assess glutathione in the blood. The 
present technique is based in the quick derivatisation of free thiol (-SH) groups by N-
etilmaleimide (NEM). The sample then suffers an acid deproteinisation, and is reacted 
with 2,4-dinitro-1-fluorobenzene (DNFB). Compounds are separated by 
chromatography (HPLC) and the glutathione-dinitrobenzene complex is detected by 
spectrophotometry. 
 So, after performing a laparotomy in the anesthetised animal, a sample of liver 
was harvested (0.2-0.3 g), and then stored in liquid nitrogen. In the day of 
quantification, samples were homogenised separately in NEM 24 mol.dm-3 (1 ml) and 
then left in repose for 1 min. After, trichloroacetic acid (TCA) 50% (m/v) was added, to 
obtain a final concentration of 20% (m/v) and the samples were placed in 0ºC for 10 
min. Then, they were centrifuged at 30000 g and 4ºC, for 20 min, in an Avanti J-25 
centrifuge (JA 25-50 rotor, Beckman Coulter Inc., USA). The supernatant was collected 
(1 ml), washed with dichloromethane (10 ml) to remove NEM traces, and left to repose 
until the formation of two distinct phases. To the aqueous phase (100 µl) we added 
Tris(hydroxymethyl)aminomethane hydrochloride (TRIS-HCl) (1 mol.dm-3, pH 10, 50 
µl) and the dye DNFB (1.5% (v/v), 150 µl). The reactive mix was incubated for 3 hrs, at 
room temperature and in a dark place. Finally, we added hydrochloric acid (HCl) 37% 
(10 µl) and eluted the samples through ion exchange HPLC. 
 The HPLC system used was made up of two solvent injection pumps (LaChrom 
L-7100, Hitachi, EUA), a spectrophotometric detector (LaChrom L-7400 UV-Detector, 
Hitachi, EUA) programmed for 355 nm, an interface (LaChrom D-7000 HPLC System, 
Hitashi, EUA), an injection loop of 20 µl (Rheodyne 7725 Sample Loop, Rheodyne, 
Germany) and an automatic injector (multi-sampler Marathon-XT v3.1, Pharmacia, 
Holland). For establishment and analysis of chromatograms we used a LaChrom D-
2500/D7500 Data File Conversion Utility software (Hitachi, USA). Additionally, the 
areas under the curves corresponding to the GSH and GSSG peaks were determined 
with the software TableCurve 2D v5.01 (Systat Software Inc., USA). 
 An ionic exchange column (LiChroCART 250-4 HPLC-Cartridge, Purospher 
Star NH2, 5 µm, Merck, Germany) was used, protected by two pre-columns 
(LiChroCART 1514960001, Merck, Germany). The mobile phase used in the elution 
was a mixture of four solvents: A, deionised water; B, acetic acid 3 mol.dm-3; C, sodium 
acetate 3 mol.dm-3; and D, methanol (purity > 99.9 %). Solvent D was eluted at a 
constant concentration. Solvents A, B and C were eluted according to a concentration 
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gradient (% v/v) throughout the elution cycle, which lasted 45 min56. The elution was 
performed at room temperature, with a constant flow of 1.2 ml/min. The column 
pressure was maintained between 170-180 bar throughout the whole procedure. 
 
 
Figure 8 – High-pressure liquid chromatography (HPLC) output example. The areas for the peaks at 
around 15 and 20 min are calculated to quantify reduced and oxidised glutathione (GSH/GSSG).  
 
 
 The elution of GSH and GSSG happened approximately at 15 min and 23 min, 
respectively. Peak detection was done by reading absorbency at 355 nm, with the area 
under the curve being proportional to the glutathione concentration in the sample. To 
determine the concentration of GSH and GSSG in the sample we performed a daily 
calibration curve, using standard solutions of GSH (ranging from 1 to 10 mM) and 
GSSG (ranging from 50 to 300 µM). These standard solutions were prepared in the 
same conditions as the biological samples. 
 
3.7. Data analysis 
 
 Data were expressed as means ± standard error of the mean (SEM) and were 
analysed, according to the case, by unpaired (ex. fasted/fed) or paired (ex. 
intact/denervated) Student t-test, one-way analysis of variance (ANOVA) followed by 
the Tukey multiple comparison test or by the two-way ANOVA followed by the 
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 From 0 to 8 min: 14% A, 3 % B, 3% C, 80% D; from 8 to 13 min: linear gradient; from 13 to 44 min: 
0% A, 10 % B, 10% C, 80% D; from 44 to 45 min: linear gradient to initial conditions. 
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Bonferroni post-test. When samples were small (<6 individuals per group), a non-
parametric version of these tests was used. 
 
3.8. Drugs and reagents 
 
 Atropine, L-NMMA, and D-glucose were purchased from Sigma-Aldrich 
Chemical. Sucrose was purchased from Panreac Quimica. Sodium pentobarbital 
(Eutasil) was obtained from Ceva. Heparin was purchased from BBraun Medical. 
Human insulin (Humulin) was obtained from Lilly. All chemicals were prepared in 
0.9% NaCl saline (BBraun). All perfusion were made with the help of Perfusor pumps 
(BBraun). 
 TCA, NEM, TRIS-HCl, HCl, methanol, dichloromethane, DNFB, GSH, and 
GSSG, were purchased from Sigma-Aldrich Chemical Co, Portugal. 
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4. RESULTS AND DISCUSSION 
 
4.1. Control of postprandial insulin sensitivity by the hepatic parasympathetic 
nerves in Wistar rats, and integration in the hepatic insulin sensitising substance 
pathway 
 
4.1.1. Context and work hypothesis 
 
The aim of this study was to assess, in the Wistar rat, if the hepatic 
parasympathetic nerves (HPN) play a crucial role in the postprandial control of whole-
body insulin sensitivity. Furthermore, an intended parallel was drawn by 
pharmacological intervention, to look at the HPN as a step of the wider pathway that 
modulates insulin-stimulated glucose uptake.  
Previous authors have established the importance of the HPN to the postprandial 
increment of insulin sensitivity for Sprague-Dawley rats (Latour and Lautt, 2002b; Xie 
and Lautt, 1996a), cats (Xie and Lautt, 1994; Xie and Lautt, 1995a; Xie and Lautt, 
1996b; Xie et al., 1993), and dogs (Moore et al., 2002). Even so, several reasons, stated 
below, prompted a basic methodological approach to this thesis practical work.  
The choice to firstly study the effect of hepatic vagal denervation, and certain 
pharmacological interventions, on fasted and postprandial insulin sensitivity of Wistar 
rats was taken considering that: 
i) Although the mentioned strain had not been previously studied in this fashion, 
specific properties of the development of Wistar rats, mentioned later on this 
dissertation, made it the most appropriate model for a considerable part of this thesis;  
ii) No previous published study described the effect of hepatic parasympathetic 
denervation on the insulin sensitivity of fasted versus fed rats, on any strain; 
iii) Several authors (Guarino et al., 2003; Sadri and Lautt, 1999; Xie and Lautt, 
1994; Xie and Lautt, 1995a; Xie and Lautt, 1996b) reported that certain 
pharmacological interventions had a similar impact on abolishing the postprandial 
increment of insulin sensitivity as the physical hepatic parasympathetic nerve ablation. 
A measure of the decrease of insulin sensitivity produced by denervation was needed 
here to compare and validate the use on this thesis of the pharmacological agents 
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described, and allow the conclusion that all interventions affect the same physiological 
pathway. 
 
At this early stage of research, this permitted to state the role of the HPN on the 
bigger picture of the hepatic insulin sensitising substance (HISS) pathway hypothesis 
(see introduction topic 1.9). This fact was pivotal in establishing the working protocols 
that were to be followed in several animal pathological models throughout the 
remainder of this doctoral thesis. 
 
The first working hypothesis was that HPN denervation would cancel the 
postprandial increment of insulin sensitivity on Wistar rats. Additionally, in the fasted 
state, when HISS action is absent, denervation would produce no effect. It was also 
hypothesised that pharmacological interventions reported to interfere with the 
parasympathetic nervous system or hepatic nitric oxide, known steps of the HISS 
pathway, would produce a magnitude of postprandial insulin resistance similar to 
hepatic denervation in Wistar rats. 
 
4.1.2. Experimental protocols 
 
Male 9 weeks old Wistar rats were divided into four groups and fasted for 16 
hours. After, one of the groups was subjected to an additional hour of fasting, while the 
other three groups were given food for 1 hour, to guarantee that they were indeed in the 
postprandial state. All animals were anesthetised at the end of the fasting or refeeding 
period.  
Each of the four groups was intended for either: i) vagotomy in fasted, ii) 
vagotomy in fed, iii) parasympathetic pharmacological blockade in fed, or iv) hepatic 
nitric oxide synthase inhibition in fed animals.  
On the fasted group, a thread was surgically placed around the hepatic vagal 
branch to prepare for the vagotomy. This was also done in one of the fed groups. On the 
second fed group no additional surgery was needed, since the pharmacological 
parasympathetic blocker was administered intravenously through the external arterio-
venous loop, which was placed in all animals for glucose sampling and continuous 
anaesthesia perfusion. In the third fed group a catheter was placed in the portal vein to 
allow for direct administration of drugs to the liver. 
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In all groups, a rapid insulin sensitivity test (RIST) was firstly performed to 
assess either postprandial or fasting whole-body insulin sensitivity, depending on the 
prandial status. Then, the fasted animals and one group of fed animals were subjected to 
the ablation of the HPN by cauterising the hepatic vagal branch. The second fed group 
had the administration of the muscarinic antagonist atropine (3 mg/kg). The last fed 
group had the administration of the nitric oxide synthase inhibitor L-NMMA (0.73 
mg/kg). A second RIST was performed in all groups.  
 
4.1.3. Results 
 
4.1.3.1. HISS blockade by surgical manipulation 
 
Basal glycaemia, measured as the baseline glycaemia for the RIST, increased 
with feeding (from 84.3±3.0 after a 17-hour fast, n=3, to 123.8±6.9 mg glucose/dl after 
refeeding, n=6, p<0.05), which is consistent with the recent ingestion and absorption of 
food.  After, it did not change with the ablation of the common hepatic vagus branch, 
either in fasted or fed animals (fasted: from 84.3±3.0 to 88.0±2.5, fed: from 123.8±6.9 
to 145.0±17.9 mg glucose/dl). Both groups showed similar weight (302.0±6.3 for fasted 
and 313.8±11.8 g for fed animals). 
The values of mean arterial pressure were not significantly altered by the hepatic 
vagotomy, independently of prandial status (fasted: from 116.0±3.1 to 117.3±1.5 
mmHg, fed: from 117.5±3.7 to 112.8±3.5 mmHg). 
 
A dynamic curve was obtained at the end of each RIST. Below (Figure 9) are 
represented the mean dynamic curves calculated for each experimental protocol 
condition: on fasted or fed animals, before or after hepatic denervation. The mean 
dynamic curves for the HPN-dependent component are also presented, calculated 
mathematically by subtracting each post-denervation dynamic curve from the matched 
control dynamic curve, in fasted and fed animals (Figure 9c). 
Additionally, the mean characteristics of the dynamic curves (action peak 
magnitude, peak time, and action curve duration for control and post-denervation 
curves; and action peak magnitude, peak time, action curve onset and offset for HPN-
dependent component curves) are shown on Table II.  
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b) Effect of denervation – Fed state 
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c) HPN-dependent component in fast and fed 
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Figure 9 – Effect of denervation on RIST profiles of fasted and fed Wistar rats. Mean dynamic 
curves for the rapid insulin tests (RIST) performed on control (bold line) and hepatic vagal branch 
denervation (thin line) conditions in fasted (a) and fed (b) Wistar rats. Mean dynamic profile curve for the 
HPN-dependent component of insulin action (c), obtained by subtracting the post-denervation curve from 
the control curve, of fed (bold line) and fasted (thin line) Wistar rats. 
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In the fasted group, RIST dynamic curves were similar before and after 
denervation. By contrast, food ingestion led to a greater action curve. This was achieved 
by an increase of peak magnitude (from 7.0±0.6, fasted control, to 13.2±0.6 mg.kg-
1
.min-1, fed control, p<0.05), and duration of the control insulin action curve (from 
27.2±0.7 in the fasted, to 33.4±1.2 min in the fed, p<0.05).  
Further, in fed animals, denervation produced an impairment of the insulin 
action curve. The surgical ablation of the HPN brought down maximum peak magnitude 
(from 13.2±1.0, fed control, to 7.2±0.5 mg.kg-1.min-1, fed denervated, p<0.05) and 
diminished the duration of insulin action (from 33.4±1.2, fed control, to 23.1±1.4 min, 
fed denervated, p<0.01); reverting both to the same levels seen on the fasted state 
(Figure 9 and Table II). 
 
 
Table II – Effect of denervation on dynamic curve main properties of fed and fasted Wistar rats. 
Dynamic profile characteristics of the control RIST, post-denervation RIST and HPN-component of total 
insulin action of fasted and fed Wistar rats (* p<0.05 vs fasted value, § p<0.01 vs fed control duration, # 
p<0.05 vs fed control peak).  
 
  Fasted (n=3) Fed (n=6) 
Peak (mg.kg-1.min-1) 7.0±0.6 13.2±1.0* 
Peak time (min) 10.5±1.8 13.2±0.6 
Control RIST 
Duration (min) 27.2±0.7 33.4±1.2* 
Peak (mg.kg-1.min-1) 6.3±0.3 7.2±0.5# 
Peak Time (min) 9.2±2.4 8.7±1.0 
Denervated RIST 
Duration (min) 25.8±1.2 23.1±1.4§ 
Peak (mg.kg-1.min-1) 1.7±0.3 7.7±0.5* 
Peak time (min) 17.2±4.1 15.6±1.0 
Onset (min) 8.6±0.3 8.0±0.9 
Offset (min) 20.5±4.7 33.0±1.4* 
HPN-dependent 
component 
Duration (min) 11.9±5.0 21.8±1.2§ 
 
 
The aforementioned results can be further analysed by calculating the area under 
each dynamic curve. That parameter is called RIST index, and the RIST indexes 
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obtained from the control and post-denervation dynamic curves, in fasted and fed 
animals, are presented below, on Figure 10. 
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Figure 10 – Effect of denervation on RIST indexes of fasted and fed Wistar rats. Rapid insulin 
sensitivity test (RIST) indexes for total insulin action in 9 weeks old male Wistar rats in the fasted and fed 
states, before (filled bars) and after hepatic parasympathetic denervation (open bars). The increment in 
insulin sensitivity seen with feeding (*** p<0.001 vs fasted control Wistar) was eliminated after 
denervation (*** p<0.001 vs fed control Wistar). 
 
 
In the fasted state, ablation of the HPN did not produce any effect on whole-
body insulin sensitivity (from 110.1±5.8 to 102.1±4.1 mg glucose/kg body weight (bw)) 
(Figure 1) in 9 weeks old male Wistar rats. On the contrary, the increment in insulin 
sensitivity observed in the immediate postprandial state, i.e., roughly two hours after 
food ingestion, was significantly impaired by the surgical ablation of the HPN (from 
228.1±18.5 to 113.1±10.1 mg glucose/kg bw, p<0.001) (Figure 10), lowering insulin 
sensitivity to the same level seen in the fasted state.  
 
The HPN-dependent component of insulin action (quantified by subtracting the 
post-vagotomy RIST index from the pre-vagotomy one) had thus an almost neglectable 
expression when insulin sensitivity was quantified in the fasted state (11.8±5.1 mg 
glucose/kg bw; corresponding to 9.9±4.0 % of total insulin action). On the other hand, 
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after food ingestion, it rose almost ten-fold (increasing to 114.9±11.7 mg glucose/kg 
bw, p<0.0001), accounting then for half of total insulin action (50.3±2.2 % of total 
insulin action, p<0.001) and for the entire postprandial increment of insulin sensitivity 
(Figure 10). The values obtained after hepatic vagotomy, in the fasted and postprandial 
states, are similar; and alike what was obtained in the fasted animals prior to 
denervation (Figure 10). 
The dynamic response of the HPN-dependent component to feeding could also 
be uncovered (Figure 1). While food ingestion did not produce changes in the onset of 
this component, it induced an increase in peak action (from 1.7±0.3 to 7.7±0.5 mg.kg-
1
.min-1, p<0.05) and a latter offset (until 20.5±4.7 min in the fasted state and until 
33.0±1.4 min in the fed state, p<0.05). This resulted in the increase of duration of the 
HPN-dependent component with feeding (from 11.9±5.0 to 21.8±1.2 min, p<0.05) 
(Table II). 
 
4.1.3.2. HISS blockade by pharmacological manipulation 
 
In regard to the administration of pharmacological substances to mimic the 
effect of hepatic denervation, the administration of iv atropine or ipv L-NMMA did not 
change basal glycaemia levels (from 115.7±4.9 to 122.7±4.6 mg glucose/dl after 
atropine, n=5, and from 134.2±5.8 to 137.0±2.9 mg glucose/dl after L-NMMA, n=5). 
The values of mean arterial pressure were not significantly altered by atropine 
administration (from 120.0±5.8 to 121.7±7.3 mmHg with atropine). In the case of L-
NMMA, the transient increase of mean arterial pressure seen during the administration 
of the drug came back to basal levels, by itself, by the time glucose measurements were 
restarted to determine the glycaemia baseline for the second RIST (from 120.0±7.0 to 
134.4±8.9 during L-NMMA administration, p<0.01, back to 118.0±7.2 mmHg by the 
end of the recovery time, approximately 30 min, p<0.01). Both groups showed similar 
weight as the ones used for the surgical denervation protocol. 
 
Both atropine and L-NMMA had the same effect on the control fed RIST profile 
(dynamic curves obtained with the same protocol illustrated on following items 4.2.3., 
4.4.2 and 4.5.1.; not shown here). Below is represented the mean RIST indexes obtained 
with both drugs, on fed Wistar rats (Figure 11). 
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Figure 11 – Effect of pharmacological intervention on fed Wistar rats. Rapid insulin sensitivity test 
(RIST) indexes for total insulin action in 9 weeks old male Wistar rats in the fed state, before (filled bars) 
and after (open bars) administration of atropine or L-NMMA (*** p<0.001 for both vs fed control 
Wistar).  
 
 
As seen with hepatic denervation, parasympathetic blockade by iv 
administration of atropine or inhibition of hepatic nitric oxide by ipv administration of 
L-NMMA leads to elimination of the postprandial increment of insulin sensitivity (from 
277.5±26.3 to 121.1±18.2 mg glucose/kg bw with atropine, and from 292.6±21.2 to 
132.7±16.3 mg glucose/kg bw with L-NMMA, p<0.001 for both) (Figure 11); lowering 
insulin sensitivity to values similar to the control fasted or denervated fed animals 
(Figure 10). 
  
Considering that the affected pathway is indeed the same, this HISS-dependent 
component of insulin sensitivity had exactly the same contribution to total insulin 
sensitivity as seen in the assessment of the HPN-dependent component in the previous 
protocol. With administration of atropine, the HISS-dependent component found was 
156.4±29.5 mg glucose/kg bw, accounting for 55.5±6.8 % of total postprandial insulin 
action. After L-NMMA, the HISS-dependent component was quantified at 159.8±32.9 
mg glucose/kg bw, accounting for 52.7±7.8 % of total postprandial insulin action. 
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4.1.4. Discussion 
 
At 9 weeks of age, the Wistar rat strain showed a clear increment in insulin 
sensitivity from the fasted to the postprandial state. Such increment was completely 
eliminated by the ablation of the HPN at the common hepatic branch level; showing the 
critical relevance of these nerves for an optimal postprandial insulin action. The same 
surgical intervention on fasted animals produced no effect on whole-body insulin 
sensitivity.  
 
The previous statements are clearly shown by the RIST dynamic profiles 
obtained in fasted and fed animals, before and after denervation. Additionally, the lack 
of involvement of the HPN on fasting insulin action of rat models is reported here for 
the first time. 
Furthermore, the dynamic curves for the HPN-dependent component of total 
insulin action were also calculated. The results obtained underline once again that while 
during fasting the HPN-dependent component has an almost nonexistent, baseline, 
action, the ingestion of food leads to an activation of the HPN-dependent component.  
This supports the concept that the activation of the parasympathetic nervous 
system, occurring at the beginning and during food ingestion (Teff, 2008; Uijtdehaage 
et al., 1992), has a role on whole-body glucose metabolism (Latour and Lautt, 2002a; 
Lautt et al., 2001; Xie and Lautt, 1994; Xie and Lautt, 1996b). More precisely, this 
HPN-dependent component seems to be wholly responsible for the increment observed 
in whole-body insulin sensitivity from the fasted to the immediate postprandial state. 
 
It is well known that, in response to a meal, circulating levels of insulin are 
increased in relation to fasting. However, the same level of hyperinsulinaemia, when 
produced experimentally in the fasted state, does not seem by itself to be able to induce 
the increase in insulin sensitivity seen in the postprandial state (Peitl et al., 2009; Xie 
and Lautt, 1994). So, in accordance with the observations performed in the present 
work, the postprandial increase in whole-body insulin sensitivity is seen when both 
signals, HPN activation and insulin, are present. Furthermore, as insulin has been shown 
to have a dose-dependent influence on the HPN-dependent component of insulin action 
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(Lautt et al., 2001), this seems to argue for the existence of a modulator effect of both 
signals on postprandial whole-body sensitivity, expressed by a common pathway. 
 
 The parasympathetic nervous system is also known to be involved in the 
modulation of insulin release from the pancreas. On one hand, it prevents the unwanted 
release of insulin during fasting (Blat and Malbert, 2001), on the other, it promotes 
insulin release upon feeding (Benthem et al., 2000; Benthem et al., 2001; D'Alessio et 
al., 2001)57. However, in the present study, by the time the control RIST is performed, 
glycaemia, and also insulinaemia, are stabilised (Lautt et al., 1998; Xie and Lautt, 
1996b); and their levels remain unchanged by hepatic parasympathetic denervation 
(Lautt et al., 1998; Xie and Lautt, 1996b). Thus, a further alteration in HPN-dependent 
component from this dynamic steady-state, that would enable us to monitor this 
component, has to come from an endogenous pulse of insulin brought about by an 
increase in plasma glucose (Frangioudakis et al., 2008), or, as in the case of the 
methodology used here, an exogenous administration of a bolus of insulin. That the 
meal-induced insulin sensitivity increment is abolished after HPN denervation, and that, 
as reported elsewhere, this can be reverted by continuous intraportal, but not 
intravenous, administration of acetylcholine (Xie and Lautt, 1996a), further recognises 
the central role of the liver in processing diverse information and effecting a control on 
peripheral metabolism.    
 
Morphologically, it has been established that the facilitative parasympathetic 
vagal signal, shown to be involved in postprandial insulin sensitivity potentiation, 
follows through the cervical vagus, the hepatic branch, and through the anterior hepatic 
plexus along the hepatic common artery (Latour and Lautt, 2002a). Ablation of the 
hepatic common artery branch of the vagus (CHB) has been reported to be enough to 
promote the total removal of the postprandial increment of insulin sensitivity (Latour 
and Lautt, 2002a), as seen here. However, the physical interruption of the CHB of the 
vagus nerve may have other consequences besides to abrogate the effect of the HPN. 
Previously considered to feed only into the liver, the CHB has been recently 
shown to innervate mainly the gastrointestinal tract, and only to a minor extent the 
                                               
57
 It has been proposed that the promotion of pancreatic insulin release is due to a periprandial 
parasympathetic suppression of the sympathetic nerve activity to the pancreas. Furthermore, this 
mechanism has been shown to be non-dependent of muscarinic receptors; so, was not inhibited by 
atropine (Benthem et al, 2001). 
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hepatoportal region (Berthoud, 2004). Furthermore, it might contain fibres of nonvagal 
origin (Prechtl and Powley, 1990). However, against this concern, Xie and colleagues 
(Xie et al., 1993) have eliminated sympathetic fibres from the hepatic anterior plexus 
with no further aggravation in insulin sensitivity. Also, since iv atropine, ipv L-NMMA, 
and selective CHB ablation produced the same effect on insulin sensitivity, it seems 
unlikely that any element other than the HPN, or any other nerve bundle innervating the 
liver but that do not pertain to the CHB (Berthoud, 2004), contributes to the 
postprandial control of glucose metabolism. 
 
The results obtained by muscarinic blockage with atropine, or nitric oxide 
synthase inhibition with L-NMMA, similar to the surgical ablation of the HPN, also 
help to integrate the HPN-dependent component on a larger physiological mechanism of 
postprandial glucose disposal management.  
Although the main site of insulin-stimulated glucose uptake in the body is the 
skeletal muscle, the present study strengthens the notion that there exists a postprandial 
increment of insulin sensitivity at the periphery which is determined by the action of an 
hepatic factor (Lang, 1954; Lautt, 1999; Mertz and Schwarzk, 1962; Petersen and 
Tygstrup, 1994). This data supports the hypothesis presented by the HISS pathway 
(Lautt, 1999), of a parasympathetic nerve signal delivered to the liver that eventually 
leads to the increase of whole-body, specifically peripheral, insulin sensitivity in the 
postprandial state.  
Indeed, dose-response curve studies in rats (Takayama et al., 2000) showed that 
the ED50 of atropine administered intraportally (5.3 ng/kg bw) was lower than that 
administered intravenously (230 ng/kg bw). Similarly, the nitric oxide synthase 
inhibitor L-NMMA has been shown, at the given dose of 0.73 mg/kg, to produce a 
similar decrease of insulin sensitivity to atropine, when administered intraportally, but 
not intravenously (Sadri and Lautt, 1999).  
Thus, the present results support the hypothesis that the referred parasympathetic 
reflex can be blocked with the same efficacy either by surgical ablation of the HPN or 
pharmacological intervention. 
 
The efficacy of the pharmacological agents described had also a relevant impact 
on the experimental methodology followed. 
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The surgical procedures used, although performed with due caution, were 
susceptible to hazard. First of all, the access and manipulation of the liver and isolation 
of the fibre bundle was very sensitive, and led sometimes to tissue damage, 
haemorrhage, or other event that influenced negatively on glucose metabolic control. 
Likewise, the catheterisation of the portal vein was prone to surgical problems. Each 
experiment that showed this was eliminated from final data analysis. However, these 
complications had sufficient relevance to warrant alternatives. 
Considering the present pharmacological results, it became possible to avoid 
some of the surgical manipulations in subsequent protocols. For the development of the 
present work, hepatic denervation could thus be forgone in favour of a pharmacological 
approach to the separation of the HPN-dependent and –independent components of 
insulin action. 
The previous resulted in the choice of the iv administration of atropine as the 
preferred protocol for assessment of the HPN, or HISS, -dependent component. The iv 
atropine dose chosen allowed hence to minimise the invasive surgery required; this 
without showing a statistically different effect on insulin sensitivity from the intraportal 
administration (Lautt et al., 1998; Takayama et al., 2000), and without exhibiting any 
undesirable secondary effect. 
 
However, atropine has other described effects that could indirectly induce 
changes in glucose metabolism. This regards specifically the possible effect of atropine 
on gastric emptying; delaying the absorption of carbohydrates to the portal circulation 
(Teff et al., 1999). Nevertheless, in the present study, atropine is given at a late stage of 
absorption and does not change blood glycaemia, hinting against a role of the 
parasympathetic fibres innervating the digestive tract on the management of insulin-
stimulated glucose disposal. 
Direct effects of atropine on hepatic glucose metabolism have also been 
reported, specifically as hepatic glucose flux alterations (Chap et al., 1985; Tordoff and 
Friedman, 1994). The fact that atropine was perfused systemically prior to gavage in the 
mentioned reports (Chap et al., 1985; Tordoff and Friedman, 1994) hints that the altered 
effect may be due to other parasympathetic responses of feeding58. More importantly, 
arterial-venous gradient studies performed in the postprandial state have shown that 
                                               
58
 A reported decrease in insulin secretion (Chap et al, 1985) seems a prime candidate. 
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denervation and/or atropine led to changes in skeletal muscle, but not on liver glucose 
uptake (Moore et al., 2002; Xie and Lautt, 1996b).  
Furthermore, studies that report alterations in hepatic glucose flux by hepatic 
vagal denervation seem to be related with chronic denervation (Matsuhisa et al., 2000; 
Xue et al., 2000), in which the liver may be showing an adaptative response. The use of 
acute hepatic vagal denervation should prevent those confounding factors in the present 
study.  
 
Still regarding possible alternate interpretations for the presented data, other 
authors (Baron et al., 1995) have proposed a link between nitric oxide inhibition and a 
decrease in insulin sensitivity by way of a decrease of blood flow and nutrient 
availability to the skeletal muscle cells59.  
Besides the fact that the present studies have registered no alteration in blood 
pressure at the time of the RIST performed after L-NMMA, a case could be presented 
based on the hypothesis of changes in the microvasculature feeding the myocytes 
(Baron et al., 2000; Vincent et al., 2006). However, the fact that we obtained the same 
decrease in whole-body insulin sensitivity with atropine and hepatic vagotomy as with 
hepatic administration L-NMMA suggests that haemodynamic changes were not 
responsible for altering glucose uptake.  
Furthermore, even if L-NMMA changed blood pressure, alterations in blood 
flow have been shown not to alter peripheral glucose uptake (Ronnemaa et al., 1999; 
Scherrer et al., 1994; Utriainen et al., 1996). In spite of that, a recent study (Levesque et 
al., 2006) reported the effect of atropine on decreasing skeletal muscle insulin-
stimulated glucose uptake and related it to a decrease in insulin-stimulated blood flow60 
(Scherrer et al., 1994; Steinberg et al., 1994; Taddei et al., 2001). This seems to be 
clearly refuted by the present results; and by the fact that either a nitric oxide synthase 
inhibitor, or a parasympathetic muscarinic antagonist, is more effective in reducing 
                                               
59
 This hypothesis states that availability of insulin and glucose from the bloodstream to skeletal muscle 
cells would be the limiting rate step in insulin-stimulated glucose uptake (Baron et al, 1995). 
60
 This proposed mechanism sprung from the notion that, in the endothelium, insulin leads to 
vasodilation, as well as potentiating the vasodilator effect of acetylcholine (Steinberg et al, 1994; Taddei 
et al, 2000). This mechanism leads to the release of vascular nitric oxide (Steinberg et al, 1994; Scherrer 
et al, 1994). Through this chain of events, insulin would control blood flow and capillary recruitment 
(Baron et al, 1995). Atropine administration would lead to decreased blood flow, poorer capillary 
recruitment, and lower nutrients availability at the peripheral tissues; thus limiting whole-body glucose 
uptake. 
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insulin sensitivity through ipv than iv administration (Sadri and Lautt, 1999; Takayama 
et al., 2000). 
 
The vagus nerve has a multitude of target organs on the abdominal region, 
possibly with a compartmentalisation of the parasympathetic nervous system that allows 
different organs to be simultaneously modulated in different forms (Kreier et al., 2003; 
Teff, 2008). Even so, all the present results taken together suggest that indeed the liver 
is the central organ in which a facilitative parasympathetic tone allows the activation of 
the HISS pathway, which in term leads to increased peripheral insulin-stimulated 
glucose uptake.  
The central role of the liver may also be glimpsed from hepatic transplant 
patients. These patients show decreased glucose tolerance, but similar hepatic glucose 
flux and hepatic glycogen content (Schneiter et al., 2000b). It is concluded that the lack 
of hepatic innervation leads to a decrease in glucose uptake in extrahepatic tissues61 
(Dhillon et al., 1992; Luzi et al., 1997; Sakamoto et al., 2002; Takahashi et al., 2001), 
expectedly the skeletal muscle (Xie and Lautt, 1996b), as has been proposed for long 
(Lang, 1954). Further, patients with liver disease show similarly peripheral impairment 
in insulin sensitivity (Lautt, 1999). 
According to our hypothesis, this will be due to an impairment in HISS 
synthesis/release; which is consistent with the emerging recognition of the liver as 
having a central role in the physiology and pathophysiology of whole-body glucose 
homeostasis (Langhans, 2003). 
 
In conclusion, any of the used protocols showed to be equally adequate to 
quantify the HPN-dependent, or, more broadly, the HISS-dependent component of 
insulin action. As shown, this component is the sole responsible for the increment of 
insulin sensitivity seen with the transition from the fasted to the fed state. The 
facilitative, and critical, contribution of the HPN was thus established, as well as the 
central role of the liver to the management of whole-body postprandial insulin 
sensitivity. 
                                               
61
 Signs of reinnervation could be detected within a 5-years timeframe from transplant (Dhillon et al, 
1992). This may be the explanation for the report of glucose metabolism amelioration 26 months after 
transplant (Luzi et al, 1997). Possibly, this happens faster in rats (Takahashi et al, 2001; Sakamoto et al, 
2002). 
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This validation of the pharmacological tools available, either for 
parasympathetic blockade or hepatic nitric oxide inhibition, allows then to avoid the 
more invasive common hepatic branch vagotomy in the studies that follow. 
 
 
 
4.2 Effect of age on postprandial insulin sensitisation 
 
4.2.1. General context and hypothesis 
 
Before analysing the relation between insulin resistance and some of the 
pathologies related to type 2 diabetes, a question was raised about the physiological 
changes in glucose metabolism; more precisely, those influenced by age.  
It has been described that glucose intolerance develops with age mainly due to 
decreased skeletal muscle insulin sensitivity and responsiveness; in humans (Davidson, 
1979) and in several rat strains (Goodman et al., 1983; Nakai et al., 1996; Narimiya et 
al., 1984; Nishimura et al., 1988; Reed et al., 1993). In time, this leads to a higher 
prevalence of type 2 diabetes in older individuals (Stout, 1994). 
Also, the occurrence of autonomic neuropathy has been widely related to the 
presence of insulin resistance and type 2 diabetes (Nakano et al., 2003). But autonomic 
neuropathy has been usually described as a complication of type 2 diabetes (Sundkvist, 
1981), arguing for a secondary role of neuropathy in the development of type 2 diabetes. 
However, the observation of mainly parasympathetic autonomic impairment in 
prediabetic subjects (Kuroda et al., 1990; Liao et al., 1995) hints to a possible role of an 
impairment of the HPN-dependent component of insulin action in the aetiology of 
diabetes. Another observation that supports this is the observation that parasympathetic 
neuropathy seems to precede both sympathetic and peripheral neuropathies (Nakano et 
al., 2003; Oikawa et al., 1986; Sundkvist, 1981). 
 
Considering this, our general working hypothesis was that the HPN-dependent 
component of insulin action decreases with age, contributing to the reported decrease in 
peripheral insulin sensitivity by compromising the postprandial increment in insulin 
sensitisation. 
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4.2.2. Total insulin sensitivity in fasted versus fed male Wistar rats at 9 and 52 
weeks of age 
 
4.2.2.1 Experimental protocols 
 
The next step in this work was then to evaluate if there is an impairment of the 
meal-induced increment of insulin sensitivity with age. 
For this, and related studies, the model chosen was the Wistar rat strain, since it 
has been considered the best suited for aging-associated studies, having less 
confounding factors (Escriva et al., 1997) and with alterations in body composition 
similar to humans (Leighton et al., 1989). Also, impaired glucose tolerance with age is 
seen well before hyperglycaemia or ß-cell failure; complications which seem to happen 
generally after 12 months of age (Koricanac et al., 2004).  
 
Using young 9 weeks old male Wistar rats as controls, we compared them with a 
group of 52 weeks old male animals of the same strain. Animals from both age groups 
were evaluated after a 16-hour fast, as before either at the fasted or fed prandial status. 
A single RIST was performed, to quantify either fasted or postprandial whole-body 
insulin sensitivity. 
 
4.2.2.2. Results  
 
Basal glycaemia rose with feeding, at both ages (from 84.6±2.3 in fasted, n=8, to 
128.3±5.8 mg/dl in fed, n=6, at 9 weeks of age, p<0.01; from 89.6±6.0 in fasted, n=7, to 
112.2±3.2 mg/dl in fed, n=9, at 52 weeks of age, p<0.01). Arterial blood pressure was 
not altered by feeding in either age group, but decreased from 9 to 52 weeks of age 
(116.7±1.5 in fasted and 117.5±3.7 in fed, at 9 weeks of age; 89.3±4.2 in fasted and 
84.4±4.1 in fed, at 52 weeks of age; p<0.001, between age groups at each prandial 
state). Weight increased consistently with age (302.2±4.0 for fasted and 313.4±9.0 g for 
fed, at 9 weeks of age; 553.9±13.2 for fasted and 591.2±20.2 g for fed, at 52 weeks of 
age; p<0.001 between age groups at each prandial state). 
For this topic, results concerning insulin sensitivity will be shown only as RIST 
indexes. Dynamic curves of similar groups can be found on the previous and next 
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topics; to the exception of 52 weeks old fasted animals. The latter however showed no 
changes in dynamic action when compared with the young fasted animals.  
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Figure 12 – Effect of age on RIST indexes of fasted and fed Wistar rats. Rapid insulin sensitivity test 
(RIST) indexes for total insulin action in male Wistar rats at 9 and 52 weeks of age, in the fasted (open 
bars) and fed (filled bars) state. The meal-induced sensitisation of insulin sensitivity, seen at 9 weeks, was 
lost by 52 weeks of age (*** p<0.001). 
 
 
As before, at 9 weeks of age, Wistar rats showed a higher insulin sensitisation 
after a meal than in the fasting state (fasted: 101.6±7.3 vs fed: 260.0±21.1 mg 
glucose/kg bw, p<0.001). By contrast, at 52 weeks of age, this meal effect has been lost 
(p<0.001). This is illustrated by the fact that, at this age, fasting and postprandial total 
insulin action were similar between them (fasted: 107.8±10.3 vs postprandial: 
118.0±19.1 mg glucose/kg bw), and also similar to the fasting response at 9 weeks of 
age (Figure 12). 
 
4.2.2.3. Discussion 
 
The course of development until 52 weeks of age produces, in male Wistar rats, 
a radical decrease in postprandial insulin sensitivity. This phenomenon seems to be due 
to a total loss of the increment of insulin sensitivity seen after a meal, as 52 weeks old 
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fed animals showed similar insulin sensitivity to the age-matched fasted ones. On the 
other hand, insulin action in the fasted state showed no alteration with age. 
 
Since previous authors reported that the decrease of insulin sensitivity which 
develops with age happened during maturation, with a slight or no increase afterwards 
(Davidson, 1979; Goodman et al., 1983; Nakai et al., 1996; Narimiya et al., 1984; 
Nishimura et al., 1988; Reed et al., 1993), the timetable of this study was expanded to 
evaluate insulin sensitivity throughout maturation in more detail. 
 
 
4.2.3. HPN-dependent and HPN-independent components of insulin sensitivity in 
fed male Wistar rats at 6, 9, 16 and 52 weeks of age 
 
4.2.3.1. Experimental protocols 
 
Male Wistar rats were evaluated at 6, 9, 16 and 52 weeks of age. Maturation was 
thus divided into two phases: from 6 to 9 weeks, corresponding to puberty, and from 9 
to 16 weeks, roughly corresponding to a young adult. Although the developmental 
stages found in the literature vary under broad intervals, it is consensual that Wistar rats 
have reached their sexual maturation by this stage. The 52 weeks old group, at a 
midpoint in the Wistar normal 24 months life expectancy, corresponds roughly to 
middle-age. 
On this protocol, all age groups were evaluated only on the postprandial state; 
but with whole-body postprandial insulin sensitivity being assessed and discerned into 
the HPN-dependent and –independent components. This enabled the evaluation of the 
possible contribution of an impairment of the HPN-dependent component to the 
observed loss of the increment of postprandial insulin sensitisation with age. 
 
Animals were subjected to a 16-hour fasting period, followed by 1 hour free 
access to food. After anaesthesia, a control RIST was performed. The control RIST was 
followed by the administration of the muscarinic cholinergic antagonist, atropine (3 
mg/kg), to block the HPN-dependent component of insulin action. After, a second, post-
atropine, RIST was performed. 
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4.2.3.2. Results  
 
Basal postprandial glycaemia, measured as the baseline for the control RIST, 
was not altered by age (137.3±12.2 at 6 weeks, n=6, 125.1±7.7 at 9 weeks, n=11, 
132.5±3.3 at 16 weeks, n=6, and 113.7±5.2 mg/dl at 52 weeks of age, n=13). 
Administration of atropine also did not alter the baseline glycaemia (129.8±13.1 at 6 
weeks, 131.8±8.3 at 9 weeks, 120.3±4.3 at 16 weeks, and 108.7±2.5 mg/dl at 52 weeks 
of age). Arterial blood pressure was shown again to be decreased at 52 weeks of age, 
now in relation to all other age groups (from 113.0±1.8 at 6 weeks, to 120.5±3.3 at 9 
weeks, 117.0±4.9 at 16 weeks, and 93.5±3.8 mmHg at 52 weeks of age, p<0.001 to 9 
weeks, and p<0.01 to 6 and 16 weeks of age). Atropine did not significantly change 
these values in any age group. Body weight increased from 234.0±8.9 g at 6 weeks, to 
314.5±10.8 g at 9 weeks, and to 566.0±12.9 g at 16 weeks of age. It further increased to 
826.5±25.4 g at 52 weeks of age. 
 
The analysis of the mean dynamic curves (Figure 13) provides us with a plethora 
of detailed information into the way insulin sensitivity, and particularly each of its 
components, changes with time. Also, the mean characteristics for the dynamic curves, 
obtained during the performed RIST and by quantification of the HPN-dependent 
component, are shown on Table III. 
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b) Insulin sensitivity after HPN blockade: HPN-independent component of insulin 
action 
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c) HPN-dependent component of insulin action 
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Figure 13 – Effect of age on RIST profiles of fed male Wistar rats. Mean dynamic profiles for the 
rapid insulin sensitivity tests (RIST) performed on control (a) and postatropine (b) conditions at 6, 9, 16 
and 52 weeks of age male Wistar rats.  Mean dynamic profile curve for the hepatic parasympathetic nerve 
(HPN)-dependent component of insulin action (c), obtained by subtracting the post-atropine curve from 
the control curve, at all age groups. 
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Age correlates with a gradual decrease of total postprandial insulin sensitivity. 
Looking at the respective mean dynamic curve graph for all age groups (Figure 13a), 
first it is observed a decrease on the duration of glucose uptake (from 44.8±1.8 at 6 
weeks to 33.1±1.6 min at 9 weeks of age, p< 0.05), which afterwards remains stable 
(30.6±2.4 at 16 weeks and 31.5±2.3 min at 52 weeks of age, p<0.01 for both vs 6 weeks 
of age) (Table III). Following the shortening of total insulin action, from 9 weeks of age 
onwards there is a gradual decrease of action peak magnitude: unchanged from 6 to 9 
weeks of age, with, respectively, 16.5±1.2 and 16.1±0.7 mg glucose.kg-1.min-1, then 
decreasing to 10.7±0.7 mg glucose.kg-1.min-1 at 16 weeks, p<0.001 versus 9 weeks, and 
then decreasing again to 6.3±0.5 mg glucose.kg-1.min-1, p<0.001 versus 16 weeks. 
For the action of insulin per se, assessed by the post-atropine RIST (Figure 4b), 
there is a decrease of peak magnitude only at 52 weeks (p<0.001 vs 6 and 9 weeks, 
p<0.05 vs 16 weeks of age). All other RIST characteristics are unchanged with age 
(Table III).  
A more interesting behaviour can be glimpsed through the HPN-dependent 
component dynamic curves. At 6 weeks of age there is still a low maximum action, i.e. 
peak magnitude, which is compensated by a longer duration of action. With puberty, 
from 6 to 9 weeks of age, we see an increase in peak magnitude (from 6.8±0.8 to 
10.8±1.0 mg glucose.kg-1.min-1, p<0.05) and a decrease in duration (from 39.0±2.4 to 
25.4±1.7 min, p<0.05). Since the onset of the HPN-dependent component is similar 
between all age groups, this decrease in duration is due to a sooner offset in action 
(from 44.5±1.8 at 6 weeks to 32.0±1.0 min at 9 weeks of age, p<0.05). With further age, 
the duration of the HPN-dependent component remains the same, while peak magnitude 
decreases (to 3.6±0.8 at 16 weeks and 4.2±0.9 at 52 weeks of age, p<0.001 vs 9 weeks). 
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Table III – Effect of age on dynamic curve main properties of fed male Wistar rats. Dynamic profile 
characteristics of the control rapid insulin sensitivity test (RIST), post-atropine RIST and hepatic 
parasympathetic nerve (HPN)-component of total insulin action of 6, 9, 16 weeks old fed Wistar rats (* 
p<0.001 vs 9 weeks, # p<0.001 vs 16 weeks, ¥ p<0.05 vs 6 weeks, $ p<0.01 vs 6 weeks, § p<0.001 vs 6 
weeks, £ p<0.05 vs 16 weeks).  
 
 6 weeks old 
(n=6) 
9 weeks old 
(n=11) 
16 weeks 
old (n=6) 
52 weeks 
old (n=13) 
Peak  16.5±1.2 16.1±0.7 10.7±0.7* 6.3±0.5# 
Peak time 14.2±0.8 13.3±0.7 13.9±0.7 11.9±1.1 
Control 
RIST 
Duration 44.8±1.8 33.1±1.6¥ 30.6±2.4$ 31.5±2.3$ 
Peak 10.8±0.8 9.8±1.1 8.6±0.5 5.7±0.4£ 
Peak Time 12.8±0.7 10.3±1.0 12.8±0.7 12.4±0.9 
Postatropine 
RIST 
Duration 31.2±2.6 23.4±1.7 29.0±2.2 30.2±2.0 
Peak 6.8±0.8 10.8±1.0¥ 3.6±0.8* 4.2±0.9 
Peak time 14.2±1.9 16.0±1.0 13.8±2.0 15.7±2.1 
Onset 5.5±1.3 6.7±1.3 8.2±1.2 10.5±1.7 
Offset 44.5±1.8 32.0±1.0¥ 25.6±3.4§ 31.2±2.8¥ 
HPN-
dependent 
component 
Duration 39.0±2.4 25.4±1.7¥ 17.3±3.7§ 20.0±2.3§ 
 
 
The area under each dynamic curve provides us the RIST index for each 
component and age. Total insulin sensitivity, quantified by the control RIST index, 
decreased progressively with age (from 351.8±27.3 at 6 weeks to 297.4±18.5 at 9 
weeks, 221.7±24.3 at 16 weeks, and 135.6±12.8 mg glucose/kg bw at 52 weeks of age; 
p<0.01 between 6 and 16 weeks of age, p<0.05 between 16 and 52 weeks of age) 
(Figure 14). 
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Figure 14 – Effect of age on RIST indexes of fed male Wistar rats: HPN-dependent and –
independent components. Rapid insulin sensitivity test (RIST) indexes for total insulin action and its 
two components in male Wistar rats at 6, 9, 16 and 52 weeks of age. The hepatic parasympathetic nerve 
(HPN)-independent component decreased from 6 to 9 weeks and remained unchanged thereafter, whereas 
the HPN-dependent component decreased radically from 9 to 52 weeks of age (* p<0.05, ** p<0.01, *** 
p<0.001). 
 
 
The two components that constitute total insulin action had different 
contributions to the observed decrease of total insulin sensitivity (Figure 14). While the 
HPN-independent component (the post-atropine RIST) decreased from 6 to 9 weeks 
(201.6±21.6 to 139.6±14.8 mg glucose/kg bw, p<0.05), and remained constant 
thereafter (127.1±17.2 at 16 weeks and 111.0±9.4 mg glucose/kg bw at 52 weeks of 
age), the HPN-dependent component remained constant from 6 to 9 weeks of age (from 
150.2±19.2 to 157.8±17.7 mg glucose/kg bw), was decreased by 16 weeks (94.6±15.3 
mg glucose/kg bw, p<0.05), and further diminished by 52 weeks of age (24.8±6.8 mg 
glucose/kg bw, p<0.05). 
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4.2.3.3. Discussion  
 
The present study uncovered that loss of postprandial insulin sensitivity with age 
is progressive from 6 to 52 weeks, from puberty to middle-age, in Wistar male rats. To 
this loss of total insulin sensitivity contributes at puberty a shorter action duration and 
then, gradually, a lower peak action of insulin sensitivity. Furthermore, it was found that 
the HPN-dependent and –independent components have different contributions to this 
decrease of insulin sensitivity with age. 
The RIST index data for the HPN-independent component show that the action 
of insulin per se decreases from 6 to 9 weeks of age, and remains stable thereafter. 
Paradoxically, the correspondent dynamic curves show only statistical difference on 
peak magnitude with age, and only at 52 weeks of age. However, a methodological note 
should be made regarding the presentation of results for the HPN-independent 
component; a note which may be able to dispel this conundrum.  
Mean dynamic curves are calculated by taking the values of each time point 
from all the RIST dynamic plots for the animals in each age group, and plotting the 
mean of those values. The dynamic profile characteristics were determined not by 
analysing those mean dynamic curves for their characteristics data, but by calculating 
the mean of the values of those characteristics from each original dynamic curve. The 
discrepancy in significance among both methods of presentation seems due to the 
alterations of this component during age being felt more in the shape of the curve than 
on its key characteristics. 
Compellingly, also the analysis of the evolution of the HPN-dependent 
component benefits from comparing different modes of presenting the data generated by 
the RIST. Looking at the RIST indexes, the HPN-dependent component remains 
unchanged from 6 to 9 weeks of age and decreases steadily thereafter. However, this 
masks the profound change that seems to occur in HPN-dependent component dynamics 
during that early stage. Indeed, at 6 weeks of age, action peak magnitude is almost half 
that at 9 weeks of age; but this is counterbalanced by a longer duration at the pubertal 
stage. As a consequence, the total amount of glucose perfused, given by the area under 
each curve, is the same; albeit curve dynamics being distinct.  
After, from 9 weeks onwards, action duration remains the same; so the decrease 
seen at 16 weeks of age is due to a lower peak action. A further decrease at 52 weeks of 
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age is again explained by a different curve shape, since peak magnitude is the same, as 
easily seen in Figure 13c. 
 
These results highlight the importance of the loss of a parasympathetically 
facilitated mechanism. Indeed, although the structure of the rat vagus nerve does not 
seem to deteriorate, not even in old age (Soltanpour and Santer, 1996), there are reports 
of an age-related functional reduction in parasympathetic activity (Buwalda et al., 1991; 
Espinola et al., 1999); by both decreased basal vagal tone and lower sensitivity to 
parasympathetic control62 (Brodde et al., 1998; Stratton et al., 2003). According to the 
present study, the effect of this impairment starts to be evident at least from 9 weeks of 
age. By 1 year of age, it has already led to the almost absolute abrogation of the HISS-
dependent component of insulin action. 
The fact that humans also show a decrease of parasympathetic tonus with age 
(De Meersman and Stein, 2007; Lehofer et al., 1999; Pfeifer et al., 1983) leads to the 
hypothesis that the HPN-dependent component is also important in the gradual glucose 
intolerance seen in elderly humans63 (Davidson, 1979; Patarrao et al., 2008; Patarrao et 
al., 2007; Rowe et al., 1983). 
It is also interesting that the autonomic nervous system seems as compromised 
in non-diabetic elderly people as in younger diabetic patients (Bramann and Aleff, 
1992). This leads to the notion that, in prediabetes, there is an acceleration of the 
parasympathetic degeneration seen with physiological ageing.  
The HPN impairment may play an important role in other pathological states 
also related to both insulin resistance and aging. Indeed, several age-related diseases 
seem to be linked with insulin resistance (Facchini et al., 2001). Parasympathetic tonus 
decrease seems to be involved in such clinical conditions as chronic liver diseases 
(Hendrickse and Triger, 1993), obesity (Peterson et al., 1988), essential hypertension 
(Quadri et al., 1994), and type 2 diabetes (Carnethon et al., 2003a; Carnethon et al., 
2003b). This again leads tentatively to a connection between the dysfunction of the 
HPN and its influence in the HISS mechanism (Lautt, 2004), the gradual decrease in 
insulin sensitivity observed in humans starting in the third or fourth decade of age 
                                               
62
 Cumulatively, changes with age in muscarinic receptors density and/or affinity may also contribute to a 
lower parasympathetic tone (Brodde et al, 1998). 
63
 Furthermore, in the last years, the use of the RIST has been validated in humans (Patarrao et al, 2007), 
and the HISS mechanism has been shown to be extremely relevant to postprandial insulin sensitivity in 
humans (Patarrao et al, 2007; Patarrao et al, 2008). 
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(DeFronzo, 1981), and the higher prevalence of impaired glucose tolerance, type 2 
diabetes, and hypertension in aged people (Stout, 1994). 
 
The 52 weeks of age male group is at a midpoint in the Wistar normal 104 
weeks life expectancy. In this middle-age stage, male Wistar rats have shown here to be 
still normoglycaemic, which is supported by others (Berthelier et al., 1997). This 
preserved normoglycaemia seems to happen with (Berthelier et al., 1997) or without 
(Zecchin et al., 2003) an increase in fasting insulinaemia by 52 weeks of age. However, 
it would be expected that, postprandially, blood glucose in these animals is being 
maintained within normal values by gradually increasing insulinaemia with age; as seen 
elsewhere in fed and gavaged Wistar rats (Bracho-Romero and Reaven, 1977; Codina et 
al., 1980). This proposition is consistent with the known compensatory 
hyperinsulinemia that is reported to develop during decreased total insulin sensitivity 
with age; at least until 52 weeks of age, after which ß-cell failure and other processes 
related to senescence have been described to possibly lead to unchecked 
hyperglycaemia (Berthelier et al., 1997; Koricanac et al., 2004). 
Other authors also report still unchanged postprandial insulinaemia at 52 weeks 
of age (Davidson, 1979; Yoshino et al., 1979) or even a decreased in insulinemia 
(Reaven et al., 1979; Willeit et al., 1997). This stresses this group as being in a cut-off 
age. A cut-off phase where middle-age reveals to be a developmental state that favours 
a breakdown in glucose metabolism control; this by finally being unable to compensate 
for the impairment of insulin sensitivity that was gradually established. Interestingly, 
human studies may supply two additional pieces of information to help consider the 
various factors that contribute to the differential outcomes seen in this developmental 
stage.  
Firstly, reaching 60 years of age seems to mark in middle-aged humans a critical 
time in terms of glucose tolerance (Fink et al., 1983). Indeed, human glucose disposal 
seems to be slowly, but gradually, impaired, until a rapid deterioration manifests from 
50 years of age onwards, independent of the development of diabetes (Davidson, 1979). 
Although still able to secrete more insulin, this hyperinsulinemia becomes unable to 
counter the progressively installed insulin resistance, and a sudden drop in peripheral 
glucose disposal is seen at this time (Davidson, 1979; Fink et al., 1983). Secondly, it has 
been reported that parasympathetic function decreases after 30-40 years of age 
(Piccirillo et al., 1998a; Piccirillo et al., 2001). 
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Thus, middle-age is revealed as a time in development where the natural 
progression of insulin resistance leads to a metabolic breakdown. To this, the decrease 
of parasympathetic activity seems to be intimately connected. The gradual decrease of 
the HPN-dependent component, which becomes practically nonexistent by this age, can 
be expected to lead to an extra burden on the direct action of insulin on peripheral 
tissues, thus quickening metabolic deterioration. Consistent with this hypothesis, it has 
been suggested (Piccirillo et al., 1998a) that a lesser impairment of vagal function can 
contribute to a longer maintenance of a proper glucose tolerance.  
 
The unchanged postprandial glycaemia observed herein also strengthens the 
notion that the development of insulin resistance by decrease of the HPN-dependent 
component can happen well before the settling of the diabetic state. Middle-aged male 
Wistar rats have a near shutdown of HPN-dependent insulin action while retaining the 
direct action of insulin on target tissues seen in young 9 weeks old animals.  
On the other hand, the changes seen during the pubertal stage, also with no 
reflection on postprandial glycaemia, seem to be related instead both to a decrease in the 
HPN-independent component, in a phase with no changes in fasting insulinaemia (Vital 
et al., 2006), and to changes in HPN-dependent component dynamics but with 
maintained efficacy. This hints to developmental changes in the HISS mechanism 
during puberty; as well as changes in intracellular components of insulin signalling 
without needing to induce changes in blood insulinaemia (Vital et al., 2006). 
 
Consistent with previous observations that loss of the HPN-dependent 
component causes a decrease of glucose uptake only in the skeletal muscle (Xie and 
Lautt, 1996b), with no alteration in liver glucose flux, age-related insulin resistance also 
does not seem to interfere with hepatic glucose flux (Berthelier et al., 1997). 
Age-related insulin resistance is described to impair specifically the peripheral 
tissues, mainly skeletal muscle (Barnard et al., 1992; Barnard and Youngren, 1992; 
Goodman et al., 1983; Nishimura et al., 1988). However, as previously described, the 
liver has an important role in the management of peripheral insulin sensitivity, through 
the HISS mechanism (Xie and Lautt, 1996b). This is most relevant in the case of liver 
transplants.  
Liver transplantation implies that all hepatic nerves are transacted (Colle et al., 
2004). Despite that, liver transplant hosts are afflicted with peripheral, but not hepatic, 
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insulin resistance (Schneiter et al., 2000b). Not surprisingly, postprandial glucose 
metabolism in aged rats is not further impaired in cases of liver transplant (Kissler et al., 
2005). This is consistent with a lack of hepatic parasympathetic inflow to the liver, 
which is not worsened by the ablation of the hepatic nerves. Similarly, peripheral 
glucose uptake is not further impaired, since the HISS mechanism is already impaired 
by age. 
 
The present observation that total postprandial insulin sensitivity decreases 
gradually and steadily from 6 to 52 weeks of age is in apparent contrast with the 
reported development of insulin resistance only in the maturation stage (Davidson, 
1979; Goodman et al., 1983; Nakai et al., 1996; Narimiya et al., 1984; Nishimura et al., 
1988; Reed et al., 1993). 
Considering that the previous studies found in the literature related to animals 
fasted for 4 to 14 hours (Goodman et al., 1983; Nakai et al., 1996; Narimiya et al., 1984; 
Nishimura et al., 1988; Reed et al., 1993), the differences between those studies and the 
present results are explained by a partial, or even total, biological shutdown of the HPN-
dependent component with fasting. Indeed, activation of the parasympathetic nervous 
system occurs at the onset and during food ingestion (Uijtdehaage et al., 1992). 
Accordingly, the HPN-dependent component is highly modulated by the prandial state, 
and increasing fasting periods have been shown to produce a time-dependent inhibition 
of the HPN-dependent component, promptly reversed by refeeding (Latour and Lautt, 
2002b; Lautt et al., 2001; Sadri et al., 2006). Thus, the previous studies on the effect of 
age on insulin sensitivity in whole-body glucose uptake can only be compared with our 
data for the HPN-independent component of insulin action, as quantified by the post-
atropine RIST index. 
 
In this respect, our observation that the HPN-independent component decreases 
from 6 to 9 weeks of age and remains stable thereafter is consistent with those studies 
by others in fasted Wistar rats (a fasting time of about 13 hours, which, according to 
prior observations (Lautt et al., 2001), is enough to produce a considerable inhibition of 
the HPN-dependent component of insulin sensitivity). These conclude that insulin-
stimulated glucose uptake decreases somewhere between 4 and 12 weeks (Nakai et al., 
1996) or 8 and 16 weeks of age (Nishimura et al., 1988), with no decrease or only a 
slight decrease with further age.  
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The time between 9 and 16 weeks of age also coincides with the greatest rate of 
body weight gain. Weight gain has been suggested as a possible determinant or 
confounding factor for the decrease of insulin sensitivity (Barzilai and Rossetti, 1995; 
Berthelier et al., 1997; Leighton et al., 1989). Although a difference has not been found 
when analysing insulin action according to weight or fat-free mass (Nishimura et al., 
1988) in fasted Wistar rats, previous studies have found a relation between obesity and 
insulin resistance in fed animals (Afonso et al., 2007a).  
While others have seen the same body weight increase profile until 16 weeks, 
they have further reported that, however, fat mass and lean body mass vary differently 
with age; fat mass is reported to rise faster than lean body mass during maturation, from 
8 to 16 weeks (Barzilai and Rossetti, 1995)64. 
The early rise in fat mass has been related to the insulin resistance seen in 
maturation, especially to abdominal fat (Coon et al., 1992; Kohrt et al., 1993). Since the 
fat pads were not weighed here, no consideration can be made to prove or disprove this 
hypothesis. However, since this is not a continuous process, i.e., the HPN-independent 
component remains similar in a phase of greater weight gain (between 9 and 16 weeks 
of age) and the HPN-dependent component decreases further in a time where weight 
gain is more stabilised (between 16 and 52 weeks of age), a direct causal effect of fat 
mass on insulin sensitivity is hard to evaluate; unless it is considered that there is a 
threshold of fat mass that influences negatively insulin sensitivity (Barzilai and Rossetti, 
1995), but even that would not explain entirely the behaviour of the HPN-dependent 
component with age. 
One approach to clarify this question would be to avert the unequal rise in 
fat/fat-free mass. Indeed, caloric restriction diets have been used to prevent fat mass 
increase (Heilbronn and Ravussin, 2003). The lack of decrease of insulin sensitivity 
with age in animals fed on these diets has been cited as further indication of the relation 
between obesity and age-related insulin resistance (Escriva et al., 2007). However, this 
seems to happen, not by maintained muscle glucose uptake, but by a compensatory 
increase in adipocyte glucose uptake (Park et al., 2006).  
Furthermore, age and obesity are reported to have a synergistic effect on 
decreasing insulin sensitivity (Catalano et al., 2005; Das, 2004); hinting to this two 
                                               
64
 This seems to happen again at a late age, associated with senescence, but then with a loss of lean body 
mass, and rise or maintenance of fat mass (Barzilai and Rossetti, 1995). 
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conditions acting on insulin sensitivity through different mechanisms (Lonnroth and 
Smith, 1986), or, at least, at different occasions.   
 
Age is reported to lead to a post-receptor defect in insulin signalling, since the 
insulin receptor machinery seems to be intact in terms of affinity and binding (Fink et 
al., 1983; Rowe et al., 1983); a decrease in insulin sensitivity but not in insulin 
responsiveness (Rowe et al., 1983).  It has been proposed that the loss of insulin 
sensitivity in aged Wistar rats may be explained by any factors that decrease the 
capacity of insulin to induce glycogen synthesis in the skeletal muscle, without affecting 
glucose transport into the cell (Leighton et al., 1989; Nishimura et al., 1988). On the 
other hand, it has been proposed, in fasted rats, that age-related decrease of insulin 
sensitivity is due to a decrease in glycolysis (Barzilai and Rossetti, 1995). Furthermore, 
in humans, when glucose uptake was matched between young and old subjects, it was 
also seen only an impairment in the intracellular oxidative pathway (Gumbiner et al., 
1992). 
Taking into account the present results, a third alternative can be forwarded: that 
to the decrease in insulin sensitivity with age contributes in large proportion the 
impairment of a pathway that either modulates the performance of the insulin receptor, 
itself still functional during ageing, or that possesses its own receptors which then 
influence intracellular insulin signalling with additive effect. In accordance with the 
previous paragraph, the latter would hint then to a role of the HPN-dependent 
component on glycolysis, rather then on whole glucose uptake. 
Interestingly, age has a direct lowering effect on hepatic GSH (Leeuwenburgh 
and Ji, 1996). This decrease of hepatic GSH can have a direct effect on the expression 
of the HPN-dependent component since it has been shown to be essential for HISS 
release/action (Guarino et al., 2003). It may also be the coincidental link between loss of 
HISS-dependent action and impairment of the intracellular glycolytic pathway with age, 
since GSH decrease also interferes with –SH enzymes, namely with several glycolytic 
enzymes (Bartoc et al., 1975; Burch et al., 1981; Chen et al., 1994b; German, 1993; 
Tiedge et al., 1997)65.  
                                               
65
 The sensitivity to –SH is also determinant in the postprandial activity of glucokinase. The potentiation 
of glucokinase activity (Chen et al, 1994b) with refeeding (Burch et al, 1981), consistent with the enzyme 
function as a “glucose sensor” (German, 1993), increases insulin secretion, in a mechanism seemingly 
modulated by the redox status of the enzyme sulfhydryl groups (Tiedge et al, 1997). Lower 
concentrations of protective thiol compounds, such as GSH, lead to a decrease in glucokinase catalytic 
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Insulin action changes with age may also sprung as a reflection of the 
involvement of insulin in the endocrine regulation at each age of the balance between 
emphasis either on growth, sexual maturation and reproduction, or longevity (Tatar et 
al., 2003). This is expected to be of particular relevance to glucose homeostasis during 
puberty, but not ageing (Velasco et al., 1998); which is consistent with our results for 
the decrease of HISS-independent component of insulin action solely through puberty. 
In accordance with our results, fasting insulin sensitivity was reported to decrease 
during puberty, independently of gender and alterations in body composition (Cook et 
al., 1993). 
Although glucose tolerance has been described as remaining unaltered through 
puberty, this has been simultaneously related to a decrease in insulin sensitivity 
compensated by an increase in insulin secretion (Bloch et al., 1987). Furthermore, this 
insulin resistance was found to affect specifically peripheral glucose metabolism; a 
probable side-effect of the insulin resistance destined to facilitate protein anabolism 
(Amiel et al., 1991). 
Puberty is a time of great endocrine/neural regulatory changes, which are also 
reflected in changes in nutrient energy fluxes (Hannon et al., 2006). During this stage, 
the insulin-like growth factor 1 (IGF1) plays an important role in the crosstalk between 
growth hormone and insulin (Dominici et al., 2005). It is believed that a common 
insulin/IGF1 signalling pathway has evolved to specialisation (Tatar et al., 2003); with 
IGF1 as the mediator of the anabolic and mitogenic activity of growth hormone (Laron, 
2001), and insulin as the main regulator of nutrient metabolism (Tatar et al., 2003). 
Nonetheless, it has been observed that IGF1 is able to stimulate insulin sensitivity 
(Clemmons, 2004), while an increase in growth hormone peripheral action reduces 
insulin sensitivity (Cook et al., 1993). 
During puberty, there is an overexpression of growth hormone (Velasco et al., 
1998), related to a stage of intense body growth (Moran et al., 2002). The decrease of 
insulin sensitivity in peripheral tissues seems to be related to the chronic effect of this 
increase in growth hormone, and is compensated by hyperinsulinemia. Additionally, 
                                                                                                                                          
activity. Likewise, fasting may lead to glucokinase inactivation through SH side group oxidation (Tiedge 
et al, 1997). 
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IGF1 seems to regulate the balance between insulin and growth hormone actions66 
(Brown-Borg, 2008; Chandrashekar et al., 2004; Chiba et al., 2008; Dominici et al., 
2005; Moran et al., 2002). 
Considering that the HISS-dependent component is not altered in magnitude 
during this phase, the altered dynamics observed may be considered as an adaptation of 
this component to the changes taking place in relation to insulin action per se. Or, 
alternatively, the changes from a longer sustained, but lower intensity, HISS action, 
may be a remnant hint to the properties of a prior contribution of HISS to the 
modulation of perinatal insulin sensitivity. For example, it may reflect the 
developmental changes in the crosstalk between insulin- and amino acids-determined 
signals in the regulation of protein synthesis (Suryawan et al., 2007). Nevertheless, this 
topic warrants further investigation before being adequately interpreted.   
Due to the importance of the crosstalk between insulin and growth hormone 
during puberty, in terms of control of sexual maturation and somatic growth, a 
pharmacological intervention at this stage to oppose the decrease in insulin action 
should not be considered lightly (Goran and Gower, 2001). Likewise, an inability to 
increase insulin secretion and/or decrease insulin extraction during puberty can be 
especially detrimental at this stage (Weiss et al., 2005). To accentuate the distinct 
metabolic vulnerability of puberty, it becomes evident that a dysfunction of HISS 
action, either inherent or acquired, would be particularly delicate. Considering the 
worsening metabolic profile related to insulin resistance in adolescents (Bacha et al., 
2006), and the increasing prevalence of type 2 diabetes in youngsters (Alberti et al., 
2004), this danger seems already palpable67 (Arslanian et al., 2005; Saad et al., 2005).  
 
                                               
66
 This crosstalk is also important for the determination of reproduction and ageing/longevity 
(Chandrashekar et al, 2004; Chiba et al, 2008). Likewise, it may explain the opposition of longevity and 
nutrient handling/somatic growth mechanisms (Brown-Borg, 2008). Indeed, processes that postpone 
senescence are related to lower metabolism, arrest growth, increased stress resistance, and repair 
functions. Also, this may be related to the effect of calorie restriction diets on prolonging longevity 
(Brown-Borg, 2008). 
67
 The “stress” originated by the decrease of insulin sensitivity from the prepubertal to the pubertal stage 
can also become remarkably revelatory of possible inherited genetic defects, specifically in the ability of 
the pancreas to compensate this insulin resistance with a higher insulin secretion. Hence, a family history 
of type 2 diabetes seems to be additionally determinant of a worse prepubertal balance between insulin 
sensitivity and insulin secretion, which leads to a lower pubertal insulin sensitivity due to the lack of an 
adequate compensatory β-cell function (Arslanian et al, 2005). Again, this makes this transition stage into 
a particularly critical time, where a dysfunction of the natural changes in the HISS-dependent component 
may provide an added pressure for the progression of type 2 diabetes by providing a greater challenge for 
the compensatory insulin secretion (Saad et al, 2005).   
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In conclusion, age is related to a gradual decrease in postprandial insulin 
sensitivity. This “physiological” insulin resistance seems to be mainly related to a 
decrease in HISS action, probably determined by a decrease in parasympathetic nervous 
function.  
The HISS-independent component is impaired during the pubertal stage and 
remains similar until middle age. The HISS-dependent component is maintained in 
magnitude during the pubertal stage, but undergoes dynamic changes in action, perhaps 
still reflection of the trans-pubertal process of development (Amiel et al., 1991). Then, 
the HISS-dependent component continues to gradually decrease, until almost non-
existence at 52 weeks of age, being responsible for the decrease in postprandial total 
insulin sensitivity up to middle-age. 
 
 
4.3. Gender comparison of postprandial insulin sensitivity with fed female Wistar 
rats at 9, 16 and 52 weeks of age. Further studies in 78 weeks old male and female 
Wistar rats. 
 
4.3.1. Context and work hypothesis  
 
For metabolic reasons, we had chosen to study only male animals. However, 
gender-related differences in the way insulin sensitivity changes with age have been 
reported (Franssila-Kallunki et al., 1992). Furthermore, the influence of the autonomic 
nervous system on insulin sensitivity may be felt differently depending on gender 
(Bonnemeier et al., 2003; Flanagan et al., 1999; Hogarth et al., 2007). 
The unique pre-menopausal hormone status has been proposed to play a role in 
protecting females against certain metabolic complications. The loss of that status with 
age has been related, among others, to a decline in parasympathetic function (Dart et al., 
2002) and the development of a state of hyperinsulinemia (Willeit et al., 1997). 
 
Our work hypothesis was that, if the female gender was more protected from 
the development of insulin resistance with age than the male gender, it would be 
observable as a lesser decrease of the HPN-dependent component of insulin action with 
age. 
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4.3.2. Experimental protocols  
 
To evaluate this, female 9, 16 and 52 weeks old Wistar rats were analysed on the 
postprandial state, achieved after a 16-hour fast followed by a 1 hour period refeeding.  
Female Wistar rats at 6 weeks of age showed several surgical difficulties due to animal 
size, which led to the exclusion of those experiments.  
Further inquiries led to the use of two other groups: one male and one female, 78 
weeks old Wistar rats. The fasting and refeeding protocol was similar, to guarantee the 
immediate postprandial state at the time of use. These later experiments were unique in 
the fact that glucose perfusion was begun not at 5 but at 3 mg/kg/min (see Material and 
Methods), to avoid overshooting the glycaemia baseline at the beginning of the RIST. 
At 78 weeks of age Wistar rats show already a mortality rate of about 35%, in a 
period commonly related to senescence. All animals with visible signs of injury, cancer, 
or general discomfort were excluded from the study.  
For all animals, after anaesthesia, a control RIST was performed, followed by 
the administration of atropine (3 mg/kg) and a second, post-atropine, RIST. 
 
4.3.3. Results  
 
Basal postprandial glycaemia was not altered by age (111.5±4.1 at 9 weeks, n=8, 
113.8±2.4 at 16 weeks, n=5, and 108.2±4.4 mg/dl at 52 weeks of age, n=5). Also, as in 
males, baseline glycaemia did not change after atropine administration (104.6±1.3 at 9 
weeks, 105.3±5.5 at 16 weeks, and 106.2±5.2 mg/dl at 52 weeks of age). Females did 
not show the decrease in arterial blood pressure with age evidenced by the males 
(109.4±2.4 at 9 weeks, 98.0±10.6 at 16 weeks, and 103.6±3.1 mmHg at 52 weeks of 
age); although arterial blood pressure in females was not significantly different from 
those in males in any age group. Again, atropine did not change blood pressure 
(108.4±4.1 at 9 weeks, 97.0±11.4 at 16 weeks, and 103.4±3.9 mmHg at 52 weeks of 
age). 
Females were always lighter compared with age-matched males. Body weight 
increased from 240.0±4.8 g at 9 weeks (p<0.0001 vs 9 weeks old males) to 317.4±17.1 
g at 16 weeks (p<0.0001 vs 16 weeks old males), and then to 446.8±14.0 g at 52 weeks 
of age (p<0.0001 vs 52 weeks old males).  
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Figure 15 – Effect of age on RIST profiles of fed female Wistar rats. Mean dynamic profiles for the 
rapid insulin tests (RIST) performed on control (a) and post-atropine (b) conditions at 9, 16, 52 and 78 
weeks of age female Wistar rats.  Mean dynamic profile curve for the HPN-dependent component of 
insulin action (c), obtained by subtracting the post-atropine curve from the control curve, at all age 
groups. 
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Figure 15 shows the mean dynamic curves obtained for all age groups. Further, 
the main characteristics for the dynamic curves are presented on Table IV. 
 
The dynamic curves for total postprandial insulin action (Figure 15a) show that a 
decrease in insulin sensitivity happened from 9 to 52 weeks of age. This was mainly due 
to a gradual lowering of peak magnitude from 9 to 52 weeks of age (becoming 
statistically different from 14.8±1.0 at 9 weeks to 8.3±0.6 mg glucose.kg-1.min-1 at 52 
weeks of age, p<0.01) (Table IV). 
When the HPN-dependent component was blocked by atropine (Figure 15b), 52 
weeks old females showed a lowered peak magnitude of insulin per se action (from 
9.8±0.7 at 9 weeks to 6.6±0.4 mg glucose.kg-1.min-1 at 52 weeks of age, p<0.05). This 
was compensated by a latter offset in action (38.8±2.4 min at 52 weeks vs 25.4±1.1 min 
at 9 weeks of age, p<0.05).  
As in male Wistar rats, the effect of age on postprandial insulin action is related 
to a decrease in the HPN-dependent component of insulin action (Figure 15c). This is 
observable by a decrease in peak action (from 8.3±1.3 at 9 weeks to 2.5±0.9 mg 
glucose.kg-1.min-1 at 52 weeks of age, p<0.05), and also to an increased flattened shape 
of the dynamic curve with age. 
This indicates that from 9 to 52 weeks of age male and female Wistar rats show 
similar development alterations in the dynamic curves of total postprandial insulin 
action, and in the HPN-dependent and –independent components.  
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Table IV – Effect of age on dynamic curve main properties of fed female Wistar rats. Dynamic 
profile characteristics of the control rapid insulin sensitivity test (RIST), post-atropine RIST and hepatic 
parasympathetic nerve (HPN)-component of total insulin action of 9, 16, and 52 weeks old fed female 
Wistar rats (* p<0.01 vs 9 weeks, # p<0.05 vs 9 weeks, § p<0.05 vs 16 weeks).  
 
 9 weeks 
old (n=8) 
16 weeks old  
(n=5) 
52 weeks old  
(n=5) 
Peak (mg glucose.kg-1.min-1) 14.8±1.0 12.6±0.8 8.3±0.6* 
Peak time (min) 12.5±0.9 12.4±1.1 16.8±0.6 
Control 
RIST 
Duration (min) 35.1±2.1 36.3±2.6 42.3±2.5 
Peak (mg glucose.kg-1.min-1) 9.8±0.7 9.4±1.5 6.6±0.4# 
Peak time (min) 13.2±0.6 12.2±1.3 17.3±0.5§ 
Post-
atropine 
RIST Duration (min) 25.4±1.1 29.5±1.8 38.8±2.4# 
Peak (mg glucose.kg-1.min-1) 8.3±1.3 5.8±0.6 2.5±0.9# 
Peak time (min) 17.0±1.7 12.8±1.4 17.3±1.9 
Onset (min) 5.5±1.0 6.2±1.7 14.8±2.9 
Offset (min) 35.1±2.1 34.3±2.7 36.3±6.0 
HPN-
dependent 
component 
Duration (min) 29.5±2.8 28.0±4.2 21.5±5.1 
 
 
To ascertain the total amount of glucose perfused during each test, the area 
under each dynamic curve was calculated. The results are shown in Figure 16.  
Total insulin action showed a tendency to decrease with age. However, unlike 
male Wistar rats, in females this decrease did not achieve statistical difference from 9 to 
52 weeks of age (from 266.5±25.8 at 9 weeks to 231.9±26.2 at 16 weeks, and 
201.4±16.3 mg glucose/kg bw at 52 weeks of age).  
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Figure 16 – Effect of age on RIST indexes of fed female Wistar rats: HPN-dependent and –
independent components. Rapid insulin sensitivity test (RIST) indexes for female Wistar rats at 9, 16, 
and 52 weeks of age (the 6 weeks group is represented blank to help comparison with the data of male 
experiments). As in males, The hepatic parasympathetic nerve (HPN)-dependent component decreased 
with age. The HPN-independent component was unchanged by age. 
 
 
When comparing these results with the ones obtained for males (Figure 14), we 
observe that males and females have similar total postprandial insulin sensitivity at 9 
and 16 weeks of age (males: from 297.4±18.5 at 9 weeks to 221.7±24.3 mg glucose/kg 
bw at 16 weeks of age). However, at 52 weeks of age, the males show to be insulin 
resistant when compared with females (135.6±12.8 for males vs 201.4±12.6 mg 
glucose/kg bw for females). This seems to indicate that the loss of total insulin action 
with age happens slower in females than in males. 
As in males, the two components of insulin action were affected differently by 
age in females (Figure 16). The HPN-independent component remained similar from 9 
to 52 weeks of age (from 132.0±10.3 at 9 weeks to 161.7±19.9 at 16 weeks, and to 
158.8±9.2 mg glucose/kg bw at 52 weeks of age). The HPN-dependent component 
decreased from 9 to 16 weeks of age (from 134.5±22.4 at 9 weeks to 65.6±4.4 mg 
glucose/kg bw at 16 weeks, p<0.05); after, at 52 weeks of age it did not show a further 
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statistically significant decrease, but evidenced still a downward trend (to 42.6±15.2 mg 
glucose/kg bw). In terms of behaviour, as already seen by the dynamic curves (Figure 
15), male and female seem to be subjected to the same manner of developmental 
changes. 
Surprisingly, comparing again males and females, the main contributor for the 
observed lack of decrease in postprandial insulin total action between 9 and 52 weeks 
old females seemed not an hypothetical preservation of the HPN-dependent component 
(24.8±6.8 in males and 42.6±15.2 mg glucose/kg bw in females), but rather an higher 
HPN-independent component at this age in females (111.0±9.4 in males vs 158.8±9.2 in 
females, p<0.05). 
 
The previous results prompted the analysis of males and females at 78 weeks of 
age; although this age was firstly not considered, being related to senescence. Indeed, 
animals presented at this time common signs of old age (ex: degraded coating, crooked 
teeth, morbid obesity, stiffened vascular walls, atherosclerotic plaques, abscesses, 
tumours, and visual and locomotion impairments). Interestingly, hypertension was not 
seen even at this age. All the animals with signs of disease or general discomfort were 
excluded from the study. 
Males had still higher body weight than females (950.0±26.3 for males, n=6, vs 
547.3±21.3 g for females, n=5, p<0.001). None showed hypertension or 
hyperglycaemia. Blood arterial pressure was still normal in both genre (90.0±4.8 for 
females and 101.2±5.3 mmHg for males), and unchanged by atropine administration 
(88.0±4.3 for females and 91.8±5.7 mmHg for males. Baseline glycaemia was also 
normal, in both gender (99.0±6.8 for males and 98.2±2.8 mg/dl for females), not 
changed by atropine (96.8±3.7 for males and 95.0±2.6 mg/dl for females).  
The dynamic profiles obtained at 78 weeks of age in male and female, before 
and after atropine administration are shown in Figure 17. 
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Figure 17 – RIST profiles of fed male and female Wistar rats at old age. Mean dynamic profiles for 
the rapid insulin tests (RIST) performed on control (a) and post-atropine (b) conditions at 78 weeks of age 
in male and female Wistar rats.  Mean dynamic profile curve for the hepatic parasympathetic nerve 
(HPN)-dependent component of insulin action (c), obtained by subtracting the post-atropine curve from 
the control curve. 
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Both gender showed qualitatively the same kind of developmental changes that 
had already been evident in their gender-matched group at 52 weeks. Also, both gender 
showed similar dynamic curves for total insulin action and for the HPN-independent 
and –dependent components (Figure 17), as well as similar characteristics (Table V). 
 
 
Table V – Dynamic curve main properties of fed male and female Wistar rats at old age. Dynamic 
profile characteristics of the control rapid insulin sensitivity test (RIST), post-atropine RIST and hepatic 
parasympathetic nerve (HPN)-component of total insulin action of 78 weeks old fed male and female 
Wistar rats.  
 
 Male 78 weeks 
old (n=6) 
Female 78 weeks 
old (n=5) 
Peak (mg glucose.kg-1.min-1) 9.7±0.9 8.3±1.3 
Peak time (min) 14.5±0.8 13.8±0.8 
Control RIST 
Duration (min) 37.2±1.8 40.3±1.0 
Peak (mg glucose.kg-1.min-1) 8.0±0.7 6.5±0.6 
Peak time (min) 15.5±1.0 14.3±1.3 
Post-atropine 
RIST 
Duration (min) 33.8±2.3 36.8±2.5 
Peak (mg glucose.kg-1.min-1) 3.8±0.5 2.4±0.6 
Peak time (min) 15.4±2.7 12.8±0.4 
Onset (min) 9.2±1.7 5.2±0.5 
Offset (min) 31.8±3.3 35.1±4.0 
HPN-
dependent 
component 
Duration (min) 22.7±3.1 28.6±3.7 
 
 
When the area under the control RIST dynamic curve was calculated, both 
gender showed similar insulin sensitivity (185.5±24.3 for male and 173.7±14.5 mg 
glucose/kg bw for females)(Figure 18). Furthermore, female showed now a statistically 
significant decrease with aging (from 266.5±25.8 at 9 weeks to 173.7±14.5 mg 
glucose/kg bw at 78 weeks of age, p<0.05), as well as the males (from 297.4±18.5 at 9 
weeks to 185.5±24.3 mg glucose/kg bw, p<0.05). 
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Figure 18 –RIST indexes of fed male and female Wistar rats at 78 weeks of age: HPN-dependent 
and –independent components. Rapid insulin sensitivity test (RIST) indexes for male and female Wistar 
rats at 78 weeks of age showed similar total insulin sensitivity between gender at this age, as well as a 
similar contribution of both components between gender. 
 
Both components of total insulin action showed similar values among gender 
(Figure 18). The HPN-independent remained unchanged by aging (138.6±18.8 for 
males and 131.7±8.6 mg glucose/kg bw for females), while the HPN-dependent 
remained impaired (46.9±11.8 for males and 40.0±14.2 mg glucose/kg bw for females). 
In males, the HPN-dependent component at 78 weeks of age, albeit showing a tendency 
to be higher than at 52 weeks of age, was still decreased in relation to the 16 weeks of 
age group (p<0.05). 
 
4.3.4. Discussion 
 
Aging has shown to lead to a consistent decrease of total postprandial insulin 
sensitivity in both genders of Wistar rats. From 9 to 78 weeks of age, the action of 
insulin per se remains similar in male and female, so this development of insulin 
resistance seems to be solely due to a decrease of the HPN-dependent component. 
The HPN-dependent component of insulin action decreased radically in both 
gender during the end of puberty. After that, it decreased more in males and showed a 
tendency to decrease in females. This seems to be related to a more radical decrease of 
the HPN-dependent component in females by 16 weeks of age. Indeed, consistent with 
this, it has been reported that gender influences differently the decrease of 
parasympathetic activity with aging, and that this difference tends to disappear when 
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middle-age is reached (Bonnemeier et al., 2003; De Meersman and Stein, 2007; Kuo et 
al., 1999). 
Estrogen, which has been described to promote parasympathetic function and, 
through nitric oxide, to limit sympathetic drive (Liu et al., 2003; Rosa Brito-Zurita et 
al., 2003), is however reported to decrease only after one year of age, well after the 
sudden decrease in the HPN-dependent component observed in females. Nonetheless, it 
may have a role in nerve growth and survival with age (Dart et al., 2002; Lavi et al., 
2007). 
 
The slightly better profile of the HPN-dependent component in old aged, 78 
weeks of age animals, especially among the males included in this study, need not be 
contradictory. By 78 weeks of age the mortality rate is already quite substantial, as well 
as animals excluded from the study for possible confounding ailments. This leads to the 
involuntary selection of animals able to maintain a better metabolic profile at this age. 
Consistently with this hypothesis, neither males nor females showed hyperglycaemia or 
hypertension at 78 weeks of age.  
Interestingly, this data also finds a parallel with human studies. Indeed, although 
parasympathetic function was shown to decrease with age (Piccirillo et al., 1998a; 
Piccirillo et al., 2001), centenarian subjects showed increased parasympathetic function 
in relation to middle-aged and following aged groups (Piccirillo et al., 1998a). Beyond 
the reported conclusion of a U-shaped curve in parasympathetic function with age 
(Piccirillo et al., 1998a), first decreasing and then increasing again in tonus, one may 
propose the alternative conclusion that those individuals that were able to reach old age 
were precisely the ones where a maintained activity of the parasympathetic nervous 
system prevented the dramatic metabolic deterioration seen during normal aging. 
 
The present results traced the developmental change in insulin sensitivity, which 
was shown to be similar between male and female in each of the young (9 weeks) and 
old aged (78 weeks) groups. This further confirms the Wistar rat strain as an adequate 
animal model of human aging, since these results are consistent with previous human 
studies (Davidson, 1979; Fink et al., 1983; Piccirillo et al., 1998a).  
In relation to the present thesis, it helped to establish the preferential age of 
analysis to proceed with studies in pathological animals models – specifically, the 9 
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weeks old group, where the HPN-dependent component seems not yet impaired by age -
, and to allow to focus on only one gender. 
 
4.4 Alterations in postprandial insulin sensitivity by high-sugar diets 
 
4.4.1. Context and general work hypothesis  
 
The development of type 2 diabetes seems to be influenced in equal parts by the 
genetic background and by the cumulative effects of lifestyle (Facchini et al., 2001). As 
sure as a balanced diet and exercise can postpone the development of the disease in 
people with a genetic disposition, and family history of diabetes (Eriksson et al., 1989; 
Lopez et al., 2008; Ten and Maclaren, 2004), also even a good genetic background may 
not be enough to prevent the deleterious effect of an unchecked lifestyle. In this 
concern, diet composition seems to play an important role in the development of insulin 
resistance and type 2 diabetes (Hu et al., 2001). 
A thoughtfully planned diet composition has been for long recognised to 
ameliorate the glycemic control of diabetic patients; and, when uncared for, to have a 
potential negative impact even on healthy individual (Himsworth, 1934). Since then, 
Western diets have been changing; and Portugal has followed this phenomenon rapidly, 
even among other Mediterranean countries (Chen and Marques-Vidal, 2007). 
One of the main characteristics in diet changes has been the increased 
consumption of refined carbohydrates. This is considered a major factor in the current 
increase of type 2 diabetes and the occurrence of the diverse facets of the metabolic 
syndrome, moreover on their rising incidence on children and young adults (Gross et 
al., 2004; Yoo et al., 2004); and this is evermore relevant in Portugal since it has an high 
percentage of daily soft drinks consumption among youngsters, in European terms 
(Vereecken et al., 2005). Likewise, the increased intake of sugar-sweetened drinks is 
also related to an increased deterioration of glucose metabolism with age (Reaven et al., 
1983) and risk of cardiovascular problems (Dhingra et al., 2007) in adults. 
Several studies have established that high-sugar feeding, including high-sucrose 
diets, lead to the decrease of whole-body insulin sensitivity (Daly, 2003), mainly in 
skeletal muscle (D'Alessandro et al., 2000; Hulman and Falkner, 1994; Kim et al., 1999; 
Pagliassotti et al., 1994), similarly in male and female (Kim et al., 1999). However, the 
relevance of the HPN, which has been shown to regulate glucose homeostasis in the 
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postprandial state, has never been assessed in studies of insulin resistance induced by 
sucrose feeding. 
Furthermore, this seemed an excellent model for the evaluation of the impact of 
nutritional factors on postprandial insulin action since it has been described as being 
free of the confounding effects of weight gain and hypertension, common in other 
models of diet manipulation (Afonso et al., 2007a; Elliott et al., 2002; Valensi, 2005). 
 
Our general work hypothesis was that the highly regulated HPN-dependent 
component of postprandial insulin action would be very sensitive to environmental 
disruption by a high-sucrose diet. 
 
4.4.2 Effect of a high-sucrose diet on Wistar and Sprague-Dawley rats 
 
4.4.2.1. Experimental protocols 
 
Since it has been shown that differences in strain characteristics between Wistar 
and Sprague-Dawley rats can lead to variations in whole-body insulin sensitivity 
(Gaudreault et al., 2001), these two strains, the most commonly used for insulin-
stimulated glucose measurements, were used in this study. 
 
Wistar and Sprague-Dawley were analysed at 9 weeks of age. For the last 6 
weeks, both strains were divided into two groups. Besides both groups being fed a 
standard solid diet, one of them had access to a bottle of water while the other had 
access to a bottle of water and an additional bottle of a 35% sucrose solution. In the 
high-sucrose-diet fed group, bottles were changed sides in the cage each time they were 
refilled to avoid habituation. Water and sucrose solution volumes consumed were 
measured to establish adherence to the high-sucrose solution supplement. 
Postprandial total insulin action was quantified by a RIST control. Following 
that, atropine was administered to block HPN influence on glucose metabolism, and a 
second RIST was performed to quantify the HPN-independent component of insulin 
action. 
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4.4.2.2. Results 
 
Wistar rats with access to a high-sucrose solution bottle plus a water bottle 
showed, with experiment time, preference for consumption of the sucrose solution 
(from 23.1±5.4 to 35.6±2.9 ml/day, p<0.05) in detriment of only water (from 32.5±4.5 
to 8.8±1.6 ml/day, p<0.001). These values did not change when the bottles were 
switched places. Rats with just a water bottle ingested 45.8±2.5 ml/day. 
The availability of a high-sucrose solution did not produce alterations in body 
weight (338.5±18.1 for standard-fed, n=8, and 340.8±18.6 g for high-sucrose, n=10). 
Likewise, basal postprandial glycaemia was not changed either by diet (125.1±7.7 with 
standard diet and 136.9±4.0 mg/dl with high-sucrose diet) or atropine (131.8±8.3 with 
standard diet and 134.3±4.4 mg/dl with high-sucrose diet). Arterial blood pressure was 
also unchanged by diet (119.5±0.5 with standard diet and 111.8±5.3 mmHg with high-
sucrose) or atropine (122.5±7.5 with standard diet and 112.4±5.7 mmHg with high-
sucrose diet). 
 
The mean dynamic profiles of total postprandial insulin action for standard- and 
high-sucrose-fed Wistar rats are shown below, on Figure 19, as well as the dynamic 
profiles obtained after atropine administration and by calculation of the HPN-dependent 
component. On Table VI are detailed the main characteristics of the aforementioned 
profiles. 
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Figure 19 – Effect of high-sucrose supplementation on RIST profiles of male 9 weeks-old Wistar 
rats. Dynamic profiles of the control (bold lines) and postatropine (thin lines) rapid insulin sensitivity test 
(RIST) for standard-fed (a) and high-sucrose-fed (b) Wistar rats. c Dynamic profile of the hepatic 
parasympathetic nerve (HPN)-dependent component of insulin action, obtained by subtracting the post-
atropine curve from the control curve, of the standard-fed (bold line) and high-sucrose-fed (thin line) 
Wistar rats. 
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There was a clear decrease in the dynamic profile of the control RIST with 
exposure to a high-sucrose diet. This decrease was seen both in maximal total response 
to insulin (peak action decreased from 15.9±0.9 in the standard-fed to 11.7±1.3 mg 
glucose.kg-1.min-1 in the sucrose-fed, p<0.01) and in the duration of total insulin action 
(from 35.8±1.8 in the standard-fed to 26.8±0.5 min in the sucrose-fed, p<0.01)(Table 
VI). 
The dynamic profiles for the post-atropine RIST in standard-fed and sucrose-fed 
Wistar rats were practically superimposed, which shows that the present high-sucrose 
diet had no effect on the HPN-independent component of insulin action. 
The previous further shows that it is solely a decrease of the HPN-dependent 
component of insulin action that is responsible for the observed diminished total insulin 
action. Peak action of the HPN-dependent is radically compromised by consumption of 
the high-sucrose supplement (from 10.0±1.1 in standard-fed to 1.5±0.6 mg glucose.kg-
1
.min-1, p<0.001), as well as the duration of action (from 26.6±2.1 in standard-fed to 
8.3±2.0 min in sucrose-fed, p<0.01). The decrease in duration of action was due to an 
earlier offset of the HPN-dependent component (from 35.4±1.9 in standard-fed to 
22.9±2.1 min in sucrose-fed, p<0.01). 
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Table VI – Dynamic curve main properties of standard and high-sucrose fed Wistar rats. Dynamic 
profile characteristics of the control RIST, the HPN-independent component (post-atropine RIST), and 
the HPN-dependent component of total insulin action (* p<0.01 standard-fed vs sucrose-fed, # p<0.001 
standard-fed vs sucrose-fed). 
 
  Standard-fed Sucrose-fed 
Peak 15.9±0.9* 11.7±1.3* 
Peak time 12.3±0.5 12.6±0.8 
Control RIST 
Offset 35.8±1.8* 26.8±0.5* 
Peak 10.8±1.1 10.2±1.2 
Peak time 11.1±0.8 11.8±0.8 
HPN-independent  
Offset 24.9±2.1 26.8±0.5 
Onset 7.2±1.0 8.9±1.7 
Peak 10.0±1.1# 1.5±0.6# 
Peak time 15.7±1.1 16.1±1.9 
Offset 35.4±1.9* 22.9±2.1* 
HPN-dependent 
Duration 26.6±2.1* 8.3±2.0* 
 
 
Figure 20 shows the previous results but now representing them by the area 
delimited by the dynamic profiles. By the RIST indexes for Wistar rats, the bars on the 
left of the figure, it is seen again that the standard-fed group had higher total insulin 
sensitivity than the sucrose-fed group (305.6±34.1 for standard-fed vs 193.9±13.7 mg 
glucose/kg bw for the sucrose-fed; p<0.05). The RIST indexes obtained after atropine 
administration were similar in the two groups (140.4±22.1 for standard-fed and 
167.4±10.8 mg glucose/kg bw for sucrose-fed). 
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Figure 20 – RIST indexes of standard and high-sucrose fed Wistar rats. Rapid insulin sensitivity test 
(RIST) indexes for the hepatic parasympathetic nerve (HPN)-independent (filled) and HPN-dependent 
(open) components of insulin action on 9 weeks old Wistar rats. The sum of both components represents 
the control RIST index for each protocol. In both strains, insulin sensitivity was significantly higher for 
the standard-fed diet group than for the high-sucrose group (** p<0.01). A lower HPN-dependent 
component accounted for this difference. 
 
 
The HPN-dependent component of insulin action was significantly lower in the 
sucrose-fed than in the standard-fed group (164.3±28.1 vs 26.5±7.5 mg glucose/kg bw; 
p<0.0001). This means that the contribution of the HPN-dependent component to total 
insulin action was diminished in sucrose-fed Wistar rats (from 52.1±6.6% in standard-
fed to 12.7±3.3% in the sucrose-fed group; p<0.0001). 
 
The Sprague-Dawley rats also did not presented changes in body weight with 
high-sucrose diet (353.9±16.3 for standard-fed, n=15, and 384.3±6.1 g for high-sucrose, 
n=5). Basal glycaemia was again unchanged by diet (118.9±3.5 with standard diet and 
109.0±4.7 mg/dl glucose with high-sucrose diet), as well as arterial blood pressure 
(92.3±7.0 with standard diet and 92.0±2.6 mmHg with high-sucrose diet). 
The dynamic profiles obtained for Sprague-Dawley rats were similarly shaped to 
the control RIST, post-atropine RIST and HPN-dependent component in Wistar rats. So 
the results are shown as RIST indexes (Figure 21). 
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Figure 21 – RIST indexes of standard and high-sucrose fed Sprague-Dawley rats. Rapid insulin 
sensitivity test (RIST) indexes for the hepatic parasympathetic nerve (HPN)-independent (filled) and 
HPN-dependent (open) components of insulin action on 9 weeks old Sprague-Dawley rats. The sum of 
both components represents the control RIST index for each protocol. In both strains, insulin sensitivity 
was significantly higher for the standard-fed diet group than for the high-sucrose group (** p<0.01). A 
lower HPN-dependent component accounted for this difference. 
 
 
The standard-fed Sprague-Dawley rats had, like what is shown in Wistar, a 
higher total insulin sensitivity than the sucrose-fed Sprague-Dawley rats (196.4±5.9 for 
standard-fed vs 95.5±16.3 mg glucose/kg bw for sucrose-fed; p<0.01) (Figure 21). 
Since the HPN-independent component was similar in both diet groups (84.7±6.0 for 
standard-fed and 61.0±10.1 mg glucose/kg bw for sucrose-fed), the reduced insulin 
action observed in sucrose-fed Sprague-Dawley rats was due to a decrease of the HPN-
dependent component (111.7±9.5 for standard-fed vs 35.3±21.4 mg glucose/kg for the 
sucrose-fed group; p<0.01).  
Accordingly, the contribution of the HPN-dependent component to the total 
insulin sensitivity was lower for the sucrose-fed group (56.0±3.7 for standard-fed and 
28.8±13.8% for sucrose-fed; p<0.05). 
Although the absolute values were lower in Sprague-Dawley than in Wistar rats, 
the percentage contribution of the HPN-dependent component was similar between the 
two strains for the standard-fed and sucrose-fed groups. 
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4.4.2.3. Discussion 
 
It has been shown here that the availability of a supplement rich in the 
disaccharide sucrose leads to decreased total postprandial insulin sensitivity. 
Furthermore, this development of insulin resistance is solely due to an impairment of 
the HPN-dependent component of insulin action. This happened identically in both 
Wistar and Sprague-Dawley rats; even though Wistar show higher insulin-stimulated 
glucose uptake than Sprague-Dawley, the partial contribution of each component of 
insulin action is similar in the two strains for either standard-fed or high-sucrose-fed 
animals. 
These results support the notion that an environmental manipulation as simple as 
a high sucrose supplement, which was used to show the effect of the increased public 
consumption of soft drinks and other sweetened products (Gross et al., 2004), leads to a 
dramatic impairment of the HPN-dependent component of insulin action. This increase 
in refined carbohydrate consumption, together with a decrease in fibre consumption, is 
reported to play a crucial role in the increased prevalence of type 2 diabetes (Gross et 
al., 2004; Henry et al., 1991). 
 
Sucrose-enriched diets have been previously reported to lead to skeletal muscle 
insulin resistance (D'Alessandro et al., 2000; Hulman and Falkner, 1994; Kim et al., 
1999; Pagliassotti et al., 1994). However, none of the previous studies took into 
consideration that insulin-stimulated glucose uptake consists of two discernable 
components, one of which is modulated by the activation of the hepatic parasympathetic 
nerves (Lautt, 1999), and the prandial status (Latour and Lautt, 2002b; Lautt et al., 
2001). 
Presently, the administration of atropine, a muscarinic antagonist, only 
decreased postprandial insulin sensitivity in standard-fed animals. High-sucrose-fed 
animals showed similar pre- and post-atropine RIST profiles, and subsequently indexes. 
Furthermore, the insulin sensitivity of post-atropine standard-fed animals was not 
statistically different from that obtained for pre- and post-atropine sucrose-fed rats, thus 
showing that the decrease in whole-body insulin sensitivity evidenced by sucrose-fed 
rats is entirely a reflection of the impairment of the HPN-dependent component of 
insulin action. It also indicates that this component is essentially absent from 9 weeks 
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old rats given access to a 35% liquid sucrose solution in complement to standard rat 
chow and regular water. Further, this supplement became the almost exclusive source of 
drinking fluids, showing a clear behavioural adherence to sweetened beverages. 
 
The RIST methodology measures whole-body insulin-stimulated glucose uptake. 
High-sucrose diets are sometimes reported to induce hepatic insulin resistance besides 
skeletal muscle insulin resistance (Pagliassotti et al., 1994; Storlien et al., 1988), which 
could hamper the conclusion drawn that related the sucrose-induced insulin resistance 
observed solely to a decrease in glucose uptake at the skeletal muscle. However, those 
reports have come from studies in fasted animals, at low doses of insulin. Higher doses 
of insulin, even in the fasted state, seem to be able to adequately suppress hepatic 
glucose output, thus revealing decreased insulin sensitivity only at the skeletal muscle 
(Pagliassotti et al., 1994). The level of insulinaemia reached in the present study, by 
being in the postprandial state and performing a test after the bolus administration of 
insulin, should be enough to assure the latter situation. 
This is consistent with the described action of the HPN-dependent component 
mainly on skeletal muscle (Lautt, 2005; Xie and Lautt, 1996b). And since there was no 
alteration in body weight or arterial pressure, obesity and hypertension may be excluded 
as confounding factors, in accordance with previous authors (Pagliassotti et al., 1994; 
Podolin et al., 1998; Santure et al., 2002; Santure et al., 2003). 
 
The disaccharide sucrose is completely hydrolysed, after digestion by the 
enzyme sucrase, into equal amounts of the monosaccharides glucose and fructose, and 
absorption, at the small intestine, happens similarly either with sucrose or with an 
equimolar mixture of glucose and fructose (Dahlqvist and Thomson, 1963). However, 
after a high-sucrose meal, fructose is metabolised much more rapidly than glucose 
(Daly et al., 2000). More, fructose has been suggested to be the moiety responsible for 
sucrose-induced insulin resistance (Thresher et al., 2000). 
Although fructose has been widely advised as a favourable carbohydrate 
substitute in the diet of diabetic subjects (Gerrits and Tsalikian, 1993), for its capacity to 
acutely produce lower postprandial glucose and insulin responses (Shiota et al., 2002) at 
catalytic amounts (Moore et al., 2001; Shiota et al., 2002), the continuous ingestion of 
this monosaccharide may induce metabolic adaptations that ultimately lead to a 
deterioration in glycemic control. 
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After digestion and absorption, fructose is rapidly taken up by the portal blood 
flow and transported mainly to the liver. Small amounts are metabolised in the small 
intestinal mucosa and the kidney, and almost none at all by the peripheral tissues 
(Hallfrisch, 1990). In the liver, fructose is phosphorylated by fructokinase and gives rise 
to an increase in the triose phosphate pool. This is done by bypassing the rate-limiting 
step of glycolysis, the enzyme phosphofructokinase (Mayes, 1993). The greater 
availability of intermediates created favours the glycolytic pathway; with a higher 
production of lactate (Mayes, 1993), seen even when catalytic amounts of fructose are 
used (Moore et al., 2001).  
The concomitant presence of fructose and glucose, as when derived from 
sucrose, induces hepatic glycogen deposition of glucose (Hallfrisch, 1990; Mayes, 
1993), which does not happen when fructose is given alone (Hallfrisch, 1990). Thus, 
after a high-sucrose content meal, while the glucose moiety is diverted to hepatic 
glycogen deposition, fructose is quickly metabolised by the liver (Daly et al., 2000) and 
predominantly driven into the production of lactate.  
 
Feeding a high-sucrose diet leads to increased intestinal absorption of both 
products of hydrolysis, fructose and glucose (Michaelis et al., 1975; Reiser et al., 1975; 
Riby et al., 1993), and the long term consumption of sucrose or fructose primes the 
organism for these changes by optimizing even more the enzymatic machinery involved 
(Mayes, 1993; Reiser et al., 1981). Fructose is transported, when present at low 
concentrations, by the GLUT 5 (Ushijima et al., 1995). The disaccharide transport effect 
of sucrose (Michaelis et al., 1975; Michaelis and Szepesi, 1974) leads to increased 
fructose absorption by action of the enzyme sucrase (Ushijima et al., 1995) and transient 
insertion of GLUT 2 into the enterocyte apical membrane (Kellett and Brot-Laroche, 
2005; Kellett et al., 2008), when fructose concentration is higher than 30 mmol/L 
(Ushijima et al., 1995), usually after meals (Kellett et al., 2008).  
Also, the aforementioned beneficial lower levels of post-meal glucose and 
insulin response to fructose ingestion have been reported to become similar to other 
sugars when there is a prolonged consumption of fructose within mixed meals 
(Hallfrisch, 1990).  
In time, sucrose supplementation leads to postprandial hyperinsulinemia (Mayes, 
1993), with an initial compensatory increase in the first peak of insulin secretion to 
maintain normoglycemia and then further deterioration in insulin kinetics with time of 
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exposure (Chicco et al., 2003). Also, GLUT2 permanent apical localisation is related to 
insulin resistance induced by sucrose/fructose ingestion and diabetes (Kellett et al., 
2008). Hyperinsulinemia may thus be favoured in an attempt to re-establish the ability 
of insulin to bind to insulin receptors in the enterocyte needed to internalise GLUT2 
(Tobin et al., 2008); which normally prevents transepithelial sugar absorption, to 
minimise postprandial glucose excursions. Impaired insulin action induced by fructose-
containing diets lead to three-fold GLUT2 protein and permanent high apical GLUT2 
insertion (Kellett et al., 2008). 
Other long term effects include increased hepatic lipogenesis and increased 
circulating triglyceride through very-low-density lipoproteins hepatic secretion. 
Together with the rise in lactate production, the hypertriglyceridemia can be a possible 
contributor to the development of skeletal muscle insulin resistance (Chicco et al., 2003; 
D'Alessandro et al., 2000).  
The present results show that the exposure to a high-sucrose diet leads primarily 
to an impairment of the HPN-dependent component of insulin action. This was obtained 
by simply providing the animals with a liquid supplement of 35% of sucrose. Changes 
in the direct action of insulin on peripheral tissues may eventually occur, product of the 
above mentioned adaptations to the high-sucrose diet (Chicco et al., 2003), but they will 
be secondary to the loss of the postprandial increment in insulin action. Indeed, 
alterations of fasting insulin sensitivity are reported to occur when the content of 
sucrose in the diet is higher than 60 %, or the content of fructose higher than 34% (Daly 
et al., 1997), while acute effects of sucrose on enzymatic activities are already seen 
when it constitutes 20 to 30 % of total diet (Michaelis and Szepesi, 1974).  
Likewise, the reports of hypertension in high-sucrose/fructose diets (Preuss et 
al., 1998; Reaven and Ho, 1991) seem to be related to higher/longer sugar doses than 
the one available in the present study (Preuss et al., 1998), which is consistent with the 
lack of change in arterial blood pressure reported herein. The sodium and potassium 
content of the diet may also be a confounding factor in the heterogeneity of 
hypertension development with high-sugar diets68 (Bezerra et al., 2001; Claxton and 
                                               
68
 The development of hypertension by sugar loading may be a consequence of the development of 
hyperglycaemia. Hyperglycaemia induces overactivity of the sympathetic nervous system, which favours 
the rise in blood pressure. On the other hand, insulin-stimulated nitric oxide has been reported to oppose 
this mechanism by suppressing sympathetic activity (Claxton and Brands, 2002). The impairment of nitric 
oxide in conditions associated with insulin resistance, hyperglycaemia, and oxidative stress may thus 
bring about the rise in blood pressure. Since the present methodology was able to render the animals 
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Brands, 2003; Johnson et al., 1993). Nonetheless, in the present study hypertension has 
been shown not to be an etiological factor to the insulin resistance induced by high-
sucrose feeding through the decrease of the HPN-dependent component.  
For all the above, it seems likely that the ability of sucrose to induce a decrease 
in insulin sensitivity is mediated by a direct metabolic effect of fructose on the HPN-
dependent component of insulin action (Brito et al., 2008). Other effects, as 
hypertension and changes in lipid profile, are most likely consequences of further 
metabolic deterioration of long-lasting high-sucrose diets (Ahrens, 1974). 
 
The present finding highlights the importance, to the study of high-sucrose-fed 
animals, of reports of decreased parasympathetic vagal activity in high-fructose-fed rats 
(Miller et al., 1999). 
Recently, an increasing emphasis is being placed on a causal effect of an 
autonomic imbalance in the metabolic syndrome (Kreier et al., 2003). In this imbalance, 
brought about by environmental factors, the decrease of parasympathetic activity seems 
to be the determining factor in the development of insulin resistance, which favours the 
progression to type 2 diabetes mellitus (Lindmark et al., 2003). An increase in 
sympathetic autonomous system activity may also play a role, aggravating this 
imbalance (Kreier et al., 2003). In this respect, high-sucrose diets seem to be able to 
induce an increase in central sympathetic outflow (Bunag et al., 1983; Freitas et al., 
2007). However, this is secondary to the impairment of insulin sensitivity (Bezerra et 
al., 2001; Hwang et al., 1987), and nonetheless may not yet be present in the model 
studied herein, since sympathetic overactivity is described to be related to the 
manifestation of hypertension (Bunag et al., 1983; Valensi, 2005), which is presently 
absent.  
This rising imbalance against parasympathetic activity is consistent with the 
present study, an example of how an environmental alteration, such as diet composition, 
can lead quickly and radically into postprandial insulin resistance through an 
impairment of hepatic parasympathetic activity. 
This also underlines the importance of postprandial insulin assessment, in 
comparison with the standard evaluation on the fasted state, as providing an early 
warning to the development of insulin resistance and, from there, of other potential 
                                                                                                                                          
insulin-resistant without becoming hyperglycaemic and/or hypertensive, this question seems definitely to 
be related to a further metabolic degradation, unrelated to the development of insulin resistance 
                                                                                                     4.Results and Discussion 
 127 
metabolic complications. Indeed, considering that HPN-dependent component action is 
vestigial in the fasted state (Lautt et al., 2001), the standard analysis would yield no sign 
of impairment after the 6 weeks of high-sucrose supplementation, when by then it has 
been shown here that almost 50% of total postprandial insulin sensitivity is lost. 
Furthermore, sucrose-induced insulin resistance in skeletal muscle has been related to 
the impairment of a humoral factor, which would explain why only in vivo, and not in 
vitro, studies show skeletal muscle insulin resistance in sucrose-fed rats when compared 
to starch-fed rats (Kim et al., 1999). This again hints to the incorporation of the HPN as 
a functional step of the broader HISS pathway. 
In further support to the relevance of the postprandial state in the evaluation of 
the impact of dietary manipulations, high-sucrose diets lead to transient peaks of 
hyperglycaemia and hyperinsulinaemia after meal ingestion (Daly, 2003; Daly et al., 
1998). And it is now believed that those episodes of hyperglycaemia are extremely 
relevant to the development of metabolic complications (Wright et al., 2006), even in 
individuals with otherwise achieved glycaemic control (Del Prato, 2002; Tuomilehto 
and Del Prato, 2001). 
 
In resume, it seems that the applied model uncovered the primary step of 
sucrose-induced insulin resistance. At a time when body weight, glycaemia, blood 
pressure and direct metabolic effects of insulin on peripheral target tissues are not yet 
compromised, both Wistar and Sprague-Dawley rats showed consistently an entire loss 
of the increment of insulin action sensitisation seen after a meal. As shown before, this 
increment is signalled through a HPN-dependent pathway, which function seems to be 
quickly impaired by a high-sucrose diet. This defect in the postprandial capability of the 
organism to deal with the increased influx of glucose and fructose will undoubtedly lead 
to several complications and metabolic degradation.  
 
It becomes thus expectable, and has been described (Chicco et al., 2003; 
Pagliassotti et al., 1996; Pagliassotti et al., 1994), that the duration of exposure may 
vary the effects of the high-sucrose diet. So, after obtaining such a radical result simply 
by providing the animals with an additional bottle of sucrose solution for 6 weeks, it 
became relevant to study the time-course of the impact of the high-sucrose diet on 
insulin sensitivity.  
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4.4.3. Effect of the duration of exposure to a liquid high-sucrose diet in Sprague-
Dawley rats 
 
4.4.3.1. Experimental protocols 
 
Since it was observed that age is also a critical factor for the status of the HPN-
dependent component of insulin action, the sucrose-diet was introduced at different 
ages, with the animals being analysed at the same final age. So, they were analysed at 
12 weeks of age, with sucrose being introduced, depending on the group, 2, 6 or 9 
weeks before.   
Sprague-Dawley rats were divided into four groups. All were given standard 
solid food and a bottle of water. At 3, 6 or 9 weeks of age the bottle of water was 
substituted by a bottle of a 35% sucrose solution. The standard-diet group had plain 
water for the entire experiment. 
 
4.4.3.2. Results 
 
The group submitted to 9 weeks of sucrose supplementation group showed, in 
comparison with the standard-fed group, higher basal glycaemia (106.3±3.3 for 
standard-fed, n=9, vs 142.3±8.8 mg/dl for 9 weeks sucrose supplemented diet, n=11; 
p<0.05) and higher body weight (459.1±4.7 for standard-fed vs 643.1±25.9 g for 9 
weeks sucrose supplemented diet; p<0.0001). For all other exposure times, sucrose-fed 
showed similar values to standard-fed rats for basal glycaemia (120.1±4.7 for 2 weeks, 
n=7, and 109.0±4.1 mg/dl for 6 weeks, n=5) and body weight (460.0±9.8 for 2 weeks 
and 489.2±29.3 g for 6 weeks of sucrose diet). Arterial blood pressure was similar 
between the standard-fed and all sucrose-fed groups (101.9±2.9 for standard-fed vs 
97.9±3.7 for 2 weeks, 92.3±7.0 for 6 weeks, and 92.0±2.6 mmHg for 9 weeks of high-
sucrose diet). 
 
Figure 22 integrates the data for the total insulin action and for each of the 
components that constitute it: HPN-dependent and –independent components of 
postprandial insulin action. 
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Figure 22 – Effect of exposure time to high-sucrose diet in Sprague-Dawley rats. Rapid insulin 
sensitivity test (RIST) indexes for the hepatic parasympathetic nerve (HPN)-independent (filled) and 
HPN-dependent (open) components of insulin action of Sprague-Dawley rats on a high-sucrose diet for 
different periods. The sum of both components represents the control RIST index. Insulin sensitivity was 
significantly higher for the standard-fed diet group than for the sucrose-fed group. The HPN-dependent 
component accounted for this variation (*** p<0.001). 
 
 
All sucrose-fed groups had similar total insulin sensitivity (106.2±12.5 with 2 
weeks of sucrose diet, n=7, 95.5±16.3 with 6 weeks of sucrose diet, n=5, and 106.6±8.4 
mg glucose/kg bw with 9 weeks of sucrose diet, n=11), which was lower than in the 
standard-fed (192.4±4.9 mg glucose/kg bw; p<0.001).  
 
Since there was no statistical difference in post-atropine RIST index between 
standard-fed and any sucrose-fed group (89.6±4.1 for the standard-fed and 78.9±10.6 
with 2 weeks of sucrose diet, 61.0±10.1 with 6 weeks of sucrose diet, and 88.8±6.7 mg 
glucose/kg bw with 9 weeks of sucrose diet), the decrease of total insulin sensitivity was 
due to lower HPN-dependent component in any sucrose-fed group (102.7±6.9 for 
standard-fed vs 28.5±7.6 with 2 weeks of sucrose diet, 35.3±21.4 with 6 weeks of 
sucrose diet, and 17.9±5.4 mg glucose/kg bw with 9 weeks of sucrose diet; p<0.001). 
Accordingly, the contribution of the HPN-dependent component to total insulin 
sensitivity was lower in all sucrose-fed groups than in the standard-fed group 
(52.5±2.6% for the standard-fed vs 26.4±6.2% with 2 weeks sucrose diet, 28.8±13.8% 
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with 6 weeks of sucrose diet, and 17.9±5.4% with 9 weeks sucrose diet; p<0.01, p<0.05 
and p<0.001, respectively). 
 
4.4.3.3. Discussion 
 
The insulin resistance caused by the liquid high-sucrose diet, through 
impairment of the HPN-dependent component of insulin action, is fully expressed after 
only 2 weeks of exposure to the source of sucrose. In contrast, the HPN-independent 
component is unchanged, even after 9 weeks of exposure to the high-sucrose diet. 
The group subjected to the longer period of sucrose exposure (9 weeks) showed 
a higher weight gain in relation to the standard-fed group. We can therefore exclude 
weight gain as a confounding factor since there was no additional increase of insulin 
resistance in this group. The added influence of obesity did not seem to have an 
additional impact on the HPN-dependent component, already impaired, or on the HPN-
independent component. It was more likely an additional effect of the high-sucrose diet; 
possibly through increased lipogenesis derived from the augmented metabolism of 
fructose (Chicco et al., 2003; Mayes, 1993). Interestingly, dietary interaction in obese 
children showed a closer relation between carbohydrate metabolism and sucrose intake 
than between the former and body weight (Kahle et al., 1982). 
In addition, since basal hyperglycaemia was only observed in the rats exposed to 
the sucrose supplement for 9 weeks, we conclude that the impairment of the HPN-
dependent component is not the result of high blood glucose levels, because sucrose-fed 
rats exposed for 2 or 6 weeks were similarly insulin resistant, despite being 
normoglycaemic. However, it is expected that the rise in blood glucose will eventually 
lead to defects by protein glycation (Gerrits and Tsalikian, 1993). 
The excess weight gain seen by the time postprandial hyperglycaemia is attained 
may be related with the surplus time that glucose is available in circulation after a meal, 
increasing the quantity diverted for adipose tissue accumulation. 
 
The high-sucrose diet has been shown to have a quick detrimental influence on 
insulin sensitivity. This supplementation has been given in all previous protocols in 
liquid form. However, questions have been raised concerning the differential effect that 
the way of delivery may have on protecting against these deleterious effects, or even 
have a beneficial effect on insulin sensitivity (Baschetti, 1999). 
                                                                                                     4.Results and Discussion 
 131 
 
4.4.4. Effect of liquid vs solid high-sucrose diet in Sprague-Dawley rats 
 
4.4.4.1. Experimental protocols 
 
The physical form in which sucrose is made available may be an important 
factor on the magnitude of the metabolic effects it elicits (Crapo and Henry, 1988; 
Kanarek and Orthen-Gambill, 1982). To study if the way of delivery of the sucrose 
supplement bore any influence on the way this diet impaired insulin sensitivity, 
Sprague-Dawley rats were divided into three groups. One received standard-solid-diet 
and water, other received standard-solid-diet and a sucrose solution, and the third group 
received high-sucrose-solid-diet and water. Since the objective was to study the possible 
protective role of the solid form, the time of exposure chosen was the longest previously 
used. 
 
4.4.4.2. Results 
 
The groups given access to a high-sucrose diet, either in the solid meal 
composition or by a liquid supplement, showed higher body weight standard-fed 
animals (441.6±42.9 for standard-fed, n=7, vs 577.5±22.3 g for solid high-sucrose, n=6, 
p<0.05, and 622.3±21.8 g for liquid high-sucrose, n=5, p<0.01). Concerning basal 
glycaemia, only the liquid high-sucrose group showed an increase in relation to the 
standard-fed (138.0±9.8 for liquid high-sucrose vs 108.7±4.2 mg/dl, p<0.05), with the 
solid high-sucrose group showing normal levels (111.7±2.8 mg/dl). Arterial blood 
pressure was unchanged (98.6±5.0 for standard-fed, 100.4±3.2 for solid high-sucrose, 
and 95.5±2.6 mmHg for liquid high-sucrose). 
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Figure 23 – Effect of delivery form of high-sucrose diet in Sprague-Dawley rats. Rapid insulin 
sensitivity test (RIST) indexes for the hepatic parasympathetic nerve (HPN)-independent (filled) and 
HPN-dependent components of insulin action of Sprague-Dawley rats fed either a standard diet or given a 
liquid or solid sucrose supplement. The sum of both components represents the control RIST index. 
Insulin sensitivity was significantly higher for the standard diet for any of the high-sucrose-fed groups. 
The HPN-dependent component accounted for this difference (*** p<0.001).  
 
 
Both liquid- and solid-sucrose-fed groups had similarly lower total insulin 
sensitivity than the standard-fed group (177.3±12.7 for standard-fed vs 100.7±10.6 for 
liquid-sucrose-fed, and 88.2±14.6 mg glucose/kg bw for solid-sucrose-fed; p<0.05 and 
p<0.001, respectively) (Figure 23).  
 
After atropine administration, the RIST indexes obtained were similar among all 
groups (86.9±8.0 for standard diet, 79.4±6.5 for liquid-sucrose diet, and 76.5±14.1 mg 
glucose/kg bw for solid-sucrose diet). The HPN-dependent component was lower in 
both sucrose-fed groups than in the standard-fed group (90.4±14.7 for standard diet, vs 
21.5±8.0 for liquid-sucrose diet, and 12.3±4.7 mg glucose/kg bw for solid-sucrose diet; 
p<0.001). Thus, the contribution of the HPN-dependent component was also lower in 
sucrose-fed animals than in the standard-fed group (48.5±6.9% with standard diet, vs 
18.9±6.1% with liquid-sucrose diet, and 14.2±6.9% with solid-sucrose diet; p<0.001). 
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4.4.4.3. Discussion 
 
The exposure to a high-sucrose intake during 9 weeks has again shown to 
produce insulin resistance, as well as other changes. Only the liquid high-sucrose group 
showed an exaggerated blood glycaemic level, which was accompanied by a higher 
weight gain. However, the normoglycaemic solid high-sucrose group evidenced already 
a higher body weight than the standard-fed. Albeit this differences in outcome, insulin 
sensitivity was similarly impaired by both forms of sucrose feeding (solid vs liquid). 
The hyperglycaemia observed in the liquid high-sucrose group may be due to the 
faster availability of sucrose to be hydrolysed in the small intestine by sucrase when 
given already in a solution. This would also lead to an increase in recruitment of 
enterocyte GLUT2, leading with continued exposure to maintained inception of these 
glucose transporters on the apical wall (Kellett et al., 2008). This exacerbate transport of 
sugars through the enterocyte brings forth higher levels of circulating glucose and 
fructose. The same amount of sucrose, arriving more sporadically and subject to a 
slower digestion, as with the solid meal, might not produce such an extreme exposure. 
 
Fructose has usually been perceived by the general consumer as having 
beneficial effects due to its supposedly healthy fruit origin and to the fact that diabetics 
are encouraged to replace other sugars in their diet by fructose. Furthermore, the use of 
high-fructose and high-sucrose sweeteners in the food industry has increased (Henry et 
al., 1991).  
The detrimental effects of a high-sucrose supplement shown herein, both by the 
magnitude and quickness of impact, illustrate the necessity of a closer scrutiny and care 
into the consumption of such products; moreover when children and youngsters are a 
preferential marketing target for most of them. But also adults may be affected, since 
people with worse metabolic profiles may be more sensitive to the detrimental effects of 
sucrose (Daly et al., 1997; Michaelis and Szepesi, 1974), and since dietary 
manipulations with sucrose have been shown to deteriorate even further the reduction in 
insulin-stimulated glucose uptake seen with age (Berdanier et al., 1979; Lautt et al., 
2009; Reaven et al., 1983). 
The fact that only the HPN-dependent component of insulin action, a pathway 
highly modulated by the prandial status, was affected at this point further argues for the 
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importance of the evaluation of this component as an early marker of peripheral insulin 
resistance. 
 
 
4.5. Hepatic insulin sensitising substance (HISS) mechanism status and role on 
insulin sensitivity in an animal model of essential hypertension 
 
4.5.1. Hepatic parasympathetic nerves (HPN)/hepatic nitric oxide (HNO) branch of 
the HISS pathway in hypertension 
  
4.5.1.1. General context and work hypothesis 
 
Hypertension seems to be associated with insulin resistance and compensatory 
hyperinsulinemia; and further with type 2 diabetes and other features of the metabolic 
syndrome (DeFronzo and Ferrannini, 1991; Ferrannini et al., 1987; Frontoni et al., 
2005; Landsberg, 2005; Reaven, 1993). The precise causal relations between these 
pathologies are still shrouded by uncertainty. Reasons have been forwarded for an effect 
of insulin resistance both on the aetiology and on the complications of hypertension 
(DeFronzo and Ferrannini, 1991; Frontoni et al., 2005; Katakam et al., 1998; Reaven, 
1991; Sowers, 2004). 
Insulin resistance and sympathovagal imbalance are believed to be important 
factors in the connection between hypertension and diabetes (Frontoni et al., 2005). 
Furthermore, the disruption of the parasympathetic response has been reported to 
worsen glucose tolerance in individuals diagnosed with hypertension (Chen et al., 
1998). Insulin resistant states are also related to dysfunctional responses of the 
autonomic nervous system to insulin, with increased sympathovagal balance 
(augmented sympathetic reactivity and unresponsive parasympathetic control); that 
could influence cardiovascular problems (Bergholm et al., 2001). Autonomic 
dysfunction seems even to exist at the prehypertensive stage (Lucini et al., 2002; 
Paolisso et al., 2000; Weston, 2000). These provide us clues to believe in the 
involvement of the HPN-dependent component in the relation between insulin 
resistance and hypertension. 
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Essential hypertension is a common cause of cardiovascular and cerebrovascular 
complications. Of idiopathic origin, a set of genetic, psychological and dietary factors 
seem to concur to its development (Das, 2001). The development of hypertension has 
been related to the presence of obesity (Reaven et al., 1996). However, since obesity has 
been shown to have in itself a detrimental effect on insulin sensitivity (Afonso et al., 
2007a; Afonso et al., 2007b; Montani et al., 2002), the two factors had to be separated.  
Thus, the spontaneously hypertensive rat (SHR) was used to evaluate the 
relation between insulin resistance and essential hypertension. The SHR is a genetic 
pathological model widely used for these studies because it presents similar symptoms 
to the corresponding human pathology (Dickhout and Lee, 1998; Lerman et al., 2005). 
Insulin resistance in essential hypertension may also be connected to a nitric 
oxide dysfunction (Nava et al., 1998). Since hepatic nitric oxide (HNO) is also a 
metabolic intervenient in the hepatic insulin sensitising substance (HISS) hypothesis 
signalling pathway, in which the HPN seem to play a crucial role, we also studied this 
component, by use of a nitric oxide synthase inhibitor; administered directly in the liver, 
through the portal vein. As before, no studies had previously been reported on the SHR 
that address the relation of the HPN or HNO to changes in postprandial insulin 
sensitivity. 
Furthermore, contradicting results put in question (Klimes and Sebokova, 1997) 
both the condition of insulin resistance and which of its common normotensive controls 
should be used – Wistar or Wistar Kyoto (WKY). Whereas several studies show a 
decreased insulin-stimulated disposal in SHR (Hulman et al., 1991; Katayama et al., 
1997; Mondon and Reaven, 1988), others report a similarity (Frontoni et al., 1992; 
Katayama et al., 1997; Natalucci et al., 2000) or even an increase (Buchanan et al., 
1992; Tsutsu et al., 1989), in comparison to WKY or Wistar. 
Considering this, besides studying the contributions of the HPN- and HNO-
dependent and –independent components of insulin action in hypertension-related 
insulin resistance, the aim of this study was to compare these characteristics among all 
three strains. The meal-induced sensitisation of insulin action was also assessed in this 
non-obese animal model of essential hypertension. 
 
Our working hypothesis was that hypertension is associated with insulin 
resistance in SHR, and that insulin resistance is related with an impairment of the HPN-
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dependent component of postprandial insulin action. We also hypothesised that other 
steps of the HISS pathway will show similar impairment. 
 
4.5.1.2. Experimental protocols 
 
Nine weeks old male Wistar, WKY and SHR rats were analysed on the 
postprandial state. All animals were under continuous anaesthesia.  
In a first batch of animals from the three strains, after a control RIST, atropine (3 
mg/kg) was administered to enable the differentiation of the HPN-dependent and –
independent components. A second RIST was performed, postatropine, providing the 
quantification of the HPN-independent component of insulin action.  
In a second batch of animals, the control RIST was performed, followed by the 
intraportal (ipv) administration of Ng-methyl-arginine (L-NMMA; 0.73 mg/kg), to 
prevent the production of HNO. 
 
4.5.1.3. Results 
 
4.5.1.3.1. Assessment of the hypertensive condition 
 
The SHR had higher arterial blood pressure than Wistar or WKY (159.2±3.7 for 
SHR, n=29, vs 118.1±3.7 for Wistar, n=18, and 106.7±2.5 mm Hg for WKY, n=20; 
p<0.001; pooled measurements done from all animals at the beginning of experiments), 
confirming the hypertensive condition in those animals. These values were not 
significantly altered with the administration of iv atropine (145.0±12.3 mmHg for SHR 
114.8±7.7 for Wistar, and 95.0±13.2 for WKY). With ipv L-NMMA, any change of 
blood pressure induced during the perfusion was transient, and no alteration was 
observed by the time the post-L-NMMA RIST was began (143.6±5.4 mmHg for SHR, 
110.3±8.9 for Wistar, and 90.0±7.3 for WKY). 
 
4.5.1.3.2. Other metabolic parameters 
 
All strains presented similar body weight (313.8±15.4 for Wistar, 283.3±11.0 for 
WKY and 278.4±9.5 g for SHR). Glycaemias were also similar among strains 
(128.4±11.0 for Wistar, 133.0±6.9 for WKY, and 123.1±7.2 mg/dl for SHR), and not 
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altered by atropine (131.8±8.3 for Wistar, 112.6±7.9 for WKY, and 130.5±8.2 mg/dl for 
SHR) or L-NMMA administration (132.8±9.8 for Wistar, 143.2±9.0 for WKY, and 
136.9±7.5 mg/dl for SHR). 
 
4.5.1.3.3. Insulin sensitivity before and after parasympathetic blockade in 
hypertension 
 
The two normotensive control strains for SHR, Wistar and WKY, showed very 
different results. Indeed, whereas SHR showed to be insulin resistant when compared 
with Wistar (296.1±16.9 for WIS, n=12, vs 217.8±19.8 mg glucose/kg bw for SHR, 
n=13; p<0.01), WKY showed similar total insulin action to SHR (209.1±13.6 for WKY, 
n=12), thus also being insulin resistant when compared with Wistar (p<0.01) (Figure 
24). 
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Figure 24 – Effect of hypertension on postprandial glucose metabolism in comparison to two 
normotensive controls; before and after muscarinic antagonism. Rapid insulin sensitivity test (RIST) 
indexes for the hepatic parasympathetic nerve (HPN)-independent (filled) and HPN-dependent (open) 
components of total insulin action for 9 weeks old male Wistar (WIS), Wistar Kyoto (WKY) and 
spontaneously hypertensive rats (SHR). The sum of both components represents the control RIST index 
for each strain. Insulin sensitivity was significantly higher for WIS than for WKY (** p<0.01) or SHR 
(** p<0.01). The HPN-dependent component accounted for these differences (p<0.05 for WKY and 
p<0.001 for SHR, not shown on the graph). 
 
 
The RIST indexes obtained after atropine administration did not show any 
significant difference between the three strains (141.3±13.6 for Wistar, 121.8±12.8 for 
WKY and 161.8±19.7 mg glucose/kg bw for SHR) (Figure 24). 
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The SHR presented a lower HPN-dependent component of insulin action than 
Wistar (55.9±16.0 for SHR vs 154.8±16.4 mg glucose/kg bw for Wistar, p<0.001), and 
with WKY showing an intermediate value, also statistically different from Wistar 
(87.1±14.6 mg glucose/kg bw, p<0.05). 
 
 
 
Figure 25 – RIST profiles of spontaneously hypertensive rats (SHR), and their normotensive 
controls Wistar and Wistar Kyoto; at 9 weeks of age. A, C and E, Dynamic profiles of the control 
(bold line) and postatropine (thin line) RISTs of Wistar, Wistar Kyoto, and SHR, respectively. B, D and 
F, Dynamic profile of the hepatic parasympathetic nerve (HPN)-dependent component of insulin action 
obtained after subtracting the post-atropine curve from the control curve of Wistar, Wistar Kyoto and 
SHR, respectively. 
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The characteristics of the dynamic profiles of the RISTs obtained before and 
after atropine administration (HPN-dependent component) as well as the HPN-
dependent component (Figure 25) are described in Table VII. 
 
 
Table VII – Dynamic curve main properties of normotensive Wistar and Wistar-Kyoto (WKY), 
and spontaneously hypertensive rat (SHR). Dynamic profile characteristics of the control rapid insulin 
sensitivity test (RIST), the hepatic parasympathetic nerve (HPN)-independent component (postatropine 
RIST), and the HPN-dependent component of total insulin action (* p<0.05 between Wistar and WKY, # 
p<0.05 between Wistar and SHR, & p<0.01 between Wistar and WKY). 
 
  Wistar WKY SHR 
Peak 16.2±0.7* 11.7±1.7* 13.3±1.2 
Peak time 11.9±0.5 13.4±1.6 12.7±0.6 
Control RIST 
Offset 34.9±1.3 29.1±1.7 30.4±1.7 
Peak 11.3±1.3* 6.3±0.7* 9.6±1.1 
Peak time 10.7±0.8 12.5±2.7 12.1±0.9 
HPN-independent  
Offset 23.4±2.0 22.1±2.8 27.3±1.9 
Onset 7.7±1.2 7.1±0.6 6.4±1.0 
Peak 10.9±1.1# 8.4±1.2 6.5±1.0# 
Peak time 16.2±1.3# 15.5±1.0 12.1±1.1# 
Offset 34.4±1.4#& 25.5±1.5& 26.3±1.8# 
HPN-dependent 
Duration 26.7±1.7*# 18.4±1.8* 19.9±2.0# 
 
 
For the characteristics related to the control and postatropine RISTs, the only 
significant differences found were surprisingly between Wistar and WKY. In relation to 
Wistar, the WKY strain showed a decrease in maximal (peak) response both in the 
control RIST (from 16.2±0.7 in Wistar to 11.7±1.7 mg glucose.kg-1.min-1 in WKY, 
p<0.05) and in the postatropine RIST (from 11.3±1.3 in Wistar to 6.3±0.7 mg 
glucose.kg-1.min-1 in WKY, p<0.05). Since SHR showed values that are intermediate for 
these characteristics, it produced no statistical difference. 
The duration of action of the HPN-dependent component was similarly 
decreased in WKY and SHR, in relation to Wistar rats (from 26.7±1.7 in Wistar to 
18.4±1.8 min in WKY, p<0.05, and 19.9±2.0 min in SHR, p<0.05). This was due to an 
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early offset of action of this component (from occurring at 34.4±1.4 min in Wistar to 
25.5±1.5 min in WKY, p<0.01, and to 26.3±1.8 min in SHR, p<0.05). 
Other alterations of the main characteristics of the dynamic profiles were only 
seen in SHR. Peak action was decreased (from 10.9±1.1 in Wistar to 6.5±1.0 mg 
glucose.kg-1.min-1 in SHR, p<0.05), as well as maximum response happened slightly 
earlier in SHR (from 16.2±1.3 in Wistar to 12.1±1.1 min in SHR, p<0.05). 
 
4.5.1.3.3. Role of hepatic nitric oxide on insulin sensitivity in essential hypertension 
 
Again, both WKY and SHR showed lower total insulin sensitivity indexes than 
Wistar (225.3±23.8 for WKY, n=8, and 238.2±10.6 for SHR, n=16, vs 298.9±8.6 mg 
glucose/kg bw for Wistar, n=6, p<0.05 in both cases). 
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Figure 26 – Effect of hypertension on postprandial glucose metabolism in comparison to two 
normotensive controls; before and after nitric oxide inhibition. Rapid insulin sensitivity test (RIST) 
indexes for the hepatic nitric oxide (HNO)-independent (filled) and HNO-dependent (open) components 
of total insulin action for 9 weeks old male Wistar (WIS), Wistar Kyoto (WKY) and spontaneously 
hypertensive rats (SHR). The sum of both components represents the control RIST index for each strain. 
Insulin sensitivity was significantly higher for WIS than for WKY or SHR (* p<0.05). The HNO-
dependent component accounted for these differences (p<0.05 for WKY and p<0.001 for SHR, not shown 
on the graph).  
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The HNO-independent component, quantified by the RIST after ipv L-NMMA 
administration, showed a significant increase in the SHR when compared with the 
WKY (151.2±6.8 for Wistar; 123.3±19.1 for WKY vs 170.0±10.9 mg glucose/kg bw for 
SHR, p<0.05) (Figure 26). 
As in the previous protocol, the HNO-dependent component was lower in SHR 
than in Wistar (68.2±7.1 for SHR vs 147.2±13.6 mg glucose/kg bw for Wistar, 
p<0.001), and with WKY showing an intermediate value, here also statistically different 
from Wistar (102.0±13.5 mg glucose/kg bw, p<0.05). 
The data for the dynamic profiles for this protocol, similar to the ones obtained 
in the previous protocol, are not shown.  
 
4.5.1.4. Discussion 
 
The aim of the study was to characterize several steps of the HISS-dependent 
and –independent components of postprandial insulin sensitivity in an animal model of 
essential hypertension, the SHR, and two normotensive controls, Wistar and Wistar 
Kyoto.   
Insulin resistance was found when comparing SHR and Wistar. This impairment 
was solely due to a dysfunction of the HISS-dependent component. However, the WKY 
has shown similar insulin sensitivity to SHR. This argues either for a secondary role of 
hypertension on the development of insulin resistance or to a separate defect on WKY 
that independently impairs the HISS-dependent component in that strain. 
 
At 9 weeks of age, SHR showed already higher arterial blood pressure and had 
lost the tendency to be lighter than the normotensive strains, as was expected (Dickhout 
and Lee, 1998). Likewise, hypertensive rats showed to be normoglycaemic.  
The insulinemias of the three strains have been described as being similar 
(Buchanan et al., 1992; Farrace et al., 1995; Swislocki et al., 1997) or augmented on the 
SHR (Chen et al., 1994a; Gouveia et al., 2000a; Mondon et al., 1989). The insulinemias 
have not been measured in the present studies. However, since the RIST constitutes a 
measure of the response of an exogenous bolus of insulin, this may not be a critical 
factor. 
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The lack of definition in genetics (St Lezin et al., 1992) between SHR, WKY, 
and Wistar, from which both the previous two strains were derived, further disturbs the 
analysis of this animal model. Authors trying to trace the way by which the strains have 
been established, and possible inconsistencies between stocks of different academic or 
commercial origin, have come across several difficulties (Furukawa et al., 1998; Kurtz 
and Morris, 1987). To try to reduce to a minimum this interference, all animals analysed 
herein were from a single commercial source. 
 
According to the present studies, SHR and WKY show similar total postprandial 
insulin sensitivity as measured by the control RIST index. Furthermore, both strains 
show decreased total postprandial insulin sensitivity when compared with Wistar rats. 
This seems due to a decrease of the HISS-dependent component of insulin action; either 
quantified by blockade of the HPN or inhibition of HNO. Surprisingly, SHR show the 
highest absolute values of the HISS-independent component, possibly hinting to a 
compensatory mechanism.   
 
Intravenous administration of the muscarinic cholinergic antagonist atropine has 
been reported to induce insulin resistance in a magnitude similar to specific hepatic 
parasympathetic denervation (Xie and Lautt, 1996a) or fasting (Lautt et al., 2001). This 
is consistent with the observation that food intake enhances parasympathetic tone 
(Uijtdehaage et al., 1992); therefore, special care has to be taken when comparing the 
available literature with our results. 
Almost all reported results were performed in fasted animals; thus, they are 
strictly comparable with our HISS-independent component data. In this respect, the 
quantification of the HISS-independent component, given by the RIST index obtained 
after atropine or L-NMMA, that is, the direct metabolic effect of insulin on its target 
tissues, showed a tendency to be augmented in SHR when compared with WKY. This is 
consistent with results obtained by other authors with animals either in the fasted state 
or where the prandial state was not monitored (Farrace et al., 1995; Frontoni et al., 
1992; Tsutsu et al., 1989). 
A possible explanation for the higher HISS-independent insulin sensitivity in 
SHR is an excess insulin-stimulated glucose disposal accounted for by the nonoxidative 
glucose metabolism pathway, representing an increase of glycogen accumulation in the 
skeletal muscle (Farrace et al., 1995; Frontoni et al., 1992), with increased activity of 
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skeletal muscle glycogen synthase (Farrace et al., 1995). That insulin-stimulated 
glucose uptake benefits from high insulin secretion is known (Chen et al., 1994a), but 
this compensatory mechanism of insulin sensitivity was not seen in any other of the 
pathophysiological models studied herein. 
 
The SHR has been described to more easily develop insulin resistance from 
stressful situations than WKY (Mondon and Reaven, 1988). This was used (Tsutsu et 
al., 1989) to explain the discrepancy towards studies where SHR were found to be 
insulin resistant in relation to WKY. Since we have observed a similar degree of insulin 
sensitivity in both strains, this is possibly another hint to the adequacy of the RIST 
technique to evaluate insulin sensitivity without inducing stress to the animals. Also, 
anaesthesia seems not to affect the results as others propose (Farrace et al., 1995; 
Frontoni et al., 1992), since we obtained, in SHR, the same augmented expression of the 
HISS-independent component of insulin action under maintained anaesthesia. 
 
The HISS-dependent component showed a decrease from Wistar to WKY, and 
even more dramatically to SHR. That is consistent with the results of other studies 
where insulin sensitivity was measured before and after feeding (Gouveia et al., 2000b; 
Swislocki et al., 1997). There, skeletal muscle glycogen content, identical between 
WKY and SHR in the fasted state, increased from fasting to refeeding in WKY, whereas 
in SHR it remained similar to fasting levels (Swislocki et al., 1997). In addition, feeding 
increased muscle glycogen content much more in Wistar than in SHR (Gouveia et al., 
2000b). Furthermore, in both studies, liver glycogen accumulation increased similarly in 
both strains, and liver glycogen total content was similar (Gouveia et al., 2000b; 
Swislocki et al., 1997), which indicates that the difference in postprandial insulin 
sensitivity between the strains is specific to the skeletal muscle. This supports the 
concept that, in the postprandial state, the skeletal muscle is further sensitised to glucose 
uptake and glycogen synthesis by a mechanism that is unable to properly function in the 
SHR. 
As Swislocki and colleagues suggested (Swislocki et al., 1997), there seems to 
exist a circulating factor that increases skeletal muscle insulin-stimulated glucose uptake 
and glycogen accumulation. Furthermore, this factor, that is here considered to be 
coincident with the HISS mechanism, was seen here to be dependent on the status of the 
HPN and HNO. 
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Insulin resistance in essential hypertension seems also to be related to 
parasympathetic dysfunction (Chen et al., 1998). More, in SHR, a reduction in vagal 
neurone number (Corbett et al., 2007) may be contributing to the loss of function. It has 
further been proposed that hypertension is rather related to an increased sympathetic 
activity resulting in sympathetic/parasympathetic imbalance (Reaven et al., 1996), but, 
even if that is the case, it seems to be preceded by an impairment of the parasympathetic 
nervous system (Valensi et al., 1998). 
Still considering that an increased sympathetic activity further disrupts the 
sympathovagal unbalance, this adrenergic overactivity would theoretically impact 
glucose metabolism on SHR in two ways: i) the chronic effect of long lasting 
hyperadrenergism would reverse the ability of catecholamines to inhibit glycogen 
synthase and insulin action (Farrace et al., 1995), and ii) the further imbalance away 
from parasympathetic function would lead to a lowering of HISS action (Lautt, 2004). 
Both these conditions seem to have been observed in the present study: a decrease in 
HISS action accompanied by an increase in HISS-independent action. 
Consistent with this hypothesis, the administration of a central sympatholytic 
drug in human hypertensive subjects has been shown to ameliorate both the 
cardiovascular profile and glucose metabolism (De Luca et al., 2000; Hausberg and 
Grassi, 2004); further indicating that sympathetic overactivity may be influencing 
negatively both conditions. 
 
Considering that WKY already show some decrease of the HISS-dependent 
component, there is also conceivable the existence of a common genetic factor between 
WKY and SHR that, at the administered insulin dose (50 mU/kg), impairs HISS action 
in both strains. In fact, a common genetic factor in SHR and WKY has already been 
proposed by others. Interestingly, it has been related to a diminished sensitivity to vagal 
activity (Ohnuma et al., 2000), which again argues in favour of a secondary role of 
hypertension in the development of insulin resistance in this animal model. This 
hypothesis also reinforces the highly sensitiveness of the HISS pathway to interference 
by genetic and environmental factors; evenmore conditions where the action of insulin 
per se is not changed or is even augmented.  
This indicates also that, although there are fears of considerable genetic 
divergence between WKY and SHR (Rapp, 1987; St Lezin et al., 1992), at least they 
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seem to share the genetic trait that is, possibly by lowering vagal tone, favouring a 
decrease of the HISS-dependent component of insulin action. 
 
The SHR show other metabolic problems that may contribute to the impairment 
of HISS action, such as a defective HNO synthesis/action. Defective nitric oxide 
synthesis has been proposed as a link between insulin resistance and hypertension 
(Scherrer and Sartori, 2000); bringing about also sympathetic overactivity, by removal 
of the central effect of nitric oxide (Sakuma et al., 1992; Souza et al., 2001).  
However, nitric oxide production may be normal or even increased in the 
presence of hypertension. Indeed, several authors report higher levels of plasma nitric 
oxide in SHR (Wu and Yen, 1999) (20% higher than in WKY), but that this nitric oxide 
action is mechanistically ineffective (Maffei et al., 2002; Nava et al., 1998). It could 
thus mean that hypertension is related to preserved production, but abnormal biological 
effect, of nitric oxide (Piatti et al., 2000). 
 
Angiotensin II is known to influence negatively NOS and insulin signalling in 
the presence of superoxide anion (Sowers, 2004). So, to the previous, may also be 
relevant the fact that angiotensin-converting enzyme inhibitors, given as 
antihypertensive drugs, are able to raise the effective action of nitric oxide (Das, 2001) 
and lead to an augmented response of GLUT4 (Katayama et al., 1997). However, even 
if antihypertensive drugs that interrupt the renin-angiotensin axis slow the metabolic 
degradation to type 2 diabetes compared to other drugs (Scheen, 2004), this action may 
not be enough to fully reinstate HISS-dependent insulin sensitivity, since other steps of 
the HISS pathway, like hepatic parasympathetic tone, seem to be impaired69. Consistent 
with this hypothesis, the mentioned effects of rennin-angiotensin inhibitors seemed to 
have no impact on insulin action or glucose tolerance (Swislocki et al., 1999).  
Nitric oxide synthase is also a physiological source of superoxide anion. 
Interestingly, HISS action was able to be mimicked by the administration of nitric oxide 
donors that release both nitric oxide and superoxide anion, but not by donors that only 
produced nitric oxide (Guarino et al., 2003). This underlines the importance of the 
balance between the production of nitric oxide and superoxide anion.  
                                               
69
 Angiotensin-converting enzyme inhibitors are also described to possibly have a sympatholytic effect 
(Hausberg and Grassi, 2004), which may additionally contribute to a removal of the negative constraints 
that surround the HISS pathway. 
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It was reported that the excess of superoxide anion in SHR may be due to a 
dysfunctional NOS (McIntyre et al., 1999). Also, the action of cofactors as 
tetrahydrobiopterin, important in controlling the balance between nitric oxide and 
superoxide (Cosentino et al., 1998; McIntyre et al., 1999) seem to be impaired in SHR 
(Hong et al., 2001), even in a prehypertensive stage70 (Cosentino et al., 1998; Shinozaki 
et al., 1999). Thus, depletion of tetrabiopterin allows NOS to produce more superoxide 
anion and hydrogen peroxide (Brown and Borutaite, 2006; Hong et al., 2001), 
increasing oxidative stress71 (Gomez-Amores et al., 2007; Power et al., 2007; 
Ruggenenti et al., 2009).   
This increased oxidative stress may play an important role in decreasing 
peripheral insulin action through a decrease in HISS action, by disruption of the 
equilibrium between nitric oxide, superoxide anion, and glutathione production, well 
before the action of insulin per se is affected. 
 
Other authors (Baron et al., 1995) link nitric oxide inhibition with a decrease in 
insulin sensitivity by way of a decrease of blood flow and nutrient availability to 
skeletal muscle cells. However, in that study blood pressure was kept augmented by 
continuous L-NMMA perfusion throughout the insulin sensitivity test. On the other 
hand, in the present study, the dose of L-NMMA given was such that enabled blood 
pressure to return to normal levels before the insulin sensitivity test was started.  
Although we have seen no alteration in blood pressure in any of the strains, at 
least not by the time the second RIST (the post-L-NMMA RIST) was started, a case 
could be presented based on the hypothesis of changes in the microvasculature feeding 
of myocytes. However, the fact that atropine had the same effect as L-NMMA, and as 
hepatic parasympathetic ablation, strengthens the hypothesis that hemodynamic changes 
were not responsible for the change in glucose uptake. Furthermore, in healthy animals, 
the administration of the nitric oxide donor SIN-1 was able to revert the insulin 
resistance produced with L-NMMA; but only when it was given ipv and not iv (Guarino 
et al., 2003), despite having a clear vasodilator effect in both cases, clearly showing that 
insulin sensitivity was reinstated by hepatic control and not through hemodynamic 
                                               
70
 Interestingly, tetrahydrobiopterin deficiency has been reported to be determined directly by decreased 
insulin action (Shinozaki et al, 1999). 
71
 Likewise, substances known to decrease superoxide anion production, as for example L-Carnitine, lead 
to increased nitric oxide bioavailability (Gomez-Amores et al, 2007). This may partly explain how it 
ameliorates simultaneously essential hypertension, glucose tolerance, and nerve conduction (Power et al, 
2007; Ruggenenti et al, 2009). 
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changes. The involvement of HISS in this mechanism seems further corroborated by 
others who report that the insulin resistance produced by L-NMMA administration 
corresponds to a lower glucose uptake at the skeletal muscle (Baron et al., 1995; 
Capaldo et al., 1991). 
The notion that the physiological insulin actions on skeletal muscle glucose 
uptake and vasodilation should be considered separately is also supported by the fact 
that different doses of insulin can show or not alterations in glucose uptake on SHR in 
relation to WKY, but at the same time show a persistent impairment on the ability of 
insulin to induce skeletal muscle vasodilation (Pitre et al., 1996). However, this 
segregation of pathways does not exclude that haemodynamics and HISS action may be 
independently impaired by a common factor72 (Lembo et al., 1992; Van De Borne et al., 
1999). 
 
 A direct causal dependence between insulin resistance and hypertension is 
possibly denied by several other experiments. Mainly, it has been reported that lowering 
blood pressure is not enough to ameliorate glucose metabolism (Reaven, 1991). 
Likewise, an α-glucosidase inhibitor, which delays carbohydrate absorption at the small 
intestine73 (Bavenholm and Efendic, 2006; Bischoff, 1995), reduces insulinaemic and 
glycaemic responses to a meal by giving acarbose, without changing blood pressure 
(Swislocki et al., 2007).  
 It seems thus plausible to consider that insulin resistance and hypertension may 
be related to similar pathophysiological mechanisms, but that they are not mutually 
determinant. Even considering that they may share some etiological similitude, the 
normalisation of either one does not necessarily mean the betterment of the other. 
 
In conclusion, the SHR is still valuable as a model of essential hypertension, but 
should be used with caution in studies related to insulin resistance. Because 
hypertensive humans show marked insulin resistance when compared with 
normotensive subjects (Gouveia et al., 2000a), the similar total insulin sensitivity of 
                                               
72
 Such common factor could be, for example, the increased sympathetic nervous activity produced in 
response to hyperinsulinaemia (Lembo et al, 1992; Van de Borne et al, 1999). 
73
 Acarbose reduces specifically postprandial blood glucose excursions and contributes to a better overall 
glycaemic control (Bischoff H, 1995). This leads also to a lowering of risk factors associated with type 2 
diabetes and cardiovascular disease, mainly those induced by blood hyperglycaemia (Bavenholm and 
Efendic, 2006). 
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WKY and SHR, as given by the control RIST indexes, suggests the use of the Wistar as 
the most adequate normotensive control for SHR in insulin sensitivity studies. 
 
4.5.2. Hepatic glutathione (GSH) branch of the HISS pathway in essential 
hypertension 
 
4.5.2.1. General context and work hypothesis 
 
The optimal action of the HISS pathway is dependent upon more than the correct 
activation of the HPN-HNO axis. It has been found that hepatic glutathione is also 
critical to the synthesis/release of HISS (Guarino and Macedo, 2006); being increased 
through a pathway independent, but convergent, to that activated by the hepatic 
parasympathetic nerves and subsequent production of hepatic nitric oxide.  
Glutathione (GSH) is ubiquitous in all tissues, but is found in especially high 
levels on the liver. Hepatic GSH synthesis is particularly dependent upon the 
availability of the amino acid cysteine, which is mostly derived from the diet (Lu, 
1999). This fact seems paramount in the relation between postprandial insulin-
stimulated glucose uptake and hepatic glutathione content (Guarino et al., 2003). 
Interestingly, it has been reported that insulin stimulates hepatic GSH synthesis 
by inducing γ–glutamylcysteine synthetase, the rate-limiting enzyme in the γ–glutamyl 
cycle (Huang et al., 2000; Lu et al., 1990; Lu et al., 1992; Lu et al., 1991; Sun et al., 
1996)74,75. 
 
The decreased bioavailability of nitric oxide may be due to increased oxidative 
stress (Brown and Borutaite, 2006; Hancock et al., 2001); which has been found to 
happen in hypertension (Touyz, 2004). Oxidative degradation of nitric oxide may 
happen through overproduction of superoxide (McIntyre et al., 1999; Zalba et al., 2001). 
The reaction of nitric oxide and superoxide anion forms peroxynitrite (Hancock et al., 
2001). This scavenging of nitric oxide has been proposed as a link between insulin 
resistance and endothelial dysfunction (Zalba et al., 2001). The formation of 
                                               
74
 Fasting and stress enhance the efflux of GSH out from the liver to the plasma. Of particular interest in 
this seems to be the effect of glucagon, which increases GSH efflux from the liver by cAMP-mediated 
membrane hyperpolarization (Lu et al, 1990; Lu et al, 1991). These factors also decrease hepatic GSH 
synthesis by inducing γ–glutamylcysteine synthetase phosphorilation (Sun et al, 1996). 
75
 Insulin does not have any effect on GSH synthetase. This is common to the factors that, like insulin, 
increase the expression of the heavy subunit of γ–glutamylcysteine synthetase (Huang et al, 2000). 
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peroxynitrite may further increase oxidative stress (Brown and Borutaite, 2006); and be 
particularly relevant to the HISS hypothesis by reacting directly with glutathione, and 
depleting its level (Jourd'heuil et al., 2001; Wink et al., 2001). Glutathione may be also 
oxidized by hydrogen peroxidase, which also comes from superoxide (Brown and 
Borutaite, 2006). Since this presents an additional way by which the HISS-dependent 
component may become further impaired, the status of reduced/oxidised hepatic 
glutathione was subsequently studied in this animal model of hypertension. 
 
Our working hypothesis was that a decrease in hepatic glutathione related to 
essential hypertension may contribute to a deterioration of postprandial insulin 
sensitivity, as GSH is essential for HISS action. 
 
4.5.2.2. Experimental protocols 
 
For the evaluation of glutathione levels in insulin resistance and hypertension, 
only Wistar and SHR were chosen. Both 9 weeks old Wistar and SHR animals were 
fasted for 16 hours and had access to food for 1 hour. After that, they were anesthetised 
and several samples of liver were collected and promptly frozen in liquid nitrogen. 
Quantification of reduced glutathione (GSH) and oxidised glutathione (GSSG) 
was done by high-performance liquid chromatography. 
 
4.5.2.3. Results 
 
At 9 weeks of age, there was no difference in postprandial hepatic glutathione 
between the hypertensive SHR (n=7) and their normotensive control Wistar (n=6), 
either in the reduced form (GSH: 5.94±0.42 for Wistar and 7.14±0.95 for SHR) or the 
oxidised form (GSSG: 86.46±20.45 for Wistar and 148.10±32.47 for SHR). So, as 
expected, the ratio of the forms (GSH/GSSG) also showed no difference between 
normotensive and hypertensive rats (a ratio of 85.01±14.90 for Wistar and 77.97±22.71 
for SHR) (Figure 27). 
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Figure 27 – Hepatic reduced and oxidised glutathione content in Wistar and spontaneously 
hypertensive rats (SHR). Values for hepatic (A) reduced glutathione (GSH) and (B) oxidised 
glutathione (GSSG). The ration between the two is also shown (C). None of these parameters show a 
statistically significant alteration with the presence of hypertension. 
 
 
4.5.2.4. Discussion 
 
Essential hypertension has been related to a state of increased vascular oxidative 
stress, inclusively by impairment of GSH availability in vascular smooth muscle cells 
(Wu and Juurlink, 2002). Concerning hepatic GSH metabolism in essential 
hypertension, studies have focused on comparing only Wistar Kyoto and SHR. In this 
respect, hepatic GSH content has been reported to be similar between these two strains 
(Binda et al., 2001; Kitts et al., 1998); however, hepatic GSH/GSSG ratio seems to 
decrease (Cediel et al., 2003; Gomez-Amores et al., 2007), indicating an increase in 
oxidative stress76.  
                                               
76
 SHR show an increase in glutathione redutase (GSSG-R), the enzyme responsible for GSH recycling, 
and a decrease in glutathione peroxidase (GSH-Px), which is involved in scavenging peroxides (Kitts et 
al, 1998; Binda et al, 2001; Cediel et al, 2003; Gómez-Amores et al, 2007). This upregulation of GSSG-R 
may show a response to an increase in oxidative stress, while the reduction in GSH-Px may be both a 
cause and a consequence of oxidative stress (Binda et al, 2001). 
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Besides using solely the Wistar Kyoto as the normotensive control for SHR, in 
these previous studies no care was given as to the prandial status; with animals being 
analysed in the fasted or ad libitum state. Thus, the present study was the first to 
determine the postprandial hepatic glutathione status in the hypertensive SHR; 
furthermore in comparison with the Wistar rat, a normotensive control that sets the SHR 
clearly as a model of insulin resistance. 
Here was shown that SHR does not present any alteration of either reduced or 
oxidised glutathione, in comparison with Wistar. The GSH/GSSG ratio is logically also 
similar between strains. We can thus conclude that SHR do not seem to present a 
deficiency in GSH metabolism in the postprandial state that would be expected to 
contribute to the decrease in the HISS-dependent component that determines the insulin 
resistance in this model of essential hypertension. 
Since hepatic GSH is noted to rise after a meal, probably both from the influx of 
dietary cysteine and from a need to match the rise in oxidative stress produced by the 
handling of nutrients, it is conceivable to consider that a deficiency in GSH metabolism 
would be sooner visible in the antioxidant function during fasting; when hepatic GSH is 
lower and, furthermore, the efflux of GSH to other tissues is paramount. This 
hypothesis seems consistent with the studies previously mentioned. Furthermore, the 
present study may already hint to an initial rise in postprandial oxidative stress, since 
SHR showed a tendency for a higher hepatic GSSG content.  
Since, at 9 weeks of age, postprandial hepatic GSH seems to be equally available 
in SHR than in Wistar, it is consequently not likely that it constitutes a constraining 
factor for HISS synthesis/action in SHR. Thus, insulin resistance in essential 
hypertension seems to be determined by an impairment of the HPN-HNO branch of the 
HISS pathway77. 
 
 
 
 
 
 
                                               
77
 The present study further underscores that mechanisms such as antioxidant defence, glucose 
metabolism, and endothelial function may depend on the same elements but seem to be impaired in a 
differentiated form. This seems especially pertinent to prevent causal assumptions to be drawn from 
changes in interrelated, but otherwise separate, physiological processes. 
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4.5.3. Postprandial increment of insulin sensitivity in SHR 
 
4.5.3.1. Context and work hypothesis 
 
All the previous studies point to the fact that the HISS pathway is responsible for 
the increment of insulin sensitivity seen after a meal. Also, the insulin resistance 
observed in SHR was attributed to a decrease in HISS action. 
In the case of the SHR then, our work hypothesis was that the insulin sensitivity 
in the fasted state was similar to the postprandial response obtained after HISS 
inhibition by administration of atropine or L-NMMA. 
 
4.5.3.2. Experimental protocols 
 
For this, a group of 9 weeks old SHR was analysed after a 17-hour fast. The 
animals were anaesthetised prior to being subjected to a control RIST. 
 
4.5.3.3. Results 
 
The RIST control index obtained in the fasted SHR (n=6) was of 150.3±22.0 mg 
glucose/kg bw (Figure 28), down from 229.1±10.6 (n=29) seen after meal ingestion 
(pooled from the results presented on items 4.5.3.1 and 4.5.3.2), p<0.01. This decrease 
was similar to the ones obtained after atropine (to 161.8±19.7 mg glucose/kg bw) and 
obtained after L-NMMA (to 170.0±10.9 mg glucose/kg bw)(again, see items 4.5.3.1 and 
4.5.3.2). 
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Figure 28 – Insulin sensitivity in the fasted and postprandial states, in an animal model of essential 
hypertension. Rapid insulin sensitivity test (RIST) indexes for fasted (JJ) and fed (PP) total insulin action 
for 9 weeks old male spontaneously hypertensive rats (SHR). The decrease of insulin sensitivity with 
fasting was similar to the one obtained with blockade of the hepatic insulin sensitising substance (HISS) 
pathway (** p<0.01). 
 
 
4.5.3.4. Discussion 
 
This shows that in SHR the postprandial increment of insulin sensitivity is 
entirely due to the HISS-dependent component, as already seen in healthy normotensive 
Wistar rats (see topic 4.1). Hence, the decrease in postprandial insulin sensitivity seen in 
hypertension is again shown to be due to a dysfunction of the HISS-dependent 
component of insulin action. 
 
Discrepancies between reports have been tentatively explained by differences in 
fasting time, especially between Wistar Kyoto and SHR. Different fasting times showed 
different results on insulin sensitivity. After a short fasting time (6h), SHR showed 
decreased insulin sensitivity in relation to Wistar Kyoto (Mondon and Reaven, 1988). In 
contrast, after a longer fasting time (24h), SHR showed augmented glucose uptake 
(Frontoni et al., 2005; Frontoni et al., 1992). Further, a fasting time just slightly shorter 
than the present study (12-14h) showed no difference between SHR and Wistar Kyoto 
(Pitre et al., 1996), at an insulin perfusion known to reflect peripheral insulin sensitivity.  
All these studies are consistent with the present results, considering that Wistar 
Kyoto still has preserved some of the HISS-dependent component action, which enables 
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some postprandial increment; on the other hand absent in SHR. Shorter fasting times 
would be insufficient to fully shutdown HISS action, thus masking the real difference 
between Wistar Kyoto and SHR in the fasted state: an augmented HISS-independent 
component in the hypertensive animals. This interpretation may also shed some light 
into the apparent disparities found among other published studies using the SHR. 
 
 
4.6. Changes in insulin sensitivity in an animal model of essential hypertension 
determined by age 
 
4.6.1. General context and work hypothesis 
 
At 9 weeks of age, SHR showed a tendency to compensate the impairment of the 
HISS-dependent component by an exacerbation of the action of insulin per se, directly 
on the skeletal muscle. Furthermore, contrary to what was seen here in healthy Wistar 
normotensive rats, ageing was reported not to impair insulin sensitivity in the SHR 
(Natalucci et al., 2003). 
Since maturation until 16 weeks of age was shown to be a crucial stage of 
development concerning changes in glucose metabolism (Ribeiro et al., 2008), it 
became relevant to study the influence of the continuous exposure to hypertension 
during this stage. 
 
Our work hypothesis was that the presence of hypertension during maturation 
would produce an even more pronounced decrease in insulin sensitivity, by further 
impairing the HISS-dependent component of insulin action. 
 
4.6.2. Experimental protocols 
 
Wistar, Wistar Kyoto and SHR rats were used, at 9 and 16 weeks of age. After a 
16 hour fasting period, all animals were fed for 1 hour and anesthetised. Total 
postprandial insulin action was evaluated by way of a control RIST. The HISS-
dependent and –independent components were quantified by performing a RIST after 
the administration of atropine (3 mg/kg). 
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4.6.3. Results 
 
The SHR showed similar total postprandial insulin sensitivity at 9 (n=13) and 16 
(n=6) weeks of age. In contrast, while Wistar Kyoto also showed similar values of total 
insulin sensitivity at both ages (n=13 and n=7) (Figure 29), Wistar showed the radical 
decrease from 9 to 16 weeks of age already seen in this dissertation (from 297.4±18.5, 
n=11, to 221.7±24.3 mg glucose/kg bw, n=6, p<0.05). 
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Figure 29 – Effect of maturation on spontaneously hypertensive rats (SHR) and normotensive 
controls. Rapid insulin sensitivity test (RIST) indexes for the hepatic insulin sensitising substance 
(HISS)-independent (filled) and HISS-dependent (open) components of total insulin action for 9 and 16 
weeks old male Wistar (WIS), Wistar Kyoto (WKY), and SHR . The sum of both components represents 
the control postprandial RIST index for each strain. Total postprandial insulin sensitivity decreases in 
Wistar with age, due to a decrease of the HISS-dependent component (* p<0.05). The HISS-dependent 
component also decreases with age in SHR, but is partially compensated by an increase in the HISS-
independent component (* p<0.05) 
 
 
For both normotensive controls, Wistar and Wistar Kyoto, the HISS-independent 
component of insulin sensitivity, quantified by the post-atropine RIST, does not change 
with age, but while in Wistar Kyoto the HISS-dependent component is also unchanged 
(Figure 29), in Wistar it decreases (from 157.8±17.7 at 9 weeks to 94.6±15.3 mg 
glucose/kg bw at 16 weeks of age, p<0.05), notably becoming of similar magnitude to 
the one observed in Wistar Kyoto at both 9 and 16 weeks of age. 
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In the hypertensive strain, SHR, while the HISS-dependent component becomes 
practically non-existent with age (from 49.1±10.3 at 9 weeks to 6.3±2.0 mg glucose/kg 
bw at 16 weeks of age, p<0.05 to SHR at 9 weeks; and p<0.001 to both Wistar and 
Wistar Kyoto at 16 weeks of age), the HISS-independent component seems to continue 
rising in a compensatory manner (from 161.0±18.2 at 9 weeks to 239.7±29.9 mg 
glucose/kg bw at 16 weeks of age, p<0.05), becoming even higher than in Wistar or 
Wistar Kyoto (p<0.01 to Wistar and p<0.05 to Wistar Kyoto at 16 weeks of age). 
 
4.6.4. Discussion 
 
By 16 weeks of age, all strains – the hypertensive SHR and the normotensive 
Wistar and Wistar Kyoto –, had similar total postprandial insulin sensitivity. This was 
due to a decrease of the HISS-dependent component of insulin action in Wistar rats; 
which at 9 weeks of age were the most insulin sensitive strain. In the SHR there was 
also a radical decrease of the HISS-dependent component; but in this case a 
compensatory increase of the HISS-independent component permitted to maintain 
similar total postprandial insulin sensitivity to the one observed at 9 weeks of age. 
Wistar Kyoto showed no alteration in either components of insulin sensitivity with age; 
however, this strain had already a lower HISS-dependent component at 9 weeks of age, 
interestingly similar to the observed in Wistar at 16 weeks of age. 
The development of insulin resistance during maturation in Wistar, solely due to 
a decrease of the HISS-dependent component, is consistent with previous published 
studies (Ribeiro et al., 2008), presented here (see item 4.2.3). The observation that 
maturation does not affect the HISS-dependent component in Wistar Kyoto does not 
seem surprising, since there is already by 9 weeks an impairment of this component (see 
item 4.5). The disappearance of the HISS-dependent component in the 16 weeks old 
SHR suggests that although hypertension seems to have a secondary role in the 
development of insulin resistance, its presence seems related to a radical worsening of 
this component of insulin action. 
 
A previous study by others (Vera et al., 2002) regarding a comparison of only 
Wistar and SHR between 9 and 16 weeks of age yielded contradictory results. This may 
have been due to the use of data obtained in the fasting state to calculate insulin 
sensitivity, when HISS is physiologically shutdown. However, it seems consensual that 
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young SHR are insulin resistant in comparison with Wistar, and that insulin sensitivity 
is more affected by maturation in Wistar than in SHR. 
Interestingly, further ageing is reported still not to induce deterioration in insulin 
sensitivity in the SHR (Natalucci et al., 2003); not even when it reaches a stage of 
senescence78 (Iwase et al., 1994). Likewise, hepatic glutathione levels, which were 
shown in the prior item not to be impaired in SHR, seem to remain adequate within the 
time frame of maturation (Vericel et al., 1994).  
 
The effect of age on decreasing the HISS-dependent component of insulin action 
is clearly shown on healthy Wistar rats. That Wistar Kyoto shows no alteration of the 
HISS-dependent component with maturation, having already at 9 weeks a similar value 
of this component to the one obtained on Wistar rats at 16 weeks of age, seems further 
indication that the effect of age per se on insulin sensitivity is limited to this magnitude. 
And if that be the case, then we can conclude that in SHR the prolonged exposure to 
hypertension is related to a complete impairment of the HISS-dependent component in 
SHR. 
Concurrently, the capability of the hypertensive strain to compensate for the 
development of insulin resistance by increasing the HISS-independent component is 
maintained at least until the end of maturation. This warrants more study, and may yet 
come to provide a new mechanism to improve insulin sensitivity. 
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 This state of senescence was characterised by an age near the mean life expectancy (26 months) and 
further hinted by a loss of body weight; in all probability due to the loss of lean body mass (Iwase et al, 
1994). 
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5. OVERALL DISCUSSION 
 
 The results presented in this thesis have reiterated the physiological importance 
of hepatic parasympathetic nervous system integrity to the postprandial disposal of 
glucose. The impacts of gender and age in this mechanism have likewise been 
evaluated. Also, surgical and pharmacological interventions have argued in favour of 
the integration of this pathway into the hepatic parasympathetic sensitising substance 
(HISS) hypothesis. 
 Lifestyle changes as simple as dietary composition have been here shown to 
produce radical alterations in the physiological increment of insulin sensitivity seen in 
the postprandial state. Furthermore, this has solidified the interpretation of the HISS 
pathway as a primary site of dysfunction in regard to alterations of postprandial insulin 
sensitivity. Correspondingly, the analysis of an animal model of hypertension, the SHR, 
has further demonstrated how the HISS-dependent and –independent components of 
insulin action can be affected in vivo in quite opposite ways. 
 
 
5.1. Methodological considerations in the assessment of whole-body insulin 
sensitivity, and critical relevance of prandial status 
 
Through the years, a multitude of different tests has been used to assess in vivo 
insulin sensitivity (Hermans et al., 1999). In the present studies, the quantification of 
whole-body insulin sensitivity was carried out using a modified euglycaemic clamp 
known as the rapid insulin sensitivity test (RIST) (Lautt et al., 1998). This test was 
specifically designed to avoid the counter-regulatory responses to the hypoglycaemia 
that follows an insulin bolus, as administered in a standard insulin tolerance test (ITT). 
The RIST has been shown to be reproducible in at least four consecutive tests in 
anaesthetised animals (Lautt et al., 1998), allowing for the assessment of insulin 
sensitivity in different conditions in the same animal, and in the same day; which is 
usually not possible with the ITT (Akinmokun et al., 1992) or the current golden 
standard test for insulin sensitivity assessment (DeFronzo et al., 1979), the 
hyperinsulinemic euglycaemic clamp (HIEC).  
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The RIST has been shown to correlate well with the ITT; except on the later 
segment (after 25 min). The RIST was also found to be more sensitive in detecting the 
HISS-dependent component of insulin action than the HIEC (Reid et al., 2002). The 
former might be explained by the hypoglycaemic response that follows the insulin 
bolus, leading to higher endogenous glucose output and tissue insulin resistance. The 
latter may happen due to the physiological shutdown of HISS action by fasting, since 
this test is performed after an overnight fast; and by the alterations produced by the 
constant perfusion of insulin, which physiologically has a pulsatile behaviour. The lack 
of pulsatility imposed by the HIEC may lead to lower insulin sensitivity (Reid et al., 
2002), by desensitisation of the insulin receptors (Shanik et al., 2008). The maintained 
continuous hyperinsulinemia may also induce an alteration in sympathovagal autonomic 
balance (Van De Borne et al., 1999); which, even if the HIEC was conducted on the 
postprandial state, would decrease parasympathetic tonus and impair HISS action. This 
is supported by the observation that insulin induces the shutdown of the HISS-
dependent component when the same dose is given not in a physiological-like pulse 
manner but in a continuous infusion (Reid and Lautt, 2004). 
 
 Since HISS action is entirely correlated with the prandial state (Lautt et al., 
2001; Patarrao et al., 2008; Sadri et al., 2006), the conclusion is drawn that, if a 
complete assessment of whole-body insulin sensitivity is desired,  it is essential to 
evaluate its status in the postprandial state. Furthermore, this becomes even more 
relevant when it is considered that postprandial alterations in glucose homeostasis seem 
to predate the ones seen in the fasted state. If we are to detect the precocious defects that 
lead to the development of type 2 diabetes, the postprandial state should be the primary 
goal; even, or especially, at a time when postprandial hyperglycaemia is not yet present.    
 Several studies have tried to look into postprandial insulin action deriving 
parameters from the oral glucose tolerance test (OGTT) (Abdul-Ghani et al., 2007). 
This was viewed as an ideal form to evaluate the roles of both insulin sensitivity and 
insulin secretion in the disposal of glucose. In line with the increasing importance 
recognised to the postprandial state, the OGTT was found to be more sensitive in 
detecting asymptomatic diabetes than fasting plasma glucose (Modan and Harris, 1994). 
More recently, it has been advocated that a meal tolerance test (MTT) would be even 
more adequate to evaluate the postprandial state. The presence of other nutrients, than 
simply glucose, in a mixed meal, produces metabolic responses of their own in regards 
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to insulin secretion, and tissue metabolism. Furthermore, the MTT has been found to be 
a more consistent and reproducible test than the OGTT79 (White et al., 1983; Wolever et 
al., 1998); and thus be able to better mimic the conditions of every-day life nutritional 
challenges. 
 However, both the OGTT and the MTT are under too many variables, and 
represent glucose disposal, and glucose fluxes, influenced by several processes. The 
RIST, on the other hand, is performed at a time when plasma glycaemia has already 
stabilised, and several processes involved in nutrient disposal have reached a dynamic 
equilibrium. In this condition, where the rate of glucose appearance equals the rate of 
disappearance, it can be argued that the machinery responsible for cell glucose uptake is 
still somewhat summoned from the stimuli provided by the meal challenge (Holloszy, 
2005). Thus, it seems possible to consider that the administration of a bolus of 
exogenous insulin, while plasma euglycaemic is maintained, will be better able to 
isolate and assess the tissue responsiveness to insulin in the postprandial state. 
 
 The experiments reported herein were performed with the animals under 
anesthesia. Still, this is expected not to impact negatively on the assessment of insulin 
sensitivity. Although pentobarbital anaesthesia has been reported to produce insulin 
resistance (Penicaud et al., 1987), previous studies done with the RIST showed no 
difference in glucose uptake between anesthetised and conscious rats (Latour and Lautt, 
2002b). A possible explanation is that maintaining euthermia, as was done in the present 
methodology by using a heating pad and a rectal probe, prevents the anaesthesia-
induced alterations in glucose metabolism (Holscher et al., 2008; Lang et al., 1987). 
 Animals in the postprandial state usually show a stabilisation of blood glycaemia 
at a value higher than the fasting blood glucose level. A noticeable fact on the 
anesthetised animals is that this postprandial blood glycaemia is maintained constant for 
several hours, well after it has started to fall in postprandial conscious animals. This 
may be due to an effect of the anaesthesia on delaying gastric emptying and on 
increasing the nutrients transit time through the intestine, by slower intestinal motility 
(Reynell and Spray, 1957). 
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 Gastroduodenal motor activity promotes a more consistent gastric emptying when both lipids and 
carbohydrates are present than only carbohydrates (White et al, 1983). Furthermore, an oral glucose load 
produces a slightly different profile of plasma glycaemia and insulinaemia as that seen after a mixed 
meal. 
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However, as much as the present results seem to support the HISS hypothesis as 
it was originally postulated (Lautt, 1999), alternative pathways to explain the hepatic 
activation of HISS have since been presented (Chen et al., 2003; Porszasz et al., 2003). 
The present work could not include a study of these alternative pathways; but, in light 
of the results obtained herein, a critical read of those reported results should be drawn 
next. 
 
By the first alternative hypothesis, the nervous facilitative signal would be, not 
of parasympathetic nature, but a nitrergic one. This would travel through the anterior 
hepatic plexus, by capsaicin-sensitive sensory fibres, and lead to the synthesis of hepatic 
nitric oxide of neural origin (Porszasz et al., 2002).  
The related papers promptly raise several methodological questions. Although 
recognising the importance of the postprandial status to insulin sensitivity (Zsuga et al., 
2004), the referred studies analyse the fasted state (Porszasz et al., 2003), the ad libitum 
state (Peitl et al., 2005), or fail to mention clearly the actual prandial status (Porszasz et 
al., 2002; Zsuga et al., 2004). Although the protocol and animals used were described as 
being identical to ones in the present thesis, Zsuga and colleagues (Zsuga et al., 2004) 
showed only one third of the postprandial whole-body insulin sensitivity reported here. 
Since the authors do not report allowing the animals access to food after an 18 hr fasting 
period, this seems consistent with the present data for fasted rats. More, in another study 
by the same group (Peitl et al., 2005), done in ad libitum fed rats, the magnitude of 
insulin sensitivity is only slightly lower than the one observed in the present results.  
Since the prandial status is critical for the magnitude of insulin sensitivity, this 
approach seems liable to produce confounding results. Differential prandial states 
introduce a greater variability by including animals with different degrees of HISS 
inactivation by fasting time (Lautt et al., 2001). 
Other methodology differences may also have a bearing on these discrepancies. 
The use of the hyperinsulinemic euglycemic clamp, shown to produce an inhibition of 
the HISS-dependent component (Reid et al., 2002), possibly through a sympathetic shift 
of the sympathovagal balance (Muscelli et al., 1998), can also be a confounding factor, 
as well as the possible inadequate use of the RIST by performing it in conditions that 
assess only the HISS-independent response. 
One study (Peitl et al., 2005) proposed to dispel the controversy among 
alternative pathways for the HISS mechanism. It aimed to focus on the direct effect of  
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the HPN on insulin sensitivity, by applying electrical stimulation after hepatic 
denervation. The fact that this produced an almost total elimination of postprandial 
insulin sensitivity is against any proof of principle in any other protocol. More, the 
study reported differential effects of atropine and hepatic denervation on insulin 
sensitivity; which are here shown to produce the same degree of insulin resistance on 
the fed state. It can be proposed that the abrogation of insulin sensitivity was by way of 
an increase of hepatic glucose output, and that this electrical stimulation does not mimic 
what was here seen in the physiological state. 
 
Another line of inquiry has purported to provide additional information 
regarding the existence of hepatic factors that may be relevant to diabetes therapy 
(Groop, 2003). Specifically, bone morphogenetic protein 9 (BMP-9) has been presented 
as a possible candidate for the elusive nature of HISS80 (Chen et al., 2003). More 
recently, a Brazilian group has further described details about how BMP-9 seems to 
affect glucose homeostasis (Caperuto et al., 2008). 
BMP-9 is secreted predominantly in the liver (Miller et al., 2000), and its 
expression and processing is decreased by prolonged fasting (Caperuto et al., 2008). 
Further, it has been shown to be impaired in insulin resistant animals (Caperuto et al., 
2008). Interestingly, BMP-9 has been reported as mediating increased acetylcholine 
synthesis and cholinergic action, at least in the central nervous system (Lopez-Coviella 
et al., 2000), and to need the combined arrival of glucose and insulin to the liver to be 
adequately expressed (Caperuto et al., 2008). However, BMP-9 influence on glucose 
homeostasis seems to differ from HISS in a most fundamental property. Administration 
of BMP-9 antibodies to fasted rats induces insulin resistance (Caperuto et al., 2008), 
when it was here observed that HISS manipulation in fasted animals did not produce 
any alteration on fasting insulin sensitivity; which is consistent with the hypothesis that 
HISS is only secreted in the postprandial state. 
 
Both the inadequacy between BMP-9 and HISS action characteristics, and the 
methodological confounders in the studies supporting the nitrergic hypothesis, and the 
discrepancies to the results presented herein, argue against the validity of any of these 
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 Throughout this initial paper (Chen et al, 2003), HISS is referred to more as a possible category of 
hepatic factors able to control glucose homeostasis than to a unique factor. Thus, BMP-9 is presented 
more as a HISS than as the HISS. Only after (Caperuto et al, 2008), is it presented as corresponding 
exactly to HISS, with the same mechanism proposed by Lautt (Lautt, 1999). 
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alternative proposals in explaining the postprandial insulin sensitivity potentiation 
mechanism. 
 
 The sequence of events that constitute the HISS mechanism have been well 
described in what relates to the signal generation in the liver and target location in the 
skeletal muscle (Guarino et al., 2004; Guarino and Macedo, 2006). This provides a 
metabolic pathway that theoretically can be inhibited/stimulated at several points (Sadri 
and Lautt, 1999; Xie and Lautt, 1994). As it is, this was confirmed in the present thesis. 
The given doses of the muscarinic cholinergic antagonist, atropine, and the nitric oxide 
synthase inhibitor, L-NMMA, were able to produce the same degree of insulin 
resistance as the surgical ablation of the HPN; also without changing the mean 
postprandial glycaemic value. Furthermore, it was shown that, both in control strains 
and in pathological models of insulin resistance, postprandial insulin action assessed 
after HISS blockade corresponds to the fasting insulin action. 
 
 
5.2. Modulation of insulin sensitivity by gender and developmental stage 
 
 Postprandial whole-body insulin sensitivity was here shown to be greatly 
dependent on age. More, depending on the developmental stage, this effect is due to 
alterations in the magnitude and/or dynamic profile81 of either the action of insulin per 
se or the modulation of insulin responsiveness82 by HISS (Kahn, 1978; Zhou et al., 
2006). To add another layer of complexity to the control of insulin sensitivity, and to the 
concurrent experimental design on this phenomenon, ageing seems to have a similar 
impact on male and female, but this effect progresses at different rates with age in each 
gender. 
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 The analysis of the dynamic profiles obtained provided here adittional metabolic information. A similar 
proposition has been made for the OGTT, which usually is analysed at the 2-hours endpoint (Zhou et al, 
2006).  
82
 Throughout this thesis, as in most of the bibliography, the effect of insulin on stimulating cell glucose 
uptake is generally addressed to as “insulin sensitivity”. However, since it corresponds to the study of a 
single dose of exogenous insulin (50 mU/kg), and not to a dose-response curve, it should be more 
correctly named “insulin responsiveness” (Kahn et al, 1978). In a strict sense, “insulin sensitivity” is 
rather related to the dose of insulin needed to produce half of the maximal insulin-stimulated glucose 
uptake (also known as the ED50); “insulin responsiveness” is related to the maximal effect achieved by 
insulin. According to the presented hypothesis, HISS acts on skeletal muscle by potentiating insulin-
stimulated glucose uptake, i.e. increasing the tissues responsiveness to insulin (augmenting insulin 
signalling either at the insulin receptor or at the intracellular signalling pathway). Nonetheless, for 
conceptual reasons, the choice was made to maintain the general term, inclosing this disclaimer.  
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 At 78 weeks of age, which corresponds to old age in humans83, Wistar rats show 
a similar marked decrease of whole-body insulin sensitivity in both genders, in 
comparison to young animals. However, this impairment is achieved more rapidly in 
males than in females. This may explain the observation sometimes alluded to that 
females are protected against the detrimental effects of age on insulin sensitivity. 
Indeed, female Wistar rats showed similar insulin sensitivity than males during 
maturation, but where less affected by middle-age. As pointed out, when old age was 
achieved, the females where as insulin-resistant as the males. These observations also 
stress the fact that, when conducting gender studies, the choice of subjects age can 
critically influence the results obtained concerning insulin sensitivity and glucose 
tolerance. 
 When this progress of insulin resistance is analysed by discriminating between 
the HISS-dependent and –independent components, more information surmises. During 
the earlier stage of sexual maturation, the direct effect of insulin on glucose uptake, i.e. 
the HISS-independent component, decreases. Considering that insulin plays multiple 
roles in physiology, and that one of the most important seems to be related with the 
control of growth, this may represent a reflex of changes in other pathways coordinated 
by insulin (Suryawan et al., 2001). Likewise, the HISS-dependent component changes 
during this phase of maturation, but not in magnitude. Maturation rather has an impact 
on HISS action dynamics: from 6 to 9 weeks of age, animals showed a remodelling of 
HISS action to a shorter duration but higher peak action. After 9 weeks of age, HISS 
action retains this duration, and decreases gradually in peak action.  
The development with further ageing of the two constituents of postprandial 
insulin action shows further differences. While the HISS-dependent component 
decreases gradually, the HISS-independent component is essentially maintained; which 
argues for a preservation of the basic machinery associated with insulin signalling 
transduction. This seems to be consistent with human studies, which indicate that the 
prevalence of impaired fasting glucose does not rise with age, unlike impaired glucose 
tolerance which does84 (Qiao et al., 2005). The present studies lead to the conclusion 
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 Representing, in Wistar rats, three quarters of their two-years mean life expectancy.  
84
 Furthermore, an index of insulin resistance calculated solely based on fasting values, and reflecting 
hepatic, but not peripheral, insulin sensitivity, was found to be weakly influenced by age (Qiao et al, 
2005). Again, this is consistent with the presented results, and the interpretation regarding the 
involvement of the HISS mechanism, primordially as a peripheral sensitizer, in the postprandial state.  
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that the gradual decrease of the HISS-dependent is the main responsible for the 
decreased postprandial insulin sensitivity with ageing.  
The loss of parasympathetic autonomic nerve function with age, reported 
elsewhere (Sloan et al., 2008), becomes especially relevant in the context of the HISS 
mechanism. Similarly, the observation that this parasympathetic function and a 
favourable sympathovagal balance are preserved in healthy centenarians (Paolisso et al., 
1999), who also present rather sustained glucose tolerance, again points to the critical 
importance that this pathway plays on the control of whole-body insulin sensitivity85 
(Bergman et al., 2007). 
 
 
5.3. Particular susceptibility of HISS action to the detrimental effect of modern 
dietary habits 
 
The critical effect of a HPN-dependent component decrease was again 
uncovered by a simple dietary manipulation. This diet change was intended to reflect 
the increase consumption of refined carbohydrates, even more important since it affects 
especially children and youngsters. This was achieved simply by providing the access to 
a source of sugared water. 
The sucrose supplement quickly produced the near abrogation of the HISS-
dependent component. Indeed, this effect was obtained with a mere two weeks of 
exposure to the 35% sucrose solution. Interestingly, the HISS-independent component 
of insulin action was unaffected, even after 9 weeks of exposure to the high-sucrose 
diet. 
Knowing that fructose is absorbed after being dissociated into glucose and 
fructose, and that fructose-rich diets have been implicated in the impairment of 
parasympathetic vagal function (Miller et al., 1999), it might be concluded that it is the 
fructose content that is producing the decrease in parasympathetic function and, alone or 
in conjunction with other processes, impairing HISS action.  
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 Rather than looking solely for characteristics that predispose for ageing-related metabolic deregulation, 
the genetic makeup of high-longevity individuals is being studied in an attempt to identify favourable 
genotypes which confer protection against the influence of age-related disease genes (Bergman et al, 
2007). It can be expected that genes that contribute to preserve or augment parasympathetic function must 
be among this group.  
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Diet-induced insulin resistance has been proposed to precede other aspects of the 
metabolic syndrome (Barnard et al., 1998), this puts into a renewed perspective the 
proposition that what the changes in modern lifestyle habits are doing is merely 
accelerating the effect of ageing on glucose homeostasis (Levi and Werman, 1998), and 
favouring the appearance of other pathologies. The present results highlight the 
hypothesis that this happens through the impairment of the HISS pathway control on 
postprandial insulin sensitivity. 
 
 
5.4. Clarification of the relation between insulin resistance and hypertension 
through the study of the HISS-dependent and –independent components     
 
 Hypertension is indicated as a common element of the metabolic syndrome. 
However, even before this cluster develops, when defects of insulin sensitivity first 
become visible, hypertension is one of the associated diseases that reach full expression 
before glucose intolerance progresses (Facchini et al., 2001; Shanik et al., 2008). To 
study the relation between insulin resistance and hypertension, the SHR, the most 
common animal model for hypertension studies, was used. 
 Early contradictory studies led to the present use of two normotensive controls, 
the Wistar and the Wistar Kyoto. This showed that the normotensive Wistar Kyoto were 
as insulin-resistant as the SHR, when compared with Wistar rats. This argued for a 
secondary role of hypertension in this animal model of insulin resistance. When the two 
components of insulin action were studied, it became evident that here too the decrease 
of postprandial insulin sensitivity was solely due to an impairment of the HISS-
dependent component. This impairment was even more marked in the hypertensive 
animals. This was not immediately seen when total postprandial insulin action had been 
assessed, since in this strain there is a compensatory increase of the HISS-independent 
component. The HISS pathway dysfunction seems thus to be connected to a genetic 
factor common among Wistar Kyoto and SHR; which effect is aggravated 
concomitantly with the presence of hypertension. 
Interestingly, the results provided by the analysis of the Wistar Kyoto may show 
an unexpected relevance in regard to human pathophysiology, and the HISS connection; 
especially in the case of young normotensive offspring of hypertensive parents. These 
healthy offspring tend to present decreased insulin sensitivity (Beatty et al., 1993; 
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Pazarloglou et al., 2007; Vlasakova et al., 2004), and to develop glucose intolerance 
(Ferrari et al., 1991). Indeed, normotensive offspring of hypertensive subjects have been 
shown to have lowered parasympathetic activity (Davrath et al., 2003; Piccirillo et al., 
2000). This fact has also been shown to be independent of the development of obesity 
(Allemann et al., 1993), a common confounding factor in the relation between insulin 
resistance and hypertension; which was here excluded by the choice of SHR animal 
model. This suggests the presence of a HISS action dysfunction in these individuals; 
further aggravated when hypertension becomes present.  
The search for genes related to the predisposition to type 2 diabetes has been 
pursued for quite some time now (Beck-Nielsen and Groop, 1994; Ridderstrale and 
Groop, 2009). It seems thus opened the hypothesis that this search might be extended to 
the genetics of the HISS-dependent component of insulin action. The genetic analysis of 
the SHR strain has already been initiated (Pravenec et al., 2004). 
 
 The development of hypertension has been related to a previous poorer 
autonomic nervous system control (Chandler and DiCarlo, 1998; Schroeder et al., 
2003), that may determine the decrease of HISS action. Indeed, the most relevant factor 
to the development of hypertension during maturation seems to be an increased 
contribution of the sympathetic nervous system (Zicha and Kunes, 1999), which would 
be expected to interfere also with the parasympathetic-controlled HISS pathway. 
However, the hypertensive state has similarly been associated with the disruption of the 
physiological action of compounds also involved on the HISS pathway; as nitric oxide 
and glutathione (Lepori et al., 2001). That HISS action worsens from the Wistar Kyoto 
to the SHR lifted the hypothesis that these other dysfunctions could have a synergistic 
effect on producing insulin resistance. 
 
The dysfunction of nitric oxide in insulin resistant states is considered a 
conundrum. Although nitric oxide action is decreased, its production seems rather to be 
increased, in type 2 diabetics (Chien et al., 2005); and even in prediabetic, insulin-
resistant offspring of type 2 diabetics (Piatti et al., 2000). This may be explained by an 
impairment of nitric oxide bioavalability (Hollenberg, 2006). More, nitric oxide seems 
to have a dual role; either being responsible for protecting tissues through neutralising 
reactive oxygen species or for favouring oxidative stress by increasing reactive nitrogen 
oxide species, apparently depending on its concentration (Wink et al., 2001). The later, 
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deleterious, effect may be related to the triggering of inflammatory and immunological 
responses86 (Sarela et al., 1999; Wei et al., 2005).  
However, in the present work, hepatic nitric oxide inhibition did not produce a 
further impairment of insulin sensitivity than the one attributable to its participation on 
the HISS pathway. Again, a causal relation is difficult to be established. 
 
Here, insulin sensitivity after nitric oxide blockade was assessed at a time when 
the effect of the inhibitor on blood pressure had already waned. The idea that the 
involvement of nitric oxide in insulin sensitivity is mostly segregated from its effect on 
hemodynamic control seems to be supported by several reversal studies. Changes of 
blood flow achieved with a nitric oxide donor do not ameliorate glucose uptake (Natali 
et al., 1998). Analogously, other drugs induce changes in insulin sensitivity but not on 
blood pressure in hypertensive (Santure et al., 2000). 
 
Glutathione is another compound with multiple physiological functions. It has 
been proposed that control of GSH efflux by insulin and glucagon may provide a 
balance between the several functions of GSH on glucose metabolism, antioxidant 
defence, and cysteine reservoir for use in other tissues (Lu et al., 1991). Nonetheless, 
control of GSH synthesis in the liver may also provide a balance between glucose 
metabolism, antioxidant defence, and acute-phase proteins synthesis within the liver 
proper (Lu et al., 1991). However, albeit hepatic GSH has been shown to be essential 
for the postprandial activation of the HISS pathway, the presented results suggest that it 
is not limiting in the dysfunction of the HISS-dependent component seen in 
hypertension. 
 
 After maturation, all three strains present similar total postprandial insulin 
sensitivity. In SHR, with the time of exposure to hypertension, the HISS-dependent 
component virtually disappears; which is accompanied by a further compensatory 
increase in the HISS-independent component. In the normotensive Wistar Kyoto, no 
alteration in either the HISS-dependent or –independent components was observed. This 
                                               
86
 This would also support the hypothesis of a balance between the constitutive and inducible isoforms of 
nitric oxide synthase, which would influence insulin-stimulated glucose uptake, through the modulation 
of HISS action. Indeed, livers from cirrhotic patients show decreased constitutive NOS activity, while 
inducible NOS activity is similar to normal individuals (Sarela et al, 1999). The increased iNOS is 
expected only in later disease stages, in parallel with an inflammatory response (Wei et al, 2005). 
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was not surprising, when the result for the other normotensive control was considered. 
Indeed, in Wistar the HISS-independent component remained unchanged, while the 
HISS-dependent component decreased, to a value similar to the one presented by Wistar 
Kyoto at both 9 and 16 weeks of age. Thus, again the progression of insulin resistance 
in these pathologies seems to be an acceleration of the normal ageing deleterious effect 
on HISS-dependent insulin sensitivity, either the organism is able to compensate or not 
for that insulin resistance. 
Interestingly, autonomic nervous system control, which is lower even during the 
development of hypertension, deteriorates with age more in normotensive than in 
hypertensive subjects (Schroeder et al., 2003). This may contribute, and even explain, 
the relative age alterations of the HISS-dependent component of insulin action between 
the three animal strains. 
 
It has been described that insulin leads, in elderly individuals, to 
vasoconstriction; when in young individuals it produces vasodilation through the 
production of nitric oxide in the endothelium (Hausberg et al., 1997). This led several 
researchers to postulate that the decrease of whole-body insulin sensitivity with age is 
related to a lack of proper distribution of insulin and glucose to the skeletal muscle cells 
(Baron et al., 2000). The vascular properties of insulin would thus regulate the ability to 
exert its metabolic functions. Other authors maintain that insulin indeed plays a role in 
the regulation of blood pressure, but that this effect is not a determinant in skeletal 
muscle glucose uptake (Scherrer et al., 1994).  
The results presented here show that the action of insulin per se on tissue 
glucose uptake, both in normal and disease animal models, is essentially maintained or 
even augmented. In contrast to this preservation, the neurohumoral mechanism by 
which whole-body is potentiated after a meal ingestion was revealed to be extremely 
vulnerable. Consequently, these results support the notion of separately controlled 
effects of insulin on glucose metabolism and blood pressure control. 
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5.5. The HISS pathway as a new paradigm in the cluster of hepatic disease, 
autonomic dysfunction, insulin resistance, and type 2 diabetes 
 
 It is well established that liver disease is accompanied by defects in whole-body 
glucose homeostasis (Tsochatzis et al., 2009), and that it can be a determining factor in 
the metabolic syndrome cluster (Haffner, 2006). Surprisingly, the initial stages of liver 
dysfunction are related not with hepatic insulin resistance, as would be expected, but to 
a decrease in peripheral insulin sensitivity; having been attributed to a decrease in 
glucose uptake and glycogen synthesis in the skeletal muscle (Selberg et al., 1993). 
Only after, defects in hepatic glucose output suppression and insulin secretion 
determine the progression to type 2 diabetes (Perseghin et al., 2000). Interestingly, this 
same behaviour is uncannily similar to the progress seen from impaired glucose 
tolerance to type 2 diabetes; specifically when insulin hypersecretion fails or is unable 
to further compensate for the insulin resistance in skeletal muscle and adipose tissue 
(Kido et al., 2000). 
The progression of liver disease seems to be also accompanied by radical 
changes in autonomic nervous system control. The increase in parasympathetic nervous 
tone from fasting to the postprandial state is quickly lost. On the other hand, the 
sympathovagal balance is preserved in early stages of the disease; both the basal ratio 
during fasting as well as the decrease of this ratio with food ingestion. However, in 
latter stages, there is an imbalance towards greater sympathetic dominance, which is 
even worsened in the postprandial state (Miyajima et al., 2001). 
This is consistent with the observation that liver injury leads to HISS 
dysfunction (Ming et al., 2006). The elements that can impact on HISS action are 
multiple, as shown herein. Further, they seem to have a cumulative effect. For example, 
a state of emotional stress leads to a worsened metabolic state of hypertensive subjects 
(Piccirillo et al., 1998b). Indeed, loss of parasympathetic tone has been proposed as a 
possible mechanistic link between the stressful outcome of low socioeconomic status 
and poor health (Hemingway et al., 2005; Sloan et al., 2005). Similarly, the state of 
insulin resistance in essential hypertension can be further aggravated by nutritional 
factors (Uchida et al., 1997). 
The aetiological importance of the decrease in hepatic parasympathetic nerve 
function to this cluster may perhaps be illustrated by the fact that insulin resistant, but 
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yet glucose tolerant, offspring of type 2 diabetic patients have been reported to show 
already an impairment of the parasympathetic nervous system (Frontoni et al., 2003). 
 
Taking into account the present results, the relation between the health status of 
the liver and hepatic parasympathetic nerves, and glucose homeostasis, seems to be far 
from coincidental. Additionally, the dysfunction of other steps of the HISS pathway 
may contribute to a general impairment of this mechanism. 
Recent studies, with administration of drugs that prevented the rise of oxidative 
stress, were able to avoid the loss of the HISS-dependent component of insulin action 
seen with ageing (Lautt et al., 2008). This importance of oxidative stress with ageing 
has been recognised to impair cysteine availability and/or GSH synthesis (Liu and Choi, 
2000) in parallel with insulin resistance (Droge, 2005; Droge and Kinscherf, 2008); 
which is consistent with the hypothesis of HISS decrease with age. Interestingly, the 
degradation of nerve conduction seen in glucose intolerance states (Viswanathan et al., 
2004) seems to be prevented by a pharmacological intervention able to address the 
aforementioned problem (Soneru et al., 1997). 
Likewise, the impairment of HISS action in animals provided a high-sucrose diet 
was recently reverted by pharmacologically mimicking both feeding signals (Lautt et 
al., 2009). Interestingly, although full recovery of HISS action was only possible with 
the simultaneous administration of both drugs (bethanechol and n-acetylcysteine), the 
parasympathetic agonist showed to produce by itself a partial improvement of 
postprandial insulin sensitivity. Other authors showed that high-sucrose diets produce a 
decrease in nitric oxide bioavailability at the onset of insulin resistance (Blouet et al., 
2007b), with postprandial glucose disposal being then ameliorated by dietary cysteine 
(Blouet et al., 2007a; Blouet et al., 2007c). 
  
 Although the chemical nature of the HISS molecule remains elusive, some of the 
characteristics of its formation and action mechanism may be speculated upon.  
 The two feeding signals are essential for the possibility of HISS action, either by 
determining its formation (as seems to be the case with cysteine to GSH synthesis) 
and/or release. However, the hypoglycaemic effect of HISS is felt on whole-body 
homeostasis only when circulating levels of insulin are increased. This raises the 
hypothesis that HISS formation is dependent upon a processing of insulin itself; 
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possibly related to the combination of GSH and nitric oxide in the liver. Indeed, insulin 
chains have been shown to be able to undergo nitrosylation (Santos et al., 2006). 
 Insulin is known to only be able to determine some of its functions when 
degraded, after being internalised while bound to the insulin receptor (Fawcett et al., 
2001). Insulin degradation is promoted by IDE. Further, hepatic IDE activity is 
increased by rising circulating insulin levels (Pivovarova et al., 2009). Thus, the rise in 
insulin in the postprandial state leads to an increase of the availability of insulin chains 
within hepatocytes; where they might be nitrosylated by increased GSH and nitric 
oxide. The ultimate fate of insulin within the hepatocyte, degradation or reprocessing, 
may be determined by the modulation of IDE by nitric oxide (Cordes et al., 2009). 
 
 In response to a meal, insulin levels rise. This insulin can produce alterations in 
the hepatocyte membrane; leading to the formation of caveolin-rich membrane domains, 
where insulin receptors are also located (Balbis et al., 2004; Vainio et al., 2002). After, 
activated insulin receptors migrate from the lipid rafts in microvilli to clathrin-coated 
pits, where they are internalised to endosomes (Carpentier et al., 1993).  
 The eNOS isoform has also been reported as being co-localised with caveolin at 
the intracellular side of the hepatocyte membrane (Jobgen et al., 2006; Viaro et al., 
2000). Postprandial acetylcholine release by hepatic parasympathetic nerves can bind to 
muscarinic receptors in the cell membrane and lead to the intracellular release of 
calcium. This activates calmodulin, which releases the eNOS from being bound to 
caveolin, and allows the production of NO (Shah et al., 2007). Additionally, increases in 
insulin and cysteine promote the synthesis of hepatic GSH (Kim and Reaven, 2004; 
Kwon and Stipanuk, 2001). Thus, insulin would be cleaved by endosomal IDE in 
concert with PDI (Jung and Thomas, 1996), with GSH as a co-substrate (Turano et al., 
2002) and a determinant of the processing pathway followed by insulin (Morgan et al., 
1985); with the simultaneous nitrosylation of the insulin fragments. Insulin molecules 
and fragments are then released into the bloodstream when the insulin receptor is 
recycled to the cell surface (Duckworth et al., 1998). 
This proposed mechanism would also explain certain defects in the HISS 
pathway. For example, increased lipid deposition may induce changes in the membrane 
lipid content, altering the relation of the insulin receptor with the lipid rafts (Vainio et 
al., 2005). Also, in liver disease, eNOS seems to be translocated away from the 
hepatocyte membrane to the nuclei (McNaughton et al., 2002), which could entail a 
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decrease in HISS synthesis. That hepatic IDE activity is inhibited by excessive 
glycaemia (Fawcett and Duckworth, 2009) hints to a possible mechanism by which a 
marginally impaired postprandial glucose disposal would exacerbate HISS dysfunction 
in a vicious cycle. GSH may also have a secondary role in HISS synthesis, by 
preserving IDE and PDI activities (Carbone et al., 2005). Indeed, they seem easily 
disruptible by thiol-alkylating compounds (Neant-Fery et al., 2008); which makes it 
particularly sensitive to oxidative stress. 
Additionally, conditions where postprandial hepatic insulin extraction is altered 
in response to peripheral insulin resistance (Hojlund et al., 2006), as ageing (Basu et al., 
2006; Matveyenko et al., 2008), hypertension (Burattini et al., 2009; Salvatore et al., 
1992), obesity (Valera Mora et al., 2003), and liver disease (Goto et al., 1995; Letiexhe 
et al., 1993) and transplantation (Schneiter et al., 2000a), may contribute to change 
intrahepatic insulin availability and synthesis of HISS. 
 
 The mode of transportation of HISS through the bloodstream to reach the target 
tissue, the skeletal muscle, is less clear, although it can be proposed to be in association 
with a carrier protein. Indeed, nitric oxide is able to circulate as an S-nitroso adduct of 
serum albumin (Di Simplicio et al., 2003; Stamler, 2004; Stamler et al., 1992).  
Once reaching the skeletal muscle, the HISS molecule would act either directly 
on the insulin receptor87, or through a specific receptor. In this respect, it has been 
shown that surface-bound PDI catalyses the transfer of the nitric oxide carried by 
extracellular S-nitrosothiols into intracellular thiols (Ramachandran et al., 2001; Zai et 
al., 1999). Consistent with the HISS hypothesis, endogenously-produced nitric oxide 
has been shown to induce effects in organs distant from the organ site of expression 
(Elrod et al., 2008).  
It seems thus possible that HISS is produced in the liver, in result of the balance 
between several nutrient signals, and that it travels through the bloodstream to 
ultimately potentiate insulin-stimulated glucose uptake at the skeletal muscle. 
 
 
 
 
                                               
87
 The insulin fragments that are released through retroendocytosis have been reported to maintain 
receptor binding and biological activity (Duckworth, 1998).  
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5.6. Conclusion and implications 
 
Type 2 diabetes is today a global problem (Yach et al., 2004). Each 10 seconds 
two more patients are diagnosed worldwide; with a particular impact on the working 
age population, in developed and developing countries alike (Siegel and Narayan, 
2008). There has been a debate about the feasibility of doing a population-wide 
screening for undiagnosed diabetes and prediabetes (Waugh et al., 2007). The present 
results argue that a crucial risk factor for metabolic deregulation, the dysfunctional 
HISS action (Lautt, 2007), is settled well before the emergence of alterations in blood 
glycaemia, arterial pressure, or body weight. The early detection of this dysfunction in 
asymptomatic individuals would most likely be ultimately cost effective, and would 
greatly decrease the morbidity and mortality that derive from type 2 diabetes and 
accompanying pathologies. 
Furthermore, the increased pressure to sanction HbA1c status as the criteria for 
the diagnosis of diabetes (ADA, 2010), and the attempt to eradicate the concept of 
prediabetes - with its different aetiologies that may impact on the success of preventive 
measures (Faerch et al., 2009) - from the clinical practice (TIEC, 2009), raises the 
concern that interventions will be applied more and more at a latter stage of glucose 
homeostasis deregulation; perhaps when HISS function, and postprandial incremental 
insulin sensitivity, are already mainly irrecoverable. 
 
The insulin signalling pathway in peripheral tissues was here shown to be more 
robust than most studies lead us to believe for the last three decades. Well before 
changes of the direct action of this energy regulatory hormone on insulin-sensitive 
tissues occurs, the postprandial potentiation provided for by the HISS pathway is 
impaired, or even absolutely lost. 
 Although genetic defects have been shown to be able to determine the 
impairment of the insulin pathway at a distal point common to both HISS-dependent 
and –independent components (Afonso et al., 2007b), other genetic factors, and the 
majority of environmental manipulations, lead to whole-body insulin resistance 
primarily by the dysfunction of the HISS-dependent component of insulin action 
(Afonso et al., 2007a; Lautt, 2007; Ribeiro et al., 2008; Ribeiro et al., 2007; Ribeiro et 
al., 2001; Ribeiro et al., 2005). 
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Figure 30 – Integrative view: from hepatic insulin sensitising substance (HISS) dysfunction to 
progression to type 2 diabetes. Conditions highlighted in the present studies, as inadequate diet, ageing, 
and possibly genetic predisposition, lead, by several mechanisms, like parasympathetic dysautonomia, to 
HISS dysfunction. This induces selective postprandial insulin resistance; with slower disposal of 
absorbed glucose in peripheral tissues, excessive glucose excursions, and hyperinsulinemia. Oxidative 
stress may worsen HISS action. Hypertension is likewise related to hyperinsulinemia and a detriment in 
parasympathetic autonomic function. Exposure to postprandial glucose intolerance favours the 
development of perpetual insulin resistance. Insulin needs and glucotoxicity contribute ultimately to the 
collapse of β-cells, and establishment of type 2 diabetes. 
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 Figure 30 integrates the dysfunction of the HISS mechanism with the 
progression to type 2 diabetes, with special emphasis on the pathologies addressed in 
the present thesis. 
 
Behavioural interventions, like nutritional control and physical activity, have 
been at the forefront of the effort for delaying the development of type 2 diabetes; 
especially in individuals with recognised risk factors (Carnethon et al., 2003a; Roumen 
et al., 2008). The fact that these activities have been described to ameliorate 
parasympathetic function (Hirsch et al., 1991; Nagai and Moritani, 2004; Wichi et al., 
2009) provides a link between them and HISS action; and highlights even more 
eloquently the impact of lifestyle in a time where overall glucose metabolism seems still 
normal. 
Drug therapy has also become an important support for addressing the 
development of type 2 diabetes (Cefalu, 2007; Hays et al., 2008). However, it has been 
described as being directed to effects rather than causes of type 2 diabetes, and to have 
several side effects associated (Moller, 2001). It should be undoubtedly more favourable 
to direct these efforts address the earlier defects in glucose homeostasis, as seems the 
case with the impairment of the HISS-dependent component of insulin action by genetic 
and environmental factors. 
 
The HISS mechanism was shown to be responsible for the increment of insulin 
sensitivity seen in the postprandial state. Here, both the hepatic parasympathetic nerves 
and hepatic nitric oxide were confirmed as vital elements in this pathway. 
The loss of HISS action happens naturally during the ageing process. 
Additionally, nutritional factors can accelerate that loss. Likewise, genetic factors seem 
to be able to diminish HISS action in healthy animals; with a further lessening if 
hypertension is present.   
Further, the analysis of these pathological animal models has lead to the 
conclusion that the dysfunction of the HISS pathway predates the development of 
obesity and hyperglycaemia. 
For all this, the observed HISS dysfunction seems to lay at the ontogeny of 
insulin resistance, and of the alteration of postprandial glucose fluxes; which may be at 
the base of type 2 diabetes and the metabolic syndrome. This strengthens the notion that 
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the HISS pathway is an attractive target for behavioural and pharmacological 
interventions; especially those that show to be able to ameliorate autonomic 
parasympathetic nervous function. 
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